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Abstract 
Animal experiments have been the standard method to assess the safety of chemicals used 
in cosmetic products for decades. However, public opinion has continued to demand that 
in vivo hazard identification methods conducted on animals are replaced with alternative 
methods. Research on alternative methods to replace in vivo toxicity testing continually 
increased over the past few decades with different alternatives developed, such as in vitro, 
in chemico and in silico approaches.   
Although different alternative techniques can be employed, no single technique can solely 
replace the complexity and an in vivo test, especially for chronic effects. Therefore, 
integrated testing strategies that can utilise the information from all available alternative 
testing approaches have been developed. Within the Adverse Outcome Pathway (AOP) 
paradigm, the molecular initiating event(s) MIE can be induced by several chemical key 
features which can be captured by structural alerts. When structural alerts for a MIE are 
compiled and supported by mechanistic and toxicity information confirming the induction 
of the same MIE, then they can be considered as an in silico profiler. 
The overall aim of the work presented in this thesis was to assess the current in silico 
profilers for carcinogenicity (both genotoxic and non-genotoxic), mutagenicity and skin 
sensitisation through assessment using multiple high-quality experimental databases. The 
research presented herein demonstrates the ability to assess the positive predictivity of two 
types of structural alert, mechanism- and chemistry-based that pertain to the endpoints and 
proposes ways to improve the overall accuracy of these profilers. In this context, this study 
has given an insight to those alerts that may be found equally in endpoint-positive or 
negative compounds, and those which may be more effectively utilised to form groups of 
analogues for read across predictions. A detailed analysis of positive predictivity of the 
available mutagenicity, carcinogenicity and skin sensitisation structural alerts and profilers 
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within the OECD QSAR Toolbox against experimental data is presented. This 
investigation showed the structural alerts that are accurate as such, and those that may need 
further refinement, or their use may need to be reconsidered. In addition, the relationship 
between scaffolds of a range of diverse compounds and carcinogenicity showed that a total 
of 17 carcinogenicity scaffolds could be identified from the available databases and could 
be used as a base for an in silico profiler. 
This work has also determined the need for further in-depth research in this area to study 
the suitability and merits of each of the alerts within the profilers currently included in the 
OECD QSAR Toolbox, and other in silico toxicity platforms, to identify the possibilities 
for improvement in their performance. This will, by implication, also improve the 
reliability of chemical read-across and grouping/categorisation for classification, labelling 
and risk assessment for regulatory use of the in silico methods.   
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 Chapter 1: Introduction 
Cosmetics and personal care products are amongst the everyday consumer products that are 
used by the vast majority of world’s population. Whilst they offer a number of aesthetic benefits, 
the intimate nature of their application on the body, and repeated exposures due to frequent use, 
mean that the presence of any harmful substance in a cosmetic product can also pose a risk of 
adverse health effects to the user. Ensuring safety of cosmetics is therefore of utmost 
importance for both the industry and the regulatory authorities. Whilst the range of cosmetic 
products is seemingly endless, they can be broadly categorised as oral-care (e.g. toothpaste, 
mouthwash), hair-care (e.g. shampoo/conditioner, hair dye), skin-care (e.g. lotion, cream), 
make-up (e.g. mascara, lipstick), deodorant/antiperspirant, perfume and fragrance products.   
 
1.1: Risk assessment and risk management 
Risk assessment and risk management are crucial elements for the development of a cosmetic 
product that help to assess and mitigate possible adverse health effects to consumers. At the 
regulatory level, these two issues are kept independent of each other. The outcome of risk 
assessment, however, provides a basis for devising appropriate risk management strategies. 
Generally, risk assessment of a cosmetic ingredient requires data and information on the 
following aspects: 
- The physicochemical characterisation of the ingredients intended to be used in a cosmetic 
product. The knowledge of physicochemical properties of the substance may provide useful 
pointers to its potential behaviour, interactions and effects in biological systems.  
- The identification and dose‒response characterisation of toxicological hazards. The 
toxicological endpoints measured for risk assessment relate to both the local and systemic 
effects that may manifest over short, medium or long terms. 
Chapter 1 
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- An exposure assessment for reasonably foreseen conditions of use. This includes 
assessment of both external exposure and internal (systemic) exposure. The latter is usually 
derived from the external exposure on the basis of the level of absorption through relevant 
routes (dermal, oral, and/or inhalation) and distribution through the body. 
All of the above data and information are used together to assess the overall risk to an average 
consumer, keeping in mind certain vulnerable groups - such as infants and children. 
Amongst the toxicological endpoints that are studied for the safety assessment of cosmetics, 
carcinogenicity is one of the most difficult to measure or predict accurately. Historically, 
testing for carcinogenicity of cosmetic ingredients has been performed using the rodent 
carcinogenicity assay (OECD 2008), whilst organ level toxicity is studied in rodents using 28 
day or 90-day using repeated-dose exposures (OECD 1995, OECD 1998). These studies are 
also used to derive a No Observed (Adverse) Effect Level (NO(A)EL), which is “the highest 
exposure level at which there are no biologically significant increases in frequency or severity 
of adverse effects between the exposed population and it appropriate control.” (EPA 1995, 
Lewis et al. 2002). For instance, a 28 or 90-day inhalation, oral or dermal repeated dose study 
in rodents can provide data to derive a N(O)AEL value for use in risk assessment. Where some 
effects are observed in these tests, a Lowest Observed (Adverse) Effect Level (LO(A)EL) may, 
instead, be derived. The LO(A)EL is “the lowest exposure level at which there are biologically 
significant increases in frequency or severity of adverse effects between the exposed population 
and its appropriate control group.” (EPA 1995, Lewis et al. 2002). The NO(A)EL value (or 
the LO(A)EL value after applying appropriate safety factor) is used along with the estimates 
of internal (systemic) exposure to estimate the Margin of Safety (MoS) for the specific 
substance. In view of the possible toxicokinetics/ toxicodynamics differences between the test 
species (generally rodents) and humans, and the variability within the human population, an 
Chapter 1 
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uncertainty factor of 100 (10 x 10 respectively) is generally applied and substances with a MoS 
equal to, or greater than, 100 are considered safe for use in cosmetic products.     
 
1.2: European Union regulation 
In Europe, safety of cosmetics is regulated under the European Union’s Cosmetic Regulation 
[Regulation (EC) No 1223/2009]. Article 2 of the Regulation regards a cosmetic product as a 
substance or mixture intended to be placed in contact with the external parts of the human body 
(epidermis, hair system, nails, lips and external genital organs) or with the teeth and the mucous 
membranes of the oral cavity with the exclusive or main purpose of cleaning or perfuming 
them, changing their appearance, protecting them, keeping them in good condition or 
correcting body odours.  
In Europe, safety assessment of cosmetics is carried out by industry, which is then assessed by 
the regulatory authorities. At the industry level, all the information relating to safety is 
maintained in a Product Information File (PIF) by the company’s Responsible Person (RP). At 
the regulatory level, the safety of cosmetic ingredients is overseen by the European 
Commission, whereas that of the final products by competent authorities in the European Union 
(EU) Member States. The European regulatory framework for cosmetic safety requires pre-
market notification of the intended use of any ingredients that fall within the regulated 
categories (the so-called Annex substances), assessment of the safety, regulatory approval and 
appropriate labelling of the final products.  
The safety data on cosmetic ingredients submitted to the European Commission are reviewed 
by a committee of independent experts (the Scientific Committee on Consumer Safety (SCCS)), 
who advise the Commission on the safety of the substance. Depending on level of the assessed 
risk to the consumer, the Commission may allow an ingredient at the levels proposed by the 
Chapter 1 
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industry, allow it with restrictions on the use levels or the types of uses, or ban its use in 
cosmetic products. As such, the Commission may place a cosmetic ingredient in one of the 
Annexes of Regulation (EC) 1223/2009: Annex II (list of prohibited substances); Annex III 
(list of restricted substances III); Annex IV (list of colourants); Annex V (list of preservatives; 
or Annex VI (list of UV-filters). 
Since 11 March 2013, the EU Cosmetic Regulation has banned animal testing of any cosmetic 
ingredient or a finished product in the EU, as well as the marketing of any cosmetic 
ingredient/product that has been tested on animals after the ban took force. This has placed a 
lot of emphasis on alternative non-animal methods to obtain data and information for risk 
assessment (Rogiers, 2019). 
 
The Registration, Evaluation, Authorisation and restriction of Chemicals (REACH) is another 
(and most influential) EU regulatory framework relating to safety of the workers and the 
environment from the chemicals that are produced and/or used at industrial scales. Since 
implementation in 2007, REACH has progressed in various phases on the basis of tonnage of 
the chemicals produced and now requires that substances imported or produced in the EU at 
one tonne per year or more should be registered with the European Chemicals Agency (EChA). 
Some cosmetic ingredients are produced or imported into the EU at high tonnages and hence 
will also be safety assessed under REACH based on data relating to physicochemical properties, 
toxicological effects and estimates of exposure. REACH also encourages the use of alternatives 
methods and the use of animal experimentation only as the last resort. Part of this is due to the 
commitment to the so-called '3Rs' principle (Reduction, Refinement, and Replacement of 
animals used in laboratory procedures) (Russell and Burch 1959).  
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1.3: Toxicological testing of cosmetic ingredients 
Toxicology is an inter-disciplinary subject that brings knowledge together from chemistry, 
pharmacology and biology. The harmful effect(s) of a test chemical observed at the organism, 
organ, (sub)cellular or molecular level are termed the toxic endpoint or adverse effect/ outcome. 
Determining the nature and the extent of an adverse effect is generally based on: 
a. Data from tests conducted in vivo on animals (e.g. rodents), as well as the information 
drawn from epidemiological studies or clinical trials on human volunteers. These data 
provide a basis for determining the levels below which the substance may be considered 
non-toxic (such as the NOAEL). 
b. Data from tests carried out in vitro using cultures of bacterial, animal or human cells, 
cultured tissues or organoids. 
c. Estimates drawn from computational (in silico) models that are based on structure-
activity rules, algorithms and / or structural alerts for toxic potential that have been 
derived from experimental data on related group(s) of chemicals. Such models allow 
for the prediction of toxicity of untested substances. 
In vivo testing has long been considered the most appropriate method for toxicological 
assessment of chemical substances to predict their potential effects in humans – albeit with 
consideration of the relevance of animal data to humans due to interspecies differences. 
Toxicological data for cosmetic safety assessment have also been historically derived from 
tests on animals in the form of measured values against specific endpoints that depict both 
short- and long-term effects in humans. These included: 
• dermal/ percutaneous absorption; toxicokinetics; acute toxicity; irritation and corrosivity 
(skin and eye); skin sensitisation; mutagenicity/genotoxicity; repeated dose toxicity; 
Chapter 1 
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• where data indicated potential long term effects, further studies on carcinogenicity and 
reproductive toxicity could be required;  
• data on photo-toxicity may be required for substances that are photo-reactive and the final 
products are intended for application on the skin exposed to sunlight;  
• where available, data from exposure to humans, e.g. data from epidemiological studies or 
clinical trials are also taken into consideration.  
 
1.4: Testing for carcinogenicity, mutagenicity or reproductive toxicity 
Although the toxicological data required for safety assessment of cosmetic ingredients cover a 
range of short- and long-term endpoints, more emphasis is placed on identifying and avoiding 
the use of those substances that may be Carcinogenic, Mutagenic or Reproductive toxicants 
(so-called “CMRs”), or may be persistent and accumulative in the body. This is because acute 
and short-term toxic effects are relatively straightforward to detect and mitigate, unlike long-
term effects, such as the risk of cancer. The current classification of CMR substances used in 
the EU is as follows: 
• Carcinogenic substances are categorised either as 1A (known to have carcinogenic potential 
for humans), 1B (presumed to have carcinogenic potential for humans); or 2 (suspected 
human carcinogen). 
• Mutagenic substances are categorised either as 1A (known to induce heritable mutations in 
the germ cells of humans); 1B (can induce heritable mutations in the germ cells of humans); 
or 2 (may cause concern for humans owing to the possibility to induce heritable mutations 
in the germ cells of humans). 
• Reproductive toxicants are categorised either as 1A (known human reproductive toxicant); 
1B (presumed human reproductive toxicant); or 2 (suspected human reproductive toxicant) 
Chapter 1 
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Under the current regulations, CMR 2 substances may be allowed in cosmetic products where 
they, in view of the exposure and concentration, have been found safe. CMR 1A or 1B 
substances are allowed only in exceptional cases that is when they comply with food safety 
requirements, inter alia as a result of their natural-occurrence in food, and that no suitable 
alternative substances exist, on the condition that such use has also been found safe (see 
Chapter 4 for more details). 
 
1.5: Alternative (non-animal) methods 
With the animal testing/marketing ban for cosmetic products under the EU Cosmetic 
Regulation, and emphasis on the 3Rs principles under other regulatory frameworks, there is an 
increasing focus on the use of alternative (non-animal) methods to obtain toxicological data for 
safety assessment (Balls, 2019). This is, in part, due to ethical reasons over, and public pressure 
opposing, the use of animals to assess the toxicity of chemicals (including cosmetic 
ingredients). In addition, scientific progress is driving the change with new approaches to 
toxicology that are more relevant to humans as well as environmental species. In particular, 
non-testing methods, such as in silico models and tools, provide a far cheaper and quicker 
option for the primary screening of chemicals for hazard identification compared to other 
methods. For instance, the average cost of a 90-day repeat-dose rodent study for a single 
chemical can be between $125,000-175,000 and requires the use of approximately 80 animals. 
Testing for long-term effects - such as carcinogenicity - may cost many times that amount. 
Thus, the use of alternatives non-animal methods offers the opportunity to reduce the cost of 
product development, the use of animals in toxicological studies, and can make the hazard 
identification process more rapid (Worth, 2019).  
By banning in vivo testing of cosmetics under Cosmetic Regulation, the EU has opened the 
door for the use of scientifically-valid alternative methods. The main approaches used for this 
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purpose are based on in vitro tests using cultures of cells, tissues or organoids, in chemico 
approaches and computational (in silico) models that are based on structure-activity based rules, 
algorithms, and structural alerts (EC 2003, EC 2006, EC 2006). The capacity of a molecule to 
react and covalently link with significant biological macromolecules, such as proteins, is 
studied by in chemico testing. An example of this technique is the measurement of the 
capability of a compound to bind to a thiol group, such as contained on the amino acid cysteine, 
by the depletion of glutathione in a standard assay (Aptula et al. 2006). In vitro assays provide 
another non-animal route to assessment of toxicological hazards. The bacterial Ames Test is 
an example of an in vitro technique which is used to assess the mutagenic potential of 
compounds with the use of a mutant strain of the bacterium Salmonella typhimurium which is 
not able to generate histidine but will revert back to the wild type in the presence of a mutagen 
(Ames et al. 1973, OECD 1997). A range of in silico models and tools that can estimate 
different toxicological endpoints, e.g. mutagenicity, skin sensitisation, teratogenicity (Enoch et 
al. 2008a, Enoch et al. 2008b, Enoch et al. 2009, Enoch et al. 2011a) is now available. These 
are used to derive toxicity estimates based on (Quantitative) Structure-Activity Relationships 
((Q)SARs), category formation (grouping) and read-across. The principles of structure-activity 
relationships (SARs) are based on the notion that biological activity (including toxicity) of a 
chemical substance is dependent on certain physicochemical and structural parameters. Thus, 
the toxicity of a yet-untested chemical may be predicted on the basis of models developed from 
SARs of groups of related substances, or through extrapolation of data from close structural 
analogues of the untested compound (the premise of category formation and read-across).   
There are, however, certain limitations to each of the different alternative methods and as such 
they cannot entirely replace the results obtained from in vivo tests in a live functional animal. 
Despite much recent scientific progress, the assessment and prediction of many complex 
toxicological endpoints, especially chronic effects, is difficult. Thus, to obtain sufficient weight 
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of evidence for risk assessment a combination of several approaches need to be employed as a 
part of an integrated testing strategy (ITS) (Hartung et al. 2013). 
 
1.5.1 Adverse Outcome Pathways and Molecular Initiating Events 
The Adverse Outcome Pathway (AOP) paradigm provides a framework that enables the 
information provided by different testing methods to be integrated and organised cohesively 
and transparently (Ankley et al. 2010, OECD 2013, Vinken 2013, Vinken et al. 2013a, Vinken 
et al. 2014). The knowledge within an AOP provides a mechanistic link between data and 
information derived from different approaches. Knowledge can be provided for the upstream 
Molecular Initiating Event (MIE) and a potential downstream adverse outcome that may be 
relevant for risk assessment. AOPs are defined by a number of key testable events at different 
levels of biological organisation - including the organ, cellular or organism level (Ankley et al. 
2010, Schultz 2010, OECD 2013, Przybylak and Schultz 2013). The progression of an AOP is 
towards the adverse event that is initiated by the interaction of a chemical and the site of action 
(the MIE), which is the primary event in the sequence. The primary interaction between the 
biological and chemical system may be obtained from the mechanistic information described 
by the MIE. The physicochemical properties and structural fragments of molecules that can 
interact via the MIE can be analysed and rationalised in terms of their mechanistic information 
and relevance. The sequential progression of toxicity from one level of biological complexity 
to another is represented in Figure 1.1. It is also recognised that the elicitation of the adverse 
effect in a biological system is a complex process which may have been provoked by multiple 
key effects at the cellular level following a single event upstream. Many, often unrelated, events 
in a pathway may combine to bring about the same adverse effect, as described by Vinken et 
al. (2013b) for the AOP for cholestasis. Other AOPs, e.g. for weak acid respiratory uncoupling, 
oestrogen receptor-mediated reproductive toxicity, voltage-gated sodium channel-mediated 
Chapter 1 
      Page 18  
neural toxicity, skin sensitisation and cholestasis have been developed accounting for a wide 
variety of adverse outcomes (Ankley et al. 2010, Schultz 2010, OECD 2011, Landesmann et 
al. 2012, OECD 2012). A more comprehensive list of the available AOPs is accessible from 
the AOP-Wiki via the AOP Knowledge Base (available from https://aopkb.org/, accessed 
17.2.2017). To assist in their implementation, the AOP framework has been standardised in an 
OECD guidance document which indicates the process by which AOPs should be developed 
and assessed for reliability and robustness (OECD 2013).  
Figure 1.1. Summary of the steps within an adverse outcome pathway and examples of the type 
of effect or activity (adapted from Ankley et al. (2010)) 
 
1.5.2 In silico profilers 
In silico methods can also be used to define and capture the MIE from an AOP pathway (Cronin 
and Richarz, 2017). The molecular fragments and chemical structures that are found to be 
responsible for inducing toxicity can be identified by these methods. One method of capturing 
2-D information relating to, e.g. DNA or protein binding, is the use of structural alerts. A 
Chapter 1 
      Page 19  
collection of structural alerts that predict the same MIE have been considered to be used as an 
in silico profiler (Enoch and Cronin 2010, Enoch et al. 2011b). The profilers can be classified 
into two main types, namely mechanistic and non-mechanistic profilers (the latter described as 
chemistry-based profilers in this thesis). A profiler that is associated with a particular endpoint 
induced by a group of structural alerts related to an MIE is termed a mechanistic profiler. Thus, 
protein binding can be indicative of skin sensitisation as it is the MIE in this AOP. Ideally, 
structural alerts that are present in the mechanistic profiler should be associated with 
experimental data that exhibit the generation of toxicity as a result of the particular MIE. In 
vivo, in vitro and/or in chemico methods can provide such experimental data. These types of 
profiler are also used for the formation of categories and hence allow for read-across from 
tested analogous chemicals to fill data gaps for toxicity prediction (Enoch et al. 2011b).  
A profiler for a particular endpoint that is based on a group of structural alerts related to 
chemistry is termed a non-mechanistic profiler. Such a profiler does not provide any 
mechanistic information about the initiation of toxicity. Instead, they may be based on 
cheminformatics, or a simple analogue/ homologue approach which indicates that a particular 
common structural group is responsible for the toxicity of the compound (Enoch and Cronin 
2010). Even when the alerts are related directly to toxicity, the nature of the chemical alerts 
obtained by this approach does not identify the mechanism by which the observed toxicity is 
brought about. The reason for this is that small molecular fragments may initiate toxicity 
through different mechanisms whereas each profiler is used in an endpoint- and context-
dependent manner. Chemistry-based profilers are nevertheless helpful in screening large 
datasets to identify which chemicals should undergo initial in vitro or in chemico tests (Cronin 
and Richarz, 2017).  
 
 
Chapter 1 
      Page 20  
        1.5.3 Category formation and read-across 
A set of chemicals having common properties may be assigned to a category according to the 
technique of chemical category formation (ECHA 2008, OECD 2011). The identification of 
chemicals having the same mechanism of action, or MIE, is one of the key means of forming 
a chemical category. Thus, a chemical category can be formed based on a structural alert for a 
particular mechanism where the same alert is present in the target chemical as well as its 
analogues. The Organisation for Economic Co-operation and Development’s (OECD’s) QSAR 
Toolbox software has been developed as a result of the need to form chemical categories for a 
wide range of toxicological endpoints with the aid of mechanistic profilers (available from 
www.qsartoolbox.org) (Schultz et al., 2018). The read-across approach uses appropriate data 
and assumes that the biological and chemical activity of similar chemicals will be similar 
(Jaworska and Nikolova-Jeliazkova 2007). This allows the prediction of activity of the target 
chemical with the help of toxicological data for chemicals belonging to the same category. This 
approach may allow for both qualitative and quantitative predictions by analysing the data 
available for analogous chemicals belonging to a specific category.  
 
1.5.4 Profiling inventories for prioritisation 
A library of information about a set of chemicals with their identities is termed a “chemical 
inventory”. Chemical inventories are created and maintained for many purposes including 
regulatory use - such as the industrial chemicals registered under REACH. The inventories 
generally do not contain toxicological data associated with the chemicals but some free-access 
and commercial databases do provide such information. In silico profilers made up of relevant 
structural alerts can be used to screen inventories - for example to identify chemicals that may 
induce certain toxicity(ies). Although chemistry-based profilers lack mechanistic information, 
they are generally still useful for read-across (Alves et al., 2016). As such, chemistry-based 
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profilers may be used to screen inventories, large datasets and chemicals that contain one, or 
more, structural alerts. The presence of a chemistry-based alert in a cosmetic ingredient could 
indicate that the chemical would require in chemico, in silico and/or in vitro analysis to gain 
further insights into the mechanism of toxicity. Thus, the chemistry-based alert can lead to 
further investigations into the possible mechanistic basis (Limban et al., 2018).   
 
1.5.5 Expert systems 
In addition to the chemistry- and mechanistically-based profilers in the OECD QSAR Toolbox 
(and other freely available software such as Toxtree), there are a number of software packages 
termed expert systems that are available on a commercial basis e.g. ChemTunes, TIMES-SS 
and DEREK Nexus (formerly DEREK for Windows). Expert systems can be based on one or 
more different approaches to predicting toxicity, such as decision trees based on rules, 
structural alerts for particular toxicity endpoint and / or nested QSARs (Dearden et al., 1997). 
Structural alerts can identify endpoints, such as skin irritation/ sensitisation, mutagenicity and 
carcinogenicity. Using expert systems, a user can quickly identify chemicals that may have the 
potential to elicit a toxic effect. Expert systems are commonly used by cosmetics and 
pharmaceutical companies to screen datasets for toxicity at early stages of product development. 
Knowledge of the potential toxicity of the lead compound(s) helps to avoid safety issues at 
later stages of the R&D pipeline. Such information can help in the development of 'safer' 
compounds where fragments associated with potential toxicity can be substituted with other 
moieties (Limban et al., 2018).  
 
1.6:  Molecular initiating events for (sub)chronic repeat dose toxicity 
Sub-chronic and chronic adverse effects of a particular substance can be identified with the 
help of repeated dose toxicity testing. In repeated dose toxicity testing, the organism is exposed 
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to the chemical to be tested either over a stipulated period of time (28 or 90 day) or for the 
complete lifespan of the organism (e.g. 2 year study in rat). Initiating events for some of the 
toxicological endpoints are known, e.g. covalent binding of the substance with a protein and 
DNA (de Groot and Noll 1983, Woodward and Timbrell 1984, Aptula and Roberts 2006, 
Aptula et al. 2006, Enoch et al. 2008a, Enoch et al. 2008b, Enoch and Cronin 2010, Enoch et 
al. 2011a, OECD 2012, Hewitt et al. 2013), however, for more complex endpoints relevant to 
this thesis, such as non-genotoxic carcinogenicity, there may only be limited clues to the MIEs.   
 
1.7: Carcinogenicity - the use of SAR approaches to identify suspect carcinogens 
In western countries, cancer is considered as one of the main causes of death after circulatory 
disease (Frankish, 2003). The National Cancer Institute (NCI) defined cancer as “a term for 
disease in which abnormal cells divide without control and can invade nearby tissues and can 
also spread to other part of the body”. Whilst substantial effort and funds have been devoted 
to research into cancer in the recent decades, cancer is still one of the main diseases causing 
death. Numerous causes for cancer have been postulated, most notable amongst them are 
exposure to carcinogens in the environment, through diet, at the work place or due to lifestyle 
(Lichtenstein et al., 2000).  
The potential of a chemical to elicit carcinogenicity and mutagenicity can be tested using a 
range of in vitro and/or in vivo test methods (Table 1.1). For genotoxicity testing, the endpoints 
are related mainly to gene mutations and chromosomal damage. In vitro methods in bacteria 
(i.e. the Ames test) or in mammalian cells are suitable and widely used to identify potential 
genotoxic chemicals. In the Ames test, the assay is usually performed both in the absence and 
the presence of an S9 fraction from rat liver to mimic the metabolic function of mammalian 
systems (Cartus and Schrenk, 2016). 
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A compound or its metabolite(s) may bind directly with DNA or exert indirect effects through 
interaction with the function of DNA leading to a positive outcome for genotoxicity. This may 
lead to an irreversible change in the DNA base sequence or a damage to the cellular genome. 
These changes, together with other effects in the cancer multistep process, e.g. suppression of 
apoptosis or DNA repair, are frequently linked to an increase in tumour rate. Rats and mice are 
primarily used to detect carcinogenic effects and general toxicity respectively, under chronic 
exposure conditions and over the lifespan of the animals. If there is a carcinogenic response in 
vivo, further in vitro and in silico investigations can provide crucial information as to whether 
the compound is carcinogenic as a result of genotoxic mode of action.  
 
Table 1.1. A summary of selected in vivo and in vitro tests to assess the possible genotoxic 
effects of a compound according to OECD TGs (OECD, 2015) 
Endpoint 
In vitro test methods 
Test Species 
Mutagenicity (reverse 
mutation) 
Ames test, Ames fluctuation test Bacteria (Salmonella 
typhimurium, Escherichia coli) 
Mutagenicity (forward 
mutation) 
Hprt test Mammalian cell lines 
Mutagenicity (forward 
mutation)/Chromosomal 
damage 
Thymidine kinase-/Mouse lymphoma 
assay 
TK6 human lymphoblastoid 
cell line; L5178Y mouse 
lymphoma cell line 
Chromosomal damage Chromosome aberration test in vitro Mammalian cell lines 
DNA strand breaks Comet assay Cells and cell lines 
In vivo test methods 
Mutagenicity Transgenic rodent somatic and germ 
cell gene mutation assays 
Transgenic rats or mice 
Chromosomal damage Micronucleus test in vivo Mammalian erythrocytes/blood 
cells 
Chromosomal damage Chromosome aberration test in vivo Mammalian bone marrow and 
mammalian spermatogonial 
cells 
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Although human cancer risk might be predicted from long-term carcinogenesis studies in 
rodents (mainly rat and mice), the cost and time required are quite high and there are ethical 
issues for the use of animals in such studies (Huff et al., 1996). Attempts have therefore been 
made to develop alternative models - including short-term biological tests (such as the tests for 
mutagenicity), or structure-based in silico models (Benigni, 2012). Understanding the 
mechanisms of chemical carcinogenesis is crucially important to design prevention plans 
(Belpomme et al., 2007). As more details of the molecular basis of carcinogenic activity 
become known, the identification of potential carcinogens by SAR analysis is also becoming 
increasingly reliable (Benigni and Bossa, 2011).  
From a mechanistic point of view, carcinogens can be regarded as being either genotoxic or 
non-genotoxic (epigenetic). As illustrated in Table 1.2, when chemicals or their metabolite(s) 
are capable of directly inducing cancer by altering genetic material in the target cells, they are 
classified as being a 'genotoxic carcinogen'. The term 'non-genotoxic carcinogen' is generally 
used for chemicals that are capable of inducing cancer by secondary mechanisms that do not 
involve direct damage to the genetic material. Whilst there are many data and much knowledge 
on the mechanisms leading to genotoxicity, it is more difficult to classify non-genotoxic 
carcinogens on the basis of mechanisms of action due to lack of specific mechanistic 
information (Hayashi, 1992). In fact, the differentiation between genotoxic and non-genotoxic 
carcinogenicity is rarely absolute as most potent genotoxic carcinogens also possess non-
genotoxic activities that could act synergistically to lead to carcinogenic process. A unifying 
feature that can help identify genotoxic carcinogens is that they are either intrinsically 
electrophiles, or are transformed to electrophilic reactive intermediates. This, however, cannot 
be said for non-genotoxic carcinogens that can act through a range of different mechanisms 
that have no apparent unifying basis (Anastas et al., 2012). 
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Table 1.2. A summary of the main differences between genotoxic and non-genotoxic 
carcinogens. 
Feature Genotoxic carcinogen Non-genotoxic carcinogen 
DNA alteration Direct Indirect (secondary) 
Mechanism  Known Multiple 
Structural Feature  Electrophiles No unifying concept 
(several) 
 
In order to gain a better understanding of the role of non-genotoxic carcinogenicity and its 
specific mechanisms of action, a thorough review is required. The outcome of this review is 
presented below as Section 1.8. 
 
1.8: Non-genotoxic carcinogenicity 
Predicting the carcinogenic potential of chemicals that act through non-genotoxic mechanisms 
is one of the major challenges in toxicology. Historically, events that could not be described 
by normal genetic principles of heritability were termed as being epigenetic. In a broad sense, 
epigenetic refers to the alteration of gene expression without changing the basic DNA sequence. 
Thus, non-genotoxic (epigenetic) carcinogenicity includes the actions of all natural or synthetic 
chemicals that may induce carcinogenic effects without involving mutation(s) in the DNA 
sequence. There has recently been huge growth in the scientific literature on the mechanisms 
of action of non-genotoxic (epigenetic) carcinogenicity; this is as a result of the greater 
importance being placed on gaining more knowledge about its mechanistic understanding and 
the molecular basis of chemical carcinogenicity (Benigni et al., 2013). Unlike genotoxic agents, 
cancer induction by non-genotoxic carcinogens may occur through alteration of multiple 
pathways. Therefore, the activities of non-genotoxic carcinogens could include the molecular 
targeting of different cellular and extracellular constituents of various organs, but not DNA 
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(Yamasaki, 1995). Cytokines and hormones that operate through cell membrane receptors and 
intracellular communication processes - such as enhancing cell proliferation and abnormal cell 
cycle kinetics – may potentially alter sensitivity to a wide variety of cell growth mediators. As 
such, they have been considered the main determining factors for the carcinogenic response 
(Klein and Costa, 1997). Mechanisms of action of non-genotoxic carcinogens are mostly 
heterogeneous and often tissue, species and gender specific. The main non-genotoxic 
mechanisms, with an emphasis on those with features amenable to interpretation by SARs, are 
illustrated in the following section. The available information is used to support a unifying 
theory that can, at least in principle, be translated to an in silico tool for interpretation through 
predictive toxicology.    
As noted above, there is a need to identify the key mechanisms of action of non-genotoxic 
carcinogenicity. Those that are known so far, along with examples of structural alerts and 
exemplar compounds that may be of use, are discussed below: 
 
1.8.1 Peroxisome proliferation 
One of the main groups of non-genotoxic carcinogens comprises a group of diverse chemicals 
that have been collectively termed as “peroxisome proliferators” (PP). Almost all eukaryotic 
cells contain cytoplasmic organelles called peroxisomes (or microbodies), that vary between 
tissues in terms of size, number and tissue profile (de Duve, 1983).  Peroxisomes play an 
important role in β-oxidation of very-long-chain fatty acids and in the biosynthesis of 
cholesterol and bile acid (Mannaerts and van Veldhoven, 1993). The possibility to induce 
noticeable peroxisome proliferation was first demonstrated in rodent liver cells after 
administration of the hypolipidemic drug clofibrate (Paget, 1963). Since then, a number of 
other compounds have been identified as peroxisome proliferators. These include herbicides, 
solvents, plasticisers, leukotriene antagonists, as well as natural compounds (Gonzalez et al., 
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1998). There is a noticeable increase in both the size and the number of peroxisomes and 
hepatomegaly after administration of the non-genotoxic agents to rodents due to hypertrophy 
and enhanced cell proliferation (Reddy et al., 1986). Administration of peroxisome 
proliferators over longer periods of time to rats and mice has been shown to result in the 
development of hepatocellular carcinomas (Rusyn et al., 2006).  
 
Figure 1.2. Peroxisome proliferation: consequences of PPARα activation in the liver and the 
proposed underlying mechanisms (adapted from Michalik et al., 2004). 
 
As shown in Figure 1.2, the exact process of how peroxisome proliferators cause tumours in 
rodent liver it is not fully understood. However, two factors are thought to be the main inducers 
of hepatocarcinogensis in rodents: 
 (i) induction of oxidative stress that leads to DNA damage; and  
(ii) enhanced cell proliferation or decreased apoptosis that alters the growth control of 
hepatocytes (Corton et al., 2000).  
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The imbalance between the production and degradation of hydrogen peroxide (H2O2) resulting 
from oxygen radical generation is the main cause of oxidative injury. H2O2 is a by-product of 
acyl-CoA oxidase, the level of which increases by 10-30 fold during the induction of 
peroxisomes, while there is only a two-fold increase in the level of catalase, which is not 
sufficient to degrade all of the H2O2 produced (Reddy et al., 1986). Additionally, it is believed 
that peroxisome proliferation increases the rate of fixation of DNA in the genome leading to 
changes in gene expression, such as increased expression of oncogenes or silencing of the 
tumour suppressor genes.   
 
Figure 1.3. Mechanism of action of peroxisome proliferation. 
 
Peroxisome Proliferator Activated Receptors (PPARs) were identified in the early 1990s as 
novel members of the steroid receptor superfamily (Schmidt et al., 1992). Figure 1.3 shows 
that binding of peroxisomes proliferators to PPARs leads to dimerisation with the Retinoid X 
Receptor (RXR). This heterodimer (PPAR-RXR) binds to DNA in a specific sequence element 
called the Peroxisome Proliferator Response Element (PPRE) that initiates gene expression and 
the production of proteins involved in fatty acids metabolism (Green and Wahli, 1994). 
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Collectively, each isotype of the PPAR family has a specific function in lipid homeostasis, as 
there are different isotypes of PPAR including PPARα, PPARβ/δ, and PPARγ (Green, 1995). 
Of particular chemical interest is the mediation of biological effects for peroxisome 
proliferators, which is mostly performed by PPARα. The primary natural ligands of PPARα 
are saturated and unsaturated fatty acids and it is highly expressed in liver, heart, kidney and 
muscle which all have higher rates of mitochondrial fatty acid oxidation. It is essential to have 
PPARα to mediate the carcinogenic response to a peroxisome proliferator in rodents, but its 
relevance to humans has been debated intensively. Noticeable differences in the response of 
peroxisome proliferators among species have been reported ranging from being highly 
susceptible in rats and mice to being highly intractable in dogs, guinea pigs, non-human 
primates and humans to short term effect of PP exposure (Bentley et al., 1993). In the case of 
humans, it is not entirely understood how resistance to peroxisome proliferators occurs while 
there is functional PPARα. The differences in PPARα expression is likely to be a probable 
explanation for the species-specific effects of PP (Tugwood et al., 1996). It was concluded that 
peroxisome proliferators are unlikely to cause human liver cancer at the expected exposure 
levels (Cattley et al., 1998). However, it cannot be disregarded that there is a dependency 
between PPARα mediated rodent liver cancer and differential PP exposure (Lai, 2004). The 
following sections discuss two special classes of the effects that have been attributed to 
peroxisome proliferators: (a) inhibition of gap junction intercellular communications and (b) 
DNA methylation.  
1.8.1.1 Inhibitors of Gap Junction Intercellular Communication: 
Gap junction intracellular communication has been shown to be inhibited by several non-
genotoxic carcinogens including agonists of PPARα (Upham et al., 2008). Adjacent cells are 
connected internally by the channels formed by the plasma membrane, termed Gap junctions 
(Klaunig et al., 2003). The channels have the same structure irrespective of which tissue cells 
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they are present in. In a typical gap junction, six subunits of connexin protein form a 
hemichannel connexon. Two connexions, one from each cell, dock to form a gap junction. 
Small ions and molecules such as calcium, glucose or growth regulators can diffuse directly 
through the gap junction between the cells and this process is known as Gap Junction 
Intercellular Communication (GJIC) (Yamasaki, 1990). GJIC is a normal phenomenon 
required for homeostatic maintenance in multicellular organisms, normal growth, development 
and tissue differentiation. Gap junction regulation can occur at the translational, post-
translational or transcriptional level. Stable or transient up or down regulation of GJIC can 
occur at any of these three levels by exogenous or endogenous chemicals involving many 
mechanisms. It has been observed that stable normal gap junction regulation is linked with 
tumour suppressor genes and abnormal gap junction regulation is linked with activated 
oncogenes. GJIC has also been shown to be reduced by many carcinogens (Trosko, 1998). 
Heterologous or homologous alteration (either connexins localisation or aberrant expression) 
of GJIC has been reported in almost all malignant cells (Yamasaki, 1990). Although the 
mechanisms underlying the relationship between GJIC inhibition and carcinogenic response 
are ambiguous, GJIC is still considered to be important in tumour promotion and hence 
carcinogenesis.  
1.8.1.2 DNA Methylating Agents:  
Altered DNA methylation patterns have been reported following exposure to peroxisome 
proliferators such as dibutyl phthalate, dichloroacetic acid, Wy-14, trichloroethylene, 
trichloroacetic acid and gemfibrozil (Tao, 2000). DNA methylation is an epigenetic 
modification which affects regulation of transcription. It is covalent addition of a methyl group 
at the 5th position of the cytosine ring within the CpG island (which is the region within DNA 
with a high frequency of CpG sites, i.e. the area where a cytosine nucleotide (C) is followed 
by guanine nucleotide (G) within the linear sequence of bases). DNA methylation is considered 
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to be a non-genotoxic mechanism involved in the promotion and initiation of carcinogenesis 
(Watson and Goodman, 2002). In both tumour tissues and cells, the altered DNA methylation 
patterns have been observed as compared to normal cells. It has been observed in the genome 
of various animal and human cancers that hypermethylation (region specific) and 
hypomethylation (global) can coexist. The most important clue is that the CpG islands are 
hypermethylated in tumour cells, however, there is no methylation at all in the CpG islands in 
normal cells. The CpG islands have more CpG regions as compared to other regions of the 
genome which are associated with coding regions or promotors of genes. Hypermethylation of 
these regions may result in transcriptional alteration or silencing of associated genes which, in 
turn, may result in inactivation of tumour suppressor genes. Alternatively, proto oncogenes, 
such as c-Jun or c-Myc can be abnormally activated by hypomethylation. Moreover, 
methylcytosine to thymine deamination can also occur by hypermethylation, which can result 
in cytosine to thymine point mutations (Robertson, 2000). In short, different changes after 
DNA methylation, such as hypermethylation, hypomethylation, altered gene expression, and 
mutation may lead to carcinogenesis. A number of structural alerts have been identified for 
peroxisome proliferation as shown in Table 1.3. 
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Table 1.3.  The main structural alerts for peroxisome proliferation (Benigni et al., 2013) 
N Alert name Structural alert An example molecular containing the 
alert that elicits peroxisome proliferation 
 
 
1 
 
Substituted 
phenoxy acids  
 
 
 
 
2 
Substituted N 
alkyl 
carboxylic acid 
  
 
 
 
 
 
3 
 
 
 
 
 
Phthalate (or 
butyl diesters 
and 
monoesters) 
 
 
 
  
4 Perfluorooctan
oic acid 
(PFOA) 
  
5 Phenoxy 
herbicide 
  
  
 
 
 
1.8.2 Inducers of oxidative stress  
Oxidative stress has been implicated in carcinogenesis in many ways (Halliwell, 2007). It is 
caused by the imbalance between the antioxidant capability of the target cell and the production 
of Reactive Oxygen Species (ROS). The short-lived ROS - such as ·OH (hydroxyl), O2- 
(superoxide anion) and non-radical oxygen derivatives such as H2O2 (hydrogen peroxide) - are 
highly reactive towards many biological entities, including lipids, proteins, nucleic acids and 
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membranes. A decrease in cell’s antioxidant resistance leads to increase in the level of ROS 
and consequently to oxidative stress and oxidative damage. Both endogenous sources 
(peroxisomes, inflammation in cell and mitochondria) and exogenous sources (radiation, 
industrial chemicals, drugs and environmental agents) can produce ROS (Klaunig et al., 2009). 
Oxidative metabolism in mitochondria and enzymes, such as cyclooxygenases, xanthine 
oxidases, lipoxygenases and NADP oxidase endogenously produces superoxide anions (Valko 
et al., 2004). The enzyme superoxide dismutase (SOD) depletes superoxide anions and the 
resulting H2O2 is removed by glutathione peroxidases and catalases. However, in the presence 
of metal ions, hydrogen peroxide can be converted to the hydroxyl radical through The Haber-
Weiss (Fenton) reaction. The hydroxyl radical is more reactive and aggressive in terms of 
modifying DNA and the production of several oxidation products (Valko et al., 2005). 
However, the hydroxyl radical cannot diffuse within cells because of its high reactivity. It is 
hypothesised that free radical hydrogen must be produced from hydrogen peroxide in the 
immediate vicinity of DNA and can easily cross cell membranes (Klaunig et al., 1995).  
 
ROS can damage DNA in several ways including DNA cross-linking, at apurinic/apyrimidinic 
sites, deoxyribose modification, breakage in single or double strands and deoxyribose 
modification. Normal in cellular DNA, repair machinery mends this damage by nucleotide 
excision and base excision repair. Where this is left unrepaired before replication, it could lead 
to genome instability, cell death or DNA mutation (Cooke, 2003). 8-Hydroxy-2′-
deoxyguanosine (8-OHdG) is the most studied oxidative DNA lesion that is produced by the 
hydroxyl radical at the C-8 position of deoxyguanosine residues. It is also a commonly used 
biomarker of oxidative stress along with its keto-enol tautomer 8-oxo-7,8-dihydro-2′-
deoxyguanosine (8-oxodG) (Valavanidis et al., 2009). In addition, 8-OHdG is highly 
mutagenic due to mispairing of adenine in the replication process (Cheng et al., 1992). High 
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levels of 8-OHdG have been observed in many studies on human cancers and animal tumours 
(Klaunig et al., 1995).  
 
ROS have also been found to induce genetic changes, such as chromosomal rearrangements 
and DNA mutations, which are the basis for the initiation of cancer (Cooke, 2003). ROS cannot 
only cause cell damage, but they can also affect cell regulation and intracellular signalling 
(Allen and Tresini, 2000). The stress activated signalling cascade starts in cells due to a change 
in the redox potential of cells by oxidative stress, which in turn activates transcription factors 
related to redox potential (Adler et al., 1999). Mitogen activated protein kinase (MAPK) 
pathways are the signalling pathways initiated by ROS. These pathways activate many factors 
including hypoxia-inducible factor-1(HIF-1), nuclear factor of activated T cells (NFAT), 
nuclear factor (NF) -κB, p53, and activator factor-1(AP-1). The expression of many DNA 
damage protective genes is controlled by these pathways, including the genes involved in DNA 
repair, induction of apoptosis, damage cell proliferation arrest and the ability of the immune 
system to repair damage (Valko et al., 2006). ROS start signalling initially by the release of 
intracellular calcium, which in turn activates the protein C kinase, a serine threonine kinase 
which regulates cell survival, migration, death and proliferation. These epigenetic effects play 
an important role in tumour promotion (Gopalakrishna and Jaken, 2000).  
 
Many epigenetic carcinogens (phenolic compounds such as o-phenylphenol, 
pentachlorophenol, and quercetin-type flavonoids) cause cancer by the induction of oxidative 
stress. A common pathway in drug transformations is oxidation of the phenols by CYP450 
enzymes that lead to the production of hydroquinone, which is oxidised into quinone. The semi-
quinone radical formed by the reduction of one electron is followed by superoxide anion 
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formation by autoxidation in the presence of oxygen and ultimately quinone regeneration 
(Bolton et al., 2000). This redox cycle produces ROS, which could lead to oxidative stress 
(Kovacic and Jacintho, 2001). 
 
Oxidative stress is also an important mode of action for toxic metals including copper, cobalt, 
aluminium and iron. These metals are collectively involved in hydroxyl radical production in 
vivo by activation in Fenton reactions and are thus termed carcinogenic metals (Valko et al., 
2005). Other metals such mercury, lead and cadmium increase ROS production indirectly by 
depleting thiol containing enzymes and antioxidants which are the major cellular antioxidants 
(Leonard et al., 2004). Chromium exists in three oxidative states - Cr(0), Cr(III), and Cr(VI). 
Cr(III) compounds are not carcinogenic to humans (Hopkins, 1991). The International Agency 
for Research on Cancer (IARC) classified Cr(VI) compounds as group 1 carcinogens to humans 
(Straif et al., 2009). Cr(VI) uses the anion channel to enter the cells as chromates interact with 
physiological phosphate and sulphate (Zhitkovich, 2005). Inside the cells, biological reducers 
(cysteine, glutathione and ascorbate) reduce Cr(VI) into Cr(III) (Standeven et al., 1992). The 
reductive reactions produce several products including radicals based on carbon, sulphur and 
Cr(V) (O'Brien, 2003). Moreover, Fenton type reactions also produce hydroxyl radicals by Cr 
forms (Shi et al., 1993). Oxidative stress is produced by two main factors: the oxidising abilities 
of Cr(V) and the formation of ROS. Besides ROS, the carcinogenicity of Cr(VI) is more 
dependent upon its DNA mutagenesis ability (Zhitkovich, 2011). These compounds can cause 
damage to DNA in different ways, including DNA-DNA cross linking, oxidative damage, Cr-
DNA adducts and DNA protein cross-linking (O'Brien, 2003). The reduction of Cr(VI) to 
Cr(III) is required for the interaction with DNA, Although that there are some recent studies 
have shown the cellular uptake of reduced Cr which was produced by extracellular redox 
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reactions (Valko et al., 2005). Cr(III) compounds are poorly permeable to the cell membrane 
and are therefore non-toxic (Costa, 1997).  
 
Arsenic is also a Group 1 carcinogen to humans (Shi et al., 2004). Inorganic arsenic, such as 
arsenate V and arsenite III, is methylated to form MMA (monomethylarsonic) and DMA 
(dimethylarsinic) in the body as a result of detoxification process (Vaskenaposhian, 2004). 
Trivalent arsenite can interact with thiol containing enzymes and proteins in their reduced state 
and inhibit several biochemical pathways. Pentavalent arsenate is less active than trivalent 
arsenite (Huang et al., 2004) but it may be reduced to arsinite in the body after absorption 
(Rosen, 2002). Arsenite has been found to cause multilocus deletion mutations in human-
hamster hybrid cells (Hei et al., 1998). Dose-dependent transformation of BALB/3T3 cells and 
Syrian hamster embryo cells was induced by sodium arsenite and sodium arsenate (Bertolero 
et al., 1987; Lee et al., 1985). Ultraviolet radiation and inorganic arsenic have also been 
reported to cause co-mutagenicity and carcinogenicity (Hughes, 2002). A number of 
mechanisms have been proposed for arsenic carcinogenesis in humans. Several studies have 
indicated different types of ROS production during arsenic metabolism including singlet 
oxygen (1O2), nitric oxide (NO•), arsenic-mediated generation of superoxide (O2•−), peroxyl 
radical (ROO•), dimethylarsinic radical [(CH3)2As•], dimethylarsinic peroxyl radical [(CH3) 
2AsOO•] and hydrogen peroxide (H2O2) (Shi et al., 2004). The mode of action of arsenic 
carcinogenesis has been linked to other effects including altered DNA repair, possibly as a 
result of oxidative stress, enhanced cell proliferation, gene amplification, cell 
progression/promotion, p53 suppression and DNA methylation (Hughes, 2002).  
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1.8.3 Inducer of hormonal imbalance  
Epigenetic carcinogenesis has also been linked to increased expression of trophic hormones 
due to hormonal imbalance. Increases in both exogenous and endogenous hormones can 
stimulate cell proliferation which, in turn, can result in the formation of tumours by greater cell 
division and random genetic errors (Henderson et al., 1988). There is a negative feedback 
regulation mechanism amongst trophic hormone target tissues and hypophysis; this acts to stop 
target gland secretion and the elimination of secreted hormones which together overproduce 
the respective pituitary hormone. If this mechanism continues for a long time it results into the 
development of tumours in over-stimulated target glands or over-reactive hypophysis. 
Many goitrogenic xenobiotics are associated with non-genotoxic mechanisms through 
hormonal imbalance. These chemicals may disrupt any biosynthesis steps including thyroid 
hormone biosynthesis, metabolism and secretion, and induce thyroid tumours from follicular 
cells (Capen, 1992). Xenobiotics use several methods to decrease thyroid activity by either 
increased excretion of the thyroid hormone in bile, interference with thyroid secretion and 
synthesis in the thyroid gland, T4 to T3 conversion disruption and hepatic mixed-function 
induction (Capen, 1992). The pituitary gland negative feedback system regulates thyroid 
stimulating hormone (TSH) secretion and synthesis, and results in sustained expression of TSH. 
Stimulation of TSH results in hyperplasia, hypertrophy and neoplasia in rodents by 
proliferation of follicular cells (Hill, 1989). However, it is believed that thyroid pituitary 
disruption mechanisms of tumorigenesis are less relevant in humans than tumorigenesis in 
rodents (Hill et al., 1998).  
Hypothalamo-pituitary-testis (HPT) axis disruption and hormonal imbalance in rodents are the 
epigenetic mechanisms which lead towards the induction of tumours in Leydig cells (interstitial 
cells that produce testosterone). These cells are stimulated by leuteinising hormone (LH) to 
produce testosterone. Negative feedback of testosterone results in the production of LH from 
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the pituitary gland (Clegg et al., 1997). In rodents this feedback is blocked by different 
chemicals with different mode of actions including oestrogen agonism, androgen antagonism, 
testosterone biosynthesis inhibition, gonadotropin releasing hormone (GnRH) agonism, 5α-
reductase inhibition, dopamine agonism and aromatase inhibition. The chemicals that are 
involved in HPT axis disruption, with the exception of dopamine agonists and GnRH, may 
pose a risk to human health. Rodents are more sensitive than humans to Leydig cell tumours 
induced by chemicals (Cook et al., 1999). 
The carcinogenic action of oestrogens is an epigenetic mechanism as well as having genotoxic 
effects. Cells expressing receptors for oestrogen, i.e. in the breast, liver and endometrium, start 
proliferating as a result of prolonged expression of oestrogen from exogenous and endogenous 
sources. The organs, whose normal growth is under hormonal control, develop hyperplasia to 
neoplasia as a result of proliferation induced by oestrogen (Henderson et al., 1988).  
 
 
1.8.4 Agonists and antagonists of the aryl hydrocarbon receptor. 
Aryl hydrocarbon receptor (AhR) mediation by different natural and synthetic chemicals can 
have many toxicological and biological effects on cells, including carcinogenesis. AhR belongs 
to the superfamily of basic helix-loop-helix/Per-Arnt-Sim (bHLH/PAS) proteins and is a ligand 
activated transcription factor. AhR agonists consist of halogenated and planar aromatic 
hydrocarbons including biphenyls, heterocyclic plant constituents, dibenzofurans and related 
chemicals and polychlorinated dibenzo-p-dioxins (Denison et al., 2002). Until now, no 
authentic AhR high affinity endogenous agonists have been identified, although there are 
studies which indicate that endogenous physiological ligands are involved in the activation of 
AhR itself and the signalling pathways of AhR. Unbound AhR complexed with co-chaperons 
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and chaperone HsP90 has been found in cellular cytosol, which translocates into the nucleus 
after binding with the ligand. In the nucleus, HsP90 and other chaperons are released and it 
associates with Ah receptor nucleus translocator (Arnt) forming an AhR:Arnt heterodimer 
(Bock and Köhle, 2006). Special DNA binding sites called Ah-responsive element (AhRE), 
dioxin responsive element (DRE), or xenobiotic responsive element (XRE) present in the target 
genes regulatory regions are recognised by this heterodimer and it binds to this site (Rowlands 
and Gustafsson, 1997). The target genes may include proliferation regulatory genes, genes 
involved in differentiation and development and Phase 1 and 2 biotransformation enzymes 
coding genes (Beischlag et al., 2008).  
 
Enhanced DNA binding results in corepressors and coactivators recruitment, chromatin 
structure remodelling and target genes transcriptional machinery activation. Constant exposure 
to agonists (for example exposure to TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)) leads 
towards toxic tissue- and species-specific effects including teratogenicity, chloracne, wasting, 
liver tumour promotion, carcinogenicity and immunotoxicity (Bock and Köhle, 2006). 
Although the role of AhR in producing these responses is observed, the underlying molecular 
mechanisms are still unknown. It is hypothesised that inappropriate or sustained activation of 
AhR results in the TCDD mediated toxicities and deregulated physiological functions (Poland 
and Knutson, 1982). In another experiment on rodents expressing mutant AhR, the role of this 
receptor in hepatocarcinogenesis promotion was demonstrated (Moennikes, 2004). It has been 
hypothesised that at the tumour initiation stage sustained AhR signalling is involved which 
facilitates the genotoxically injured cells selective survival. Nuclear proteins and signalling 
factors, AhR/Arnt crosstalk have also been described (Puga et al., 2009). Specifically, crosstalk 
with the oestrogen receptor. 
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1.8.5 Summary of the findings on mechanisms of non-genotoxic carcinogenicity 
 
As described in Section 1.8, most carcinogenic chemicals associated with a non-genotoxic of 
action have been reported to act through one or more of the following mechanisms: 
1. Peroxisome proliferation, which may result from either induction of oxidative stress; 
enhanced cell proliferation or decreased apoptosis; inhibition of gap junction intercellular 
communication; or DNA methylation.  
2. Induction of oxidative stress, that may result from either an increase in the production of 
oxyradicals, or a decrease in the cell’s antioxidant capacity that may lead to DNA damage 
in several ways - such DNA cross-linking, at apurinic/apyrimidinic sites, breakage in single 
or double strand and deoxyribose modification. 
3. Induction of hormonal imbalance 
4. Agonist and antagonist of aryl hydrocarbon receptor (AhR), which is a ligand activated 
transcription factor.  
Knowledge of these key mechanisms of action has the capability to provide a basis for further 
evaluation and in silico analysis of these important effects 
 
1.9:  The potential use of in silico tools for the identification of non-genotoxic carcinogen 
With regard to developing in silico tools for the prediction of the toxic effects of cosmetics 
ingredients, there has been a great deal of research undertaken. For instance, Safety Evaluation 
Ultimately Replacing Animal Testing-1 (SEURAT-1) was a cluster of European projects 
created in response to the Seventh Amendment of the final deadline for the Cosmetic Directive 
in January 2011. It comprised a collaboration of one co-ordination project and six research 
projects encompassing 70 European Universities, commercial companies and research 
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institutes. The SEURAT-1 Cluster operated for five years (2011-2015) with the aim of reducing 
the reliance on in vivo repeated dose toxicity tests by beginning the process of replacing it with 
in silico and in vitro methods. The COSMOS Project was one of the six research projects of 
SEURAT-1; the main objectives of COSMOS were as follows: 
a. The formation of an inventory of cosmetic ingredients including their chemical 
structures as well as, where possible, toxicological data. 
b. The collection and compilation of recent sources of the toxicological data from the 
literature and regulatory sources. 
c. The development of new software to be applied in the analysis of the repeated dose 
toxicity of the cosmetics towards humans. 
The safety of cosmetics ingredients within the European Union was supported by the 
development of new tools with the aid of the COSMOS project and other collaborative projects 
associated with SEURAT-1. It was also envisaged that the results of the six research projects 
could help provide a basis for alternative techniques and tools in the identification of toxicity 
of chemicals used in pharmaceutical industry (Cosmostox.eu, 2019).   
The main outputs from the COSMOS Project were the development of the COSMOS database 
(https://cosmosdb.eu/cosmosdb.v2/) which focussed on repeated dose toxicity data for 
cosmetics ingredients, amongst other endpoints and data. The data were used to enrich and 
enhance the datasets available for derivations of Threshold for Toxicological Concern (TTC) 
values (Yang et al., 2017). In addition, a number of innovative computational approaches for 
the assessment of chronic toxicity endpoints (notably liver toxicity) were developed in the 
COSMOS Project. The new modelling approaches were developed around the use of 
knowledge of MIEs for endpoints such as hepatic steatosis (Mellor et al., 2016) and PPARγ 
dysregulation (Al Sharif et al., 2017). Overall, the COSMOS Project illustrated the possibility 
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of modelling a complex endpoint when appropriate and mechanistically based in silico models 
were developed. 
Taken as a whole, the SEURAT-1 Cluster enabled better use of the data from new methods. 
There were at least two major contributions including development of a set of read-across case 
studies proposed by Berggren et al., (2015). The case studies provided a number of learnings 
for the development collation of data and justification of similarity hypotheses (Schultz and 
Cronin, 2017) as well as the definition of uncertainties in read-across (Schultz et al., 2019). In 
addition, the SEURAT-1 Cluster developed a workflow, or strategy or safety assessment in the 
case of no data, with decisions made on an exposure basis in the first place, then leading to use 
of new types of data. The type of sequential approach was termed an ab initio chemical safety 
assessment workflow and demonstrated the utility of combining together different types of 
information (Berggren et al., 2017). Overall the SEURAT-1 philosophy, and COSMOS Project 
in particular, demonstrated that information on chemistry can be used to make assessments of 
complex and subtle toxicities, especially when combined into integrated frameworks of data 
gathering.  
 
1.10:  Context and research aims of this thesis: 
The safety of cosmetic products is of utmost importance in relation to consumer health because 
of the large variety of products, the frequency of use and the intimate nature of applications on 
the body. In Europe, ensuring safety of cosmetics is jointly undertaken by industry and 
regulatory authorities. The European regulatory framework for cosmetic safety requires pre-
market notification of the intended use of any ingredients that fall within the regulated 
categories, assessment of safety, regulatory approval, and appropriate labelling of the final 
products. At the regulatory level, safety of cosmetic ingredients is assessed by an independent 
committee of experts (the Scientific Committee on Consumer Safety, SCCS) before they are 
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allowed by the European Commission to be used in cosmetic products. The safety assessment 
of final products is overseen by the competent authorities in the EU Member States. Ensuring 
overall safety of the final products placed on the market, nevertheless, remains responsibility 
of the industry.  
Safety assessment of cosmetic ingredient/products requires detailed information and data 
relating to the physicochemical properties and toxicological hazard of ingredients, as well as 
the possible route(s) and the extent of consumer exposure. The toxicological data for hazard 
identification/ characterisation are generally drawn from a systematic scheme that involves 
testing against set endpoints that can provide information on potential acute (short-term) and 
chronic (long-term) adverse effects. The most difficult endpoints to measure accurately in this 
regard are those that are indicative of long-terms effects, such as reproductive and 
developmental effects and carcinogenicity. The available tests for gene mutation and DNA 
damage can indicate the potential of a cosmetic ingredient to be a genotoxic carcinogen. 
However, identifying non-genotoxic carcinogens is a particular challenge due to the lack of a 
single mode of action. As non-genotoxic carcinogens can act through alteration of multiple 
pathways, and generally without a change in DNA sequence, predicting the potential 
carcinogenicity of a non-genotoxic chemical is one of the current major challenges in 
toxicology, although as shown in Section 1.8 the main mechanisms can be defined.  
The EU Cosmetic Regulation (EC) No 1223/2009 has also resulted in a ban on animal testing 
of cosmetics ingredients since 11 March 2013. This means that all toxicological data for 
cosmetic ingredients and products need to be drawn from alternative (non-animal) methods. 
This has made testing of cosmetic ingredients for non-mutagenic carcinogenicity even more 
challenging. A battery of in vitro tests is available for certain endpoints but results from 
different tests may generate contradictory or equivocal results. In this context, the use of in 
silico models and read-across tools provides a useful alternative means to obtain additional 
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supporting evidence which, when used in conjunction with other lines of evidence, can 
strengthen the overall weight of evidence for safety assessment. In silico approaches can also 
provide important clues to the mode of action of a chemical to inform in vitro testing and the 
models and structural alerts can enable toxicological assessment of other substances. In this 
regard, the European SEURAT-1 Cluster went some way to demonstrate a reduction in the 
reliance on in vivo repeated dose toxicity tests and providing a strategy to replace it with read-
across, in silico and in vitro methods. As part of the SEURAT-1 cluster, the COSMOS project 
specifically aimed to use new alternative tools for safety assessment of cosmetic ingredients.  
In keeping with the research aims of the COSMOS project, the overall aim of this research was 
to evaluate and develop in silico models for the human health effects of cosmetic ingredients, 
focussing on read-across and (Quantitative) Structure-Activity Relationships ((Q)SARs) for 
carcinogenicity and skin sensitisation. The specific objectives to achieve this aim were: 
i. To review the state of the art of grouping approaches, (Q)SARs and available software 
to predict the toxicity of cosmetic ingredients, including the mechanisms of 
carcinogenicity and their relationship to existing Adverse Outcome Pathways (AOPs) 
with an emphasis on non-genotoxic mechanisms.  
ii. To identify and evaluate existing data for the carcinogenic potential of the chemicals, 
as well as repeated dose toxicity, skin sensitisation, dermal absorption and metabolism, 
assessing quality of both physicochemical and toxicological data. 
iii. To assess existing structural alerts for human health effects allowing for the formation 
of chemical categories, read-across supported by ToxCast data and (Q)SARs supported 
by data for key events in AOPs.  
iv. To study the chemical space of cosmetics ingredients and materials utilising and 
building on the COSMOS inventory through the analysis of descriptors of molecular 
structure and physicochemical properties. 
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v. To develop relevant case studies to provide a proof of concept for cosmetics-related 
materials focussing on relevant classes of chemicals such as aluminium and the 
phthalates. 
An extensive literature search was performed as part of this thesis and this indicated that a 
range of in silico models, read-across tools and expert systems is available. These are discussed 
in more detail in Chapters 3 and 5. In addition, certain structural alerts have been identified for 
some known non-genotoxic mechanisms of carcinogenicity. For example, a small number of 
structural alerts have been associated with peroxisome proliferation, e.g. substituted phenoxy 
acids, substituted N-alkyl carboxylic acids, phthalates (or butyl diesters and monoesters), 
perfluorooctanoic acid and phenoxy herbicides. These are discussed in more detail in Chapter 
2. A general comparison between the performance of genotoxic and non-genotoxic carcinogen 
structural alerts was also conducted in Chapter 2. This comparison showed that the positive 
predictivity for genotoxic carcinogen structural alerts was more accurate and effective 
compared to non-genotoxic carcinogen alerts. A detailed analysis of positive predictivity of all 
available mutagenic structural alerts and profilers within the OECD QSAR Toolbox when 
compared to experimental mutagenicity data from the CCRIS dataset was conducted in Chapter 
3. In Chapter 4, the relationship between scaffolds of a range of diverse compounds and 
carcinogenicity (both genotoxic and non-genotoxic) was analysed using a dataset of Ames 
assay data for 10,543 compounds from the SAR genotoxicity database, and carcinogenicity 
data for 2,870 compounds from the SAR carcinogenicity in the Leadscope® database 
(Leadscope.com, 2018). Chapter 5 illustrates how essential it is to know the accuracy of the 
different profilers within the OECD QSAR Toolbox for carcinogenicity, mutagenicity and skin 
sensitisation in terms of sensitivity, specificity and accuracy, and to investigate possibilities for 
improvement.
 Chapter 2: Assessment of currently available structural alerts for genotoxic and non-
genotoxic carcinogens 
 
2.1: Introduction:  
 
Mutagenicity and carcinogenicity are considered amongst the most significant toxicological 
concerns for human health. As such, they are part of the standard information requirements for 
regulatory and other risk assessment. To understand the mechanistic basis of these endpoints, 
Miller et al. (1977; 1981) described the electrophilic theory of chemical carcinogenesis which 
helped rationalise a wide variety of carcinogenic chemicals identified during the 1970s. 
Miller’s theory gave a mechanistic basis for these chemicals to act as mutagens (i.e., in the 
Ames test). It also stated that various carcinogenic compounds possessed alkylating and 
electrophilic characteristics. Thus, electrophilic acylating agents are one of the key groups of 
chemicals that can be considered as direct-acting carcinogens. In addition, Miller et al. also 
reported that there are other carcinogenic chemical compounds, other than acylating agents, 
such as aromatic amines, which may undergo electrophilic reaction following metabolism. In 
this way, the (chemical) structural basis of genotoxic carcinogens began to be established.  
It is now well known that a significant proportion of the direct acting chemical carcinogens are 
electrophilic in nature. However, many genotoxic carcinogenic chemicals that are not 
electrophilic behave as such in vivo, as they can react with nucleophilic groups of proteins and 
nucleic acids present in cells and tissue (Miller and Miller, 1981). Miller’s work inspired 
different researchers to work further in this field. For instance, different strains of genetically 
engineered Salmonella typhimurium have been developed to test specific individual chemical 
classes, such as alkylating or intercalating chemical carcinogens (Maron and Ames, 1983). The 
Salmonella, or Ames, Test is an in vitro model for detecting chemical mutagenicity and consists 
of different bacterial strains that are susceptible to a large array of DNA damaging agents 
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(Ames, 1984). The Ames Test was developed from mutant forms of the bacterium S. 
typhimurium, whereby when the bacterial DNA interacts with a potential genotoxic chemical, 
the change in DNA provides evidence for mutagenicity of the chemical.  
Miller’s hypothesis supporting the use of Salmonella in the Ames Test was relevant at that time 
in relation to the mechanism of action as carcinogens were thought to be mainly the result of 
genotoxic interactions (Ashby, Tennant, 1988). In due course, the theory regarding the 
electrophilic activity of many chemical carcinogens has also been incorporated into a more 
general theory of chemical carcinogenesis. According to the theories at that time, the initiation 
of cancer was due either to genetic mutation, or a carcinogen's ability to damage DNA directly 
(Arcos and Argus, 1995). However, there is yet another type of carcinogen termed “epigenetic” 
which does not bind covalently to DNA and hence does not damage DNA directly. As a result, 
epigenetic (non-genotoxic) carcinogens are negative in the most commonly and frequently used 
assays for mutagenicity (Woo, 2003). As discussed in Chapter 1, there are a number of diverse 
mechanisms of action of epigenetic carcinogens.  
Structural alerts  
The term ‘structural alert’ was defined by Dr John Ashby, who also contributed to the 
compilation of a list of structural alerts following the electrophilicity theory proposed by Miller 
(Ashby, 1985; Ashby and Tennant, 1988). Structural alerts are defined as being a definable 
fragment within a molecule (i.e., a functional group or substructure) representing a structure-
activity relationship (i.e., inducing carcinogenic activity). Thus, the potential classes of 
chemicals that can induce cancer can be identified by structural alerts for carcinogenicity. 
Depending on their definition, structural alerts for genotoxic carcinogenicity are considered 
suitable to identify mutagenic compounds, as the main mode of action of this type of carcinogen 
(i.e., genotoxic carcinogen) is modification and direct interaction with DNA. Structural alerts 
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for carcinogenicity have been identified from experimental data on animals or from 
observations on human epidemiological studies.  
There are many reasons why the majority of carcinogenic structural alerts were obtained from 
data derived from rat and mice toxicological studies. These animals are preferred as 
investigational models because of their relatively low cost and ease of maintenance (compared 
to other non-rodent assays), short life span and higher susceptibility to tumour induction, as 
well as the accessibility of characterised strains (Huff et al., 1991; Fung et al., 1995; Huff and 
Haseman, 1999). Whilst short-term mutagenicity assays help in the detection of potential 
genotoxic carcinogens within a much shorter timeframe, non-genotoxic carcinogens cannot be 
identified easily or exclusively by the use of long-term carcinogenicity studies. These rodent 
bioassays, in conjunction with bacterial Ames and other in vitro tests for mutagenicity, provide 
an indication of carcinogenicity.  
Models based on structural alerts play a major role in predictive toxicology. Software platforms, 
both commercial (e.g., DEREK Nexus from Lhasa Ltd) and non-commercial (e.g., Oncologic 
by the US EPA) use structural alerts as the basis to predict mutagenicity/carcinogenicity. 
Whilst structural alerts generally predict genotoxic carcinogens well, their ability to identify 
non-genotoxic carcinogens is still in infancy. (Woo, 2003) reported different characteristics of 
non-genotoxic carcinogens as well as relating them to structural alerts. As mentioned in 
Chapter 1, non-genotoxic carcinogens have different modes of action and cannot be explained 
by a clear unifying theory. The main non-genotoxic mechanisms of carcinogenicity can be 
mainly grouped into the following mechanisms (see Section 1.8 for more details):  
1) Peroxisome proliferation, which includes: 
a) Inhibitors of gap junction intercellular communication 
b) DNA methylating agents 
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2) Inducers of oxidative stress  
3) Inducers of hormonal imbalance 
4) Agonists and antagonists of aryl hydrocarbon receptor. 
 
Relationship of mechanism of action to structural alerts: 
In general, if a single structural alert represents the same or similar chemical class, then it may 
be assumed to exhibit a similar mode of toxic action. The major chemical groups identified by 
the structural alerts responsible for direct acting genotoxic carcinogens are sulphur-compounds, 
epoxides, aziridines, α-haloethers and lactones (Benigni et al., 2008). For the purposes of this 
Chapter, the mode of action of epoxides will be analysed in detail as a representative example.  
Epoxides alkylate DNA and this may lead to carcinogenic effects. The strained epoxide ring 
breaks open easily to form a carbonium ion, which is responsible for the initiation of this 
alkylation reaction. This, in turn, leads to the substance being able to react with a nucleophilic 
site, such as DNA, forming 2-hydroxy-2-alkyl adducts (Singer and Grunberg, 1983). Thus, 
chemicals containing epoxide groups are strongly associated with the induction of mutations 
in cells and/or cancer induction. The chemical mechanism of the reaction of an epoxide with 
DNA is shown in Figure 2.1: 
C
C
O
δ+
δ- O- C C+
DNA
 
Figure 2.1. Mechanism of epoxide attack on DNA (Benigni et al., 2008). 
 
There are other structural alerts for functional groups relating to genotoxic carcinogens that are 
not directly acting, but may become genotoxic following metabolic activation. Due to the 
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complexity of some of the metabolic pathways e.g. involving more than a single metabolic step, 
a structural alert could point to a range of final toxicological outcomes. For instance, aromatic 
imines and amines may be metabolically activated to electrophiles and hence have the potential 
to induce carcinogenicity. A study in mice revealed that the oxidation of aromatic amides and 
amines formed N- hydroxyarylamines and N-hydroxyarylamides, respectively induced by 
cytochrome P-450 c (BNF-B) and d (ISF-G). The metabolic conversion of nitroso, nitro, and 
hydroxylamine derivatives also generates amine groups. Another example of the complexity 
of metabolic activation is that seven nitroaromatic hydrocarbons are generated through the 
formation of N-hydroxyarylamine as an intermediate in the presence of cytosolic and 
microsomal enzymes that act as a catalyst.  
The process of the reduction of nitro groups in microsomes can be replicated experimentally 
in the presence of a cytochrome P-450 complex obtained from rat liver isozymes, namely c 
(PB-B), d(PB-B), b (PB-B), and e (PB-D). The enzymes responsible for cytosolic 
nitroreductase activity include DT-diaphorase, alcohol dehydrogenase and enzymes having 
xanthine and aldehyde groups. The main activation pathway is the nitrogen oxidation and 
reduction reaction as shown in Figure 2.2. However, there are certain aromatic amines, as well 
as aromatic nitro compounds, that are converted to electrophilic compounds through a ring 
oxidation pathway. Unlike other direct electrophilic metabolites, such as hydroxyarylamines, 
epoxides, and iminoquinones, N-hydroxyarylamides need to go through the esterification 
process to be capable of reacting with DNA (Benigni, 2005).  
 
 
Chapter 2 
 
      Page 51  
NH2 NH
Ac
Acetyl CoA
cytochrome P450s
NH
OH
N
OH
Ac
NH
OAc
N
OAc
Ac N
OSO3
Ac
Trans acetylase
Electrophilic metabolites
Covalent binding to DNA
Toxic effect (mutation and cancer)  
Figure 2.2. The main oxidation pathway of aromatic amines leading to potentially carcinogenic 
metabolites (Benigni, 2005). 
Using more than a single SA is appropriate for some chemical classes as it the mechanism of 
action of certain groups, such as the aliphatic halogens, is more complicated. As shown in 
Figure 2.3, the mechanism of action of aliphatic halogens may switch from genotoxic to non-
genotoxic pathways depending on the degree of halogenation and the whether the carbon 
skeleton is a cyclic or linear. The short chain mono-halogenated alkanes, as well as alkenes and 
dihalogenated alkanes, act directly as alkylating agents (as genotoxic mechanism) either 
without, or after, conjugation with GSH. Conversely, the mechanism of action of poly-
haloalkanes is either a non-genotoxic or a free radical mechanism.  
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With regard to halogenated cycloalkanes (and cycloalkenes), it is more appropriate to use 
multiple structural alerts as the mechanism of action of carcinogenicity is still unclear and 
possibly genotoxic (i.e., alkylation) either directly or after metabolic activation, although non-
genotoxic mechanisms have also been proposed. For example, Woo et al. (2002) suggested 
non-genotoxic mechanisms for halogenated cycloalkanes to involve: 
a. Hormonal imbalance 
b. Degranulation of the rough endoplasmic reticulum 
c. Inhibition of other intercellular mechanisms. 
    
 
Figure 2.3. The complexity of carcinogenicity mechanism of actions for aliphatic halogens 
(Benigni, 2005). 
In contrast to complex carcinogenicity testing, in silico toxicology offers an extremely 
attractive option in terms of being a rapid and low cost methodology. It also provides the 
possibility to reduce animals use and make tests more directed and mechanistically based. As 
Mono halogenated alkanes 
(and alkenes) 
Dihalogenated alkanes (and 
alkenes) 
Polyhalogenated alkanes 
(and alkenes) 
halogenated cycloalkanes 
(and alkenes) 
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such, structural alerts also provide a means to understand and interpret the mechanisms of 
genotoxicity and therefore help in the classification of potential carcinogens. The structural 
alerts published by Benigni et al. (2013) and summarised in Tables 2.1 and 2.2 are considered 
the most advanced list to evaluate both the genotoxic and non-genotoxic carcinogenicity 
potential of chemicals. These structural alerts have also been implemented as a rule-base 
system in the Toxtree software and the OECD QSAR Toolbox.  
Table 2.1. Currently identified non-genotoxic carcinogen structural alerts (Benigni et al., 2013). 
 
NO 
 
 Mechanism of action* 
 
Alert Name 
1 HI Thiocarbonyl  
2 HI Poly halocycloalkane 
3 AHR Halogenated benzenes 
4 AHR Halogenated dibenzodioxines 
5 HI Steroidal oestrogen  
6 PP Substituted phenoxy acids 
7 PP Substituted n-alkylcarboxylic acids 
8 PP Phthalates 
9 PP Perflourooctanoic acid (PFOA) 
10 PP Tri, tetraflouroethylene 
11 AHR Indole-3-carbonyl 
12 OXS Pentachlorophenoles 
13 OXS 2-Phenylphenols 
14 OXS Quercetin flavonoid 
15 HI Benzimidazolea 
16 HI Imidazoles ,benzamidazoles 
17 HI Dicarboximides 
18 HI Dimethylpyridinse 
19 OXS Metals 
20 HI Benzsulfonic ether 
21 OXS 1,3-Benzdioxole 
22 PP Phenoxy herbicides 
23 HI Alkyl halides 
 
  
*PP: peroxisome proliferator, OXS: oxidative stress, HI: hormonal imbalance, AHR: 
aryl hydrocarbon receptor agonist and antagonist. 
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Table 2.2. Currently identified genotoxic carcinogen structural alerts (Benigni et al., 2013). 
 
NO 
 
 Mechanism of action 
 
Alert Name 
1  
 
 
 
 
Direct DNA 
Alkylation  
 
Alkyl (C5) or benzyl esters of sulphonic or phosphonic acid 
2 N-methylol derivatives 
3 S- or N- mustards 
4 Propiolactones and propiolsulfones 
5 Epoxides and arizidines 
6 Aliphatic halogens 
7 Alkyl nitrites 
8 α, β-Unsaturated carbonyls 
9 Simple aldehydes 
10                Quinones 
11                Alkyl and aryl N-nitroso groups 
12  
 
 
 
Indirect DNA 
Alkylation  
 
Monohaloakenes 
13 Hydrazines 
14 Aliphatic azo and azoxys 
15 Alkyl carbamate and thiocarbamates 
16 Azide and triazene groups 
17 Aliphatic N-nitro groups 
18 α, β-Unsaturated alkoxy group 
19 Pyrrolizidine alkaloids 
20 Alkenylbenzenes 
21 Steroidal oestrogen (genotoxic and non genotoxic) 
22 Direct Acylation Isocyanate and isothiocyanate groups 
23  
 
Amino aryl DNA 
adduct formation 
Aromatic ring N-oxides 
24 Aromatic nitroso groups 
25 Nitro Aromatics 
26 Aromatic amines and hydroxyl amine & its derived esters 
27 Aromatic mono and dialkylamino groups 
28 Aromatic N-acyl amines 
29 Aromatic diazo groups 
30 DNA adduct 
formation by 
Intercalation 
Polycyclic Aromatic Hydrocarbons 
31 Heterocyclic Polycyclic Aromatic Hydrocarbons 
32 Coumarins and Furocoumarins 
 
Given the utility of structural alerts for all toxic endpoints, and potential benefits in using them 
for the prediction of carcinogenicity, it is perhaps surprising that there have been no, or few, 
systematic assessments of their performance, coverage and relevance. This is particularly 
pertinent to non-genotoxic carcinogens where an assessment of the available structural alerts 
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could assist in the identification of their strengths, but also clarification of chemical or 
mechanistic space that is not well covered. The aim, therefore, of this chapter was to assess the 
currently available structural alerts and in silico models for both genotoxic and non-genotoxic 
carcinogenicity. The analysis focussed on four main mechanisms of non-genotoxic carcinogens: 
peroxisome proliferation, hormonal imbalance, oxidative stress, and aryl hydrocarbon receptor 
agonism/antagonism as well as the five main mechanism of action of genotoxic carcinogen: 
direct DNA alkylation, indirect DNA alkylation, direct acylation, amino aryl DNA adduct 
formation and DNA adduct formation by intercalation. In this study, the performance of the 23 
structural alerts for non-genotoxic carcinogenicity described by Benigni et al. (2013), listed in 
Table 2.1 and as implemented within the Toxtree software, has been assessed by comparison 
with experimental cancer data compiled in the Carcinogenic Potency Database (CPDB).  
 
 
2.2:  Methods:  
2.2.1 Dataset used: 
Carcinogenic Potency Database (CPDB) 
Data relating to cancer causing chemicals were compiled from the Carcinogenic Potency 
Database (CPDB), which is freely available from http://toxnet.nlm.nih.gov/cpdb/cpdb.html. 
This database is a widely used and unique international resource comprising the results of 6,540 
chronic, long-term animal carcinogenicity tests on 1,547 chemicals in rats, mice, dogs, 
hamsters and non-human primates. All important information is included for each experiment 
to interpret the bioassay, such as strain, species and sex of the test animal along with other 
details relating to the experimental protocol used, e.g. the route of administration, average daily 
dose and duration of dosing. Information is also provided on the tumour type, tumour incidence, 
carcinogenic potency (TD50) and statistical significance of the results. TD50 can be very useful 
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for comparison and analysis of the relative carcinogenicity of compounds as it provides a 
standard qualitative measure.  
2.2.2:  Review process of non-genotoxic structural alerts 
The workflow shown in Figure 2.4 outlines the steps in the assessment of the current non-
genotoxic structural alerts discussed in this chapter. This workflow is split into two sections: 
the first section is related to the filtering and extraction of CPDB cancer data. The second 
section is related to the review process using the rule-based expert system Toxtree version 
2.6.13 (downloaded in April 2016) which is freely available from 
http://toxtree.sourceforge.net. Toxtree predicts different types of toxicological hazard and 
modes of action by applying decision tree approaches; it can be used for initial hazard 
assessments (Pavan and Worth, 2008). The review process was conducted after converting the 
extracted structures from SMILES format to SD/SDF format using the Open Babel programme 
version 2.3.2 (downloaded in April 2016) which is freely available from 
https://openbabel.org/docs/dev/Installation/install.html.  
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 Figure 2.4. Workflow for the process undertaken to assess structural alerts for non-genotoxic              
carcinogenicity. 
The individual steps of the workflow summarised in Figure 2.4 are described below.  
Step 1: CPDB downloaded as an Excel datasheet: 
Results were downloaded from the CPDB for the full list of 6,540 experiments on 1,547 
chemicals as an Excel spreadsheet. The information downloaded included the full details 
regarding the diversity of bioassay designs in the CPDB, e.g., dose ranges tested, number of 
dose groups and the frequency of testing per chemical. 
 
Step 2: Chemicals filtered according carcinogenic activity, mutagenicity and species 
The process of filtering the downloaded CPDB data is detailed below.  
1. Using the “sort & filter” tool in Excel, the 1,548 chemicals were filtered to select only 
those chemicals that are negative (inactive) in the Ames test in the column 
2. Chemicals filtered according to carcinogenic 
activity, mutagenicity and species 
3. SMILES extracted for non-genotoxic  
carcinogens, genotoxic carcinogens, genotoxic 
non-carcinogens and non-genotoxic non-
carcinogens. 
4. SMILES converted to a SDF file in Open Babel 
for use in the Chemotyper and Toxtree 
5. Dataset run through Toxtree to review the 
Benigni et al. (2013) structural alerts  
1. CPDB downloaded as an Excel datasheet  
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(ActivityOutcome_CPDBAS_Mutagenicity), as shown in  Figure 2.5. This indicates 
which chemicals have a higher probability of an epigenetic carcinogenicity mechanism. 
 
Figure 2.5. Screenshot of the Excel spreadsheet showing filtrated carcinogenic data that are 
inactive in the Ames test in order to extract non-genotoxic carcinogens from the CPDB. 
 
2. Only data for rats were included in the filtered dataset from the “species” column. Data 
for other species, such as mice and rhesus and cynomolgus monkeys, were excluded 
from the dataset, as shown in Figure 2.6. 
3. Only “active” chemicals that initiate carcinogenicity were selected from the 
“ActivityOutcome_CPDBAS_Rat” column, resulting in the selection of 150 non-
genotoxic carcinogenic chemicals to the rat.  
4. All mixtures and inorganic substances were excluded from the list using the column 
“STRUCTURE_ChemicalType”. 
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5. The same process was conducted using the same filtering process as described above 
to produce three additional groups for comparison. This produced 240 genotoxic 
carcinogens, 108 genotoxic non-carcinogens and 242 non-genotoxic non-carcinogens. 
 
 
Figure 2.6. Screenshot of the Excel spreadsheet showing the exclusion of data for species other 
than the rat to select rat carcinogens only from the activity outcome column.  
 
Step 3: SMILES strings extracted for non-genotoxic carcinogens, genotoxic carcinogens, 
genotoxic non-carcinogens and non-genotoxic non-carcinogens. 
 
One hundred and fifty non-genotoxic carcinogenic chemical structures, in SMILES strings, 
were copied from the column “STRUCTURE_SMILES” using the “find & select” tool, 
selecting only visible cells as shown in  Figure 2.7. The same process was performed for 
the other three groups of compounds. Once selected, SMILES strings were pasted into a 
new Excel sheet and saved as a txt file. 
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Figure 2.7. SMILES strings copied from the “STRUCTURE_SMILES” column in the CPDB 
Excel spreadsheet. 
 
Step 4: SMILES converted to a SDF file in Open Babel for use in the Chemotyper and 
Toxtree. 
The most important information about chemicals is easily exchanged using the SDF file format. 
SDF files include all necessary information about training/test set molecules (i.e., identifiers of 
all compounds, CAS/ InChI/ name/ formula, 3D structures, experimental and predicted values 
of target properties/parameters and the values of the molecular descriptors utilised). 
In order to convert and store the filtered list of chemical structures, the open source Open Babel 
programme version 2.3.2 was used. This program is designed to search, convert and store 
chemical data from molecular modelling. Open Babel version 2.3.2 for Windows is freely 
available at http://openbabel.org/. Open Babel was used as follows: 
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1. The SMILES strings of the non-genotoxic carcinogens and the three other groups 
were saved as a .txt file to act as the input into Open Babel – its content was 
visualised to confirm it was recorded correctly. 
2. In order to save the output as a SDF file, the name and the path of the output file 
were specified as shown in Figure 2.8.  
3. In case of an error occurring for certain chemical structures during the conversion 
process, Open Babel offers a choice to continue and override to the next structure 
in the input SMILES list to avoid any delays or error in structure conversion process 
which was activated before the conversion process.   
4. All four resultant SDF files were saved in separate files to be used in Toxtree. 
 
Figure 2.8. Screenshot of the Open Babel software showing the input (SMILES) and output 
(SDF) format. 
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Step 5: The data sets were run through Toxtree to review Benigni et al.’s (2013) structural 
alerts: 
Toxtree is a programme developed by IDEAconsult Ltd. (Sofia, Bulgaria) for researchers and 
other stakeholders (especially in industry) to predict various types of toxic effects using 
decision trees to place chemicals into appropriate categories. It includes Benigni et al.’s (2013) 
rules for mutagenicity and carcinogenicity. Chemical structures can be entered into Toxtree 
using SMILES strings, SDF files, and over 110 other chemical file formats. If a structural alert 
is present in a molecule this is highlighted and can be recorded. The Toxtree software was used 
as described below. 
1. First, it is essential to choose the correct decision tree to predict carcinogenicity and 
mutagenicity. This was selected by clicking on method from the main tabs and then 
choosing the desired tree from “select decision tree”. 
2. As illustrated in  Figure 2.9, a list of available decision trees was shown, including 
that required to use Benigni et al.’s (2013) structural alerts, under the name of 
“carcinogenicity (genotox & nongenotox) by ISS”.  
 
Figure 2.9. The choice of decision tree for “Carcinogenicity prediction by ISS”. 
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3. The 150 chemicals determined to be non-genotoxic to rat were entered into Toxtree 
as a SDF file and the alerts run on them using the (estimate) tab for each chemical. 
This   process was also applied to the 240 chemicals determined to be genotoxic 
carcinogen to rat. 
4. All structures containing one or more of Benigni et al.’s (2013) structural alerts for 
either genotoxic or non-genotoxic carcinogenicity were highlighted in Toxtree with 
a brown warning message for non-genotoxic carcinogen and red for genotoxic 
carcinogen under the estimation tab, as shown in Figure 2.10. The presence of an 
alert was counted as a positive result. 
 
 
 
Figure 2.10. Structural alert for the non-genotoxic carcinogenicity for benzyl butyl phthalate. 
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5. The SDF files for the third and fourth groups of chemical structures (non-
carcinogens) were also entered Toxtree to evaluate the negative predictivity of the 
“carcinogenicity (genotox & nongenotox) by ISS” decision tree. 
 
 
 
2.2.3 Statistical analysis  
The results of the predictions were analysed in Excel using a four-way contingency table. The 
performance of 23 non genotoxic carcinogen structural alerts, 32 genotoxic carcinogen 
structural alerts and the overall performance of ISS carcinogenicity profiler which includes 
both genotoxic and non-genotoxic structural alerts was assessed against the two groups of 
substances, 390 carcinogens and 350 non carcinogens. The true positive rate (sensitivity) was 
calculated for both non genotoxic and genotoxic carcinogens alone and then compared with the 
true positive rate of the ISS carcinogenicity profiler which includes both. All substances among 
the 390 carcinogenic group that were correctly predicted either by non-genotoxic or genotoxic 
carcinogenic structural alerts were counted as true positives, if it failed to predict the 
carcinogenic substances, then it was counted as a false negative. Among the group of 350 non 
carcinogenic substances, the true negative rate (specificity) was calculated for both non-
genotoxic and genotoxic carcinogenic for structural alerts alone and then calculated for ISS 
carcinogenicity profiler as a whole. All substances among the group of 350 non carcinogens 
that were falsely predicted as carcinogenic will be counted as false positive and, if not, were 
counted as true negative predictions. 
 
 
 
 
 
Chapter 2 
 
      Page 65  
2.3. Results and discussion: 
 
The aim of this chapter was to assess the currently available structural alerts for both genotoxic 
and non-genotoxic carcinogenicity, focussing on the main four mechanisms of action of non-
genotoxic carcinogenicity: peroxisome proliferation, hormonal imbalance, oxidative stress, 
and aryl hydrocarbon receptor agonism/antagonism and the main five mechanisms of action of 
genotoxic carcinogenicity: direct DNA alkylation, indirect DNA alkylation, direct acylation, 
amino aryl DNA adduct formation and DNA adduct formation by intercalation. In this Chapter, 
the performance of 23 structural alerts for non-genotoxic carcinogenicity and 32 structural 
alerts for genotoxic carcinogenicity as described by Benigni et al. (2013) and coded within 
Toxtree version 2.6.13, was assessed by comparison with experimental data for carcinogenicity 
which were compiled in, and retrieved from, the CPDB.  
Analysis of the CPDB found 390 substances in the CPDB to be experimentally determined to 
be carcinogenic in rats. Of these 390 substances, 150 were non-genotoxic (i.e., negative in the 
Ames test). The remaining 240 substances were positive in the Ames test, i.e., rat genotoxic 
carcinogens. The analysis also found 350 substances to be experimentally determined to be 
non-carcinogenic in the rat. All 740 substances were assessed using Toxtree version 2.6.13, 
applying the carcinogenicity rules by ISS. The predictions were compared with the 
experimental results.  
The number of correct predictions for the carcinogenic compounds is reported in Table 2.3. 
For positive prediction of non-genotoxic carcinogenic substances, only 41 out of the total 150 
were correctly assigned as being carcinogenic. Thus, the predictively of Toxtree with regard to 
the positive identification of non-genotoxic carcinogens was only 27.3%. This is in a sharp 
contrast to 91% predictivity for genotoxic carcinogenic compounds (223 positively predicted 
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out of 240) and shows the limitation of the currently available structural alerts in relation to the 
identification of non-genotoxic carcinogenic chemicals.  
Table 2.3. Prediction of genotoxic and non-genotoxic carcinogenicity using the ISS Rulebase 
in Toxtree v2.6.13. 
 
2.3.1 Genotoxic carcinogen structural alerts: 
The most common structural alerts to predict genotoxic carcinogens were for the aromatic 
amines and nitro aromatics, with 51 and 40 hits respectively. These substances become 
carcinogenic through the aminoaryl DNA adduct formation as an indirect acting agent (Benigni, 
2005). The structural alerts for compounds that exert their action by alkylating mechanisms 
were also predictive, as the indirect acting agent alkyl and aryl N-nitroso groups were found in 
 
 
Name and classification 
of substances’ groups  
 
Number of substances 
predicted by the 23 
structural alerts as non-
genotoxic carcinogen in 
Toxtree 
 
 
Number of substances 
predicted by the 32 
structural alerts as 
genotoxic carcinogen in 
Toxtree 
 
ISS carcinogenicity 
profiler (genotoxic and 
non-genotoxic) 
 
 
Carcinogen 
390 Substances 
Non-Genotoxic 
150 Substance 
 
       41 True Positive  
 
     223 True Positive 
 
264 
True 
positive 
126 
False 
Negative Genotoxic  
240 Substance 
 
Non-carcinogen 
350 Substances 
Genotoxic  
108 Substance 
 
     11 False Positive 
 
 
 
    114 False Positive 
 
 
125 
False 
positive 
225 
True 
Negative Non-Genotoxic 
242 Substance 
 
 
 
 
 
True positive rate (sensitivity) % 
 
Positive Predictive Value: 
 
78.8% 
 
Sensitivity among 150 
non-genotoxic 
carcinogens:  
 
27.3% 
 
Positive Predictive 
Value: 
 
66.1% 
 
Sensitivity among 240 
genotoxic carcinogens:  
 
92% 
 
 
 
68% 
 
True negative rate (specificity) % 
  
64% 
 
 
Chapter 2 
 
      Page 67  
39 out of 240 genotoxic substances. Direct acting agents (i.e. aliphatic halogens) were found 
in 20 genotoxic substances. The other structural alerts listed in Table 2.5 were present in 
different substances; however, they were limited in number compared to aromatic amines and 
nitro aromatic structural alerts. The alerts were grouped in Table 2.5 based on the main 
mechanisms of action, as some of the alerts were poorly represented among the experimental 
carcinogens. 
As shown in Table 2.4, seventeen experimentally determined genotoxic carcinogenic 
substances were not flagged by genotoxic carcinogenic structural alerts out of the total of 240; 
however, some were obviously carcinogenic, including formaldehyde, selenium sulfide, 
sodium nitrite and tetra-nitromethane. Nevertheless, there was no common link that could be 
used to group these structures to derive a new rule. 
One of these seventeen carcinogenic substances is selenium sulfide which is used as an anti-
dandruff in shampoos. It is believed that selenium sulfide controls dandruff via its anti-
Malassezia effect, rather than by its antiproliferative effect although it has an effect in reducing 
cell turnover (Milani et al., 2003). Malassezia is a genus of fungi that is naturally found on the 
skin surfaces of many animals, including humans. It has anti-seborrheic properties as well as 
cytostatic effect on cells of the epidermal and follicular epithelium. Excessive oiliness after use 
of this agent has been reported in many patients as adverse drug effect (Ranganathan and 
Mukhopadhyay, 2010). 
Selenium sulfide is reasonably anticipated to be a human carcinogen based on sufficient 
evidence of carcinogenicity from experimental studies in animals. Oral exposure of selenium 
sulfide caused tumours in two rodent species and at two different tissue sites. Administration 
of selenium sulfide by stomach tube caused liver cancer (hepatocellular carcinoma) in rats of 
both sexes and in female mice. In female mice, it also increased the combined incidence of 
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benign and malignant lung tumours (alveolar/bronchiolar adenoma and carcinoma) (NCI 
1980b). When applied topically, selenium sulfide and selsun, an antidandruff shampoo 
containing 2.5% selenium sulfide, did not cause tumors in mice; however, these studies were 
considered inconclusive, because the study length was limited to 88 weeks by the animals’ 
early death resulting from amyloidosis (NCI 1980a,c). 
Another chemical substance that has been determined experimentally as being a non-genotoxic 
carcinogen, and not identified by non-genotoxic carcinogenic alerts, was potassium bromate 
(KBrO3). This is an oxidising agent that has been used as a food additive and in the cosmetic 
industry. Although adverse effects are not evident in animals fed bread-based diets made from 
flour treated with KBrO3, the agent is carcinogenic in rats and nephrotoxic in both man and 
experimental animals when given orally. It has been demonstrated that KBrO3 induces renal 
cell tumours, mesotheliomas of the peritoneum and follicular cell tumours of the thyroid. In 
addition, experiments aimed at elucidating the mode of carcinogenic action have revealed that 
KBrO3 is a complete carcinogen, possessing both initiating and promoting activities for rat 
renal tumorigenesis. However, the potential seems to be weak in mice and hamsters. Active 
oxygen radicals generated from KBrO3 were implicated in its toxic and carcinogenic effects, 
especially because KBrO3 produced 8-hydroxydeoxyguanosine in the rat kidney (Kurokawa 
et al., 1990).  
In general genotoxic carcinogen structural alerts showed a high sensitivity rate among large 
number of carcinogenic substances compared to non-genotoxic alerts.  
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Table 2.4. Identity of 17 out of 240 experimentally genotoxic carcinogen which were not 
identified by the ISS genotoxic rule base 
Numb
er 
Chemical Name IUPAC SMILES String 
1 acrylonitrile C=CC#N 
2 4-amino-1-β-D-
ribofuranosyl-1,3,5-
triazin-2(1H)-one 
N/C1=N/C(=O)N(/C=N1)[C@@H]2O[C@H](CO)[C@@H](
O)[C@H]2O 
3 potassium bromate Br(=O)(=O)[O-].[K+] 
4 buta-1,3-diene C=CC=C 
5 naphthalen-1-yl 
methylcarbamate 
O=C(OC1=C2C(=CC=C1)C=CC=C2)NC 
6 trichloro(nitro)methane ClC([N+](=O)[O-])(Cl)Cl 
7 2,6-dimethyl-1,3-
dioxan-4-yl acetate 
CC1CC(OC(O1)C)OC(=O)C 
8 dimethyl phosphonate O=P(H)(OC)OC 
9 formaldehyde C=O 
10 sodium nitrite O=N[O-].[Na+] 
11 1,4-benzoquinone 
dioxime 
ON=C1C=CC(=NO)C=C1 
12 selenium sulfide [Se]=S 
13 8-hydroxy-6-
(methyloxy)-3a,12c-
dihydro-7H-
furo[3',2':4,5]furo[2,3-
c]xanthen-7-one 
O=C1C2=C(C=C3C(=C2OC4=CC=CC(=C14)O)C5C(O3)OC
=C5)OC 
14 styrene C=CC1=CC=CC=C1 
15 tetranitromethane O=[N+](C([N+](=O)[O-])([N+](=O)[O-])[N+](=O)[O-])[O-] 
16 propane-1,2,3-triyl 
trioctanoate 
O=C(OC(COC(=O)CCCCCCC)COC(=O)CCCCCCC)CCCC
CCC 
17 zinc 
bis(dimethyldithiocarba
mate) 
S=C([S-])N(C)C.[S-]C(N(C)C)=S.[Zn+2] 
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Table 2.5. Percentage of structural alerts flagged among the group of genotoxic carcinogens 
organised according to chemical reactivity domain.  
 
Mechanism 
of Action 
 
 
Structural Alert 
Number of 
genotoxic 
carcinogens 
containing 
this alert 
Total number of 
genotoxic 
carcinogen 
structural alerts by 
this mechanism  
Percentage of the 
genotoxic 
carcinogen 
structural alerts of 
this mechanism  
out of total  
 
 
 
 
Alkylating 
(Direct acting 
agent) 
 
 
 
 
Alkyl (C5) or benzyl esters 
of sulphonic or phosphonic 
acids 
4  
 
 
 
 
 
 
91 
 
 
 
 
 
 
 
35% 
N-methylol derivatives 0 
S- or N- mustards 4 
Propiolactones and 
propiolsulfones 
3 
Epoxides and arizidines 10 
Aliphatic halogens 20 
Alkyl nitrite 1 
α, β-Unsaturated carbonyls 2 
Simple aldehydes 1 
Quinones 7 
Alkyl and aryl N-nitroso groups 39 
 
 
Alkylating 
(Indirect 
acting agent) 
 
Monohaloakenes 7  
 
 
 
 
32 
 
 
 
 
 
  13% 
Hydrazines 10 
Aliphatic azo and azoxy 2 
Alkyl carbamate and 
thiocarbamate 
4 
Azide and triazene groups 3 
Aliphatic N-nitro groups 1 
α, β-Uunsaturated alkoxy 
groups 
0 
Pyrrolizidine Alkaloids 3 
Alkenylbenzenes 2 
Steroidal oestrogens 
(genotoxic & non-
genotoxic) 
0 
Acylating 
(Direct acting 
agent) 
Isocyanate and 
isothiocyanate groups 
 
3 
 
3 
 
2% 
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Amino aryl 
DNA adduct 
forming 
(indirect 
acting agent) 
Aromatic ring N-oxides 0  
 
 
 
119 
 
 
 
 
43% 
Aromatic nitroso groups 1 
Nitro aromatic 40 
Aromatic amines and 
hydroxyl amine and their 
derived esters 
51 
Aromatic mono and 
dialkylamino groups 
7 
Aromatic N-acyl amines 7 
Aromatic diazo groups 14 
Intercalating 
and DNA 
adduct 
forming 
(indirect 
acting agent) 
Polycyclic Aromatic 
Hydrocarbons 
5  
 
19 
7% 
Heterocyclic Polycyclic 
Aromatic Hydrocarbons 
11 
Coumarins and 
furocoumarins 
4 
 
2.3.2: Non genotoxic structural alerts:  
Table 2.6 shows, among the 150 non-genotoxic carcinogens, hormonal balance and oxidative 
stress structural alerts were more often detected among the total group, with more than 46% 
and 24% hits respectively. Thiocarbonyl and alkyl halides were the highest detected alerts 
amongst the hormonal imbalance group, while metals and benzodioxol were detected more 
amongst the oxidative stress group. Nearly 71% of all non-genotoxic carcinogens were detected 
by hormonal imbalance or oxidative stress. Aryl hydrocarbon agonist and antagonist and 
peroxisome proliferator structural alerts were less detectable compared to hormonal imbalance 
and oxidative stress, as shown in Figure 2.11. The number of structural alerts for aryl 
hydrocarbon and peroxisome proliferator is still limited and there is a need to do more research 
to produce new structural alerts based on experimental results for additional chemical 
substances. 
Only 41 non-genotoxic carcinogen substances, out of 150, were identified correctly by these 
23 non-genotoxic carcinogen structural alerts. This means that 109 substances experimentally 
determined as non-genotoxic carcinogen were not identified by these structural alerts. These 
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109 non-genotoxic carcinogen substances are listed in Table 2.7 in order to allow investigation 
of why these non-genotoxic carcinogens are not identified and to develop the structural alerts 
further. 
As shown in Table 2.6 (alert number 10, oxidative stress), there are only three non-genotoxic 
carcinogens containing a structural alert for a metal. These three substances are 
dicopper:tetrasodium 3,3'-[(3,3'-dihydroxybiphenyl-4,4'-diyl)di(E)diazene-2,1-diyl]bis(5-
amino-4-hydroxynaphthalene-2,7-disulfonate), mercury(2+) dichloride and dimethylarsenic 
acid. The three substances contained copper, mercury and arsenic respectively and thus they 
were flagged by the structural alert for metals to be non-genotoxic carcinogens. However, after 
reviewing the list of 109 experimentally non-genotoxic carcinogenic substances that were not 
identified by the non-genotoxic carcinogen alerts in Table 2.7, there are another three 
substances containing heavy metals and not identified by the alert for metals. These three 
substances were cadmium dichloride, lead(2+) diacetate and zinc ethane-1,2-
diylbis(dithiocarbamate). This indicates that the structural alert for metals was only predicting 
copper, mercury and arsenic as non-genotoxic carcinogens but it was failed to predict 
substances that contain other metals such as lead, cadmium and zinc although that they have 
known carcinogenic activity with the same oxidative stress mechanism.  
The low true positive rate for non-genotoxic carcinogen shows the need to include more 
structural alerts to give more coverage for this type of carcinogen. Further detailed assessment 
of the performance of both genotoxic and non-genotoxic carcinogen structural alerts is 
performed in the next chapters. 
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Table 2.6. Percentage of non-genotoxic structural alerts flagged among the non-genotoxic 
carcinogen experimental group of chemicals based their mechanism of action. 
 
 
 
No 
 
 
 
Mechanism of 
action  
 
 
 
Structural Alert Name 
Number of 
nongenotoxic 
carcinogens 
containing 
this alert 
Total number of 
non-genotoxic 
carcinogen structural 
alerts by this 
mechanism  
Percentage of non 
genotoxic carcinogen 
structural alerts of this 
mechanism 
Out of total  
1  
 
 
 
Hormonal 
Imbalance 
Thiocarbonyl  6  
 
 
 
 
19 
 
 
 
 
46.3% 
 
 
 
2 Poly halocycloalkane 3 
3 Benzimidazole 1 
4 Imidazole,benzamidazole 1 
5 Dicarboximide 1 
6 Dimethylpyridine 0 
7 Benzsulfonic ether 3 
8 Alkyl halide 4 
9 Steroid oestrogen M/N 0 
10  
 
 Oxidative Stress 
Metals 3  
 
10 
 
 
24.4% 
11 1,3-Benzdioxole 4 
12 Pentachlorophenole 1 
13 2- Phenylphenol 1 
14 Quercetin flavonoid 0 
15  
Aryl 
Hydrocarbon 
Agonist-
Antagonist 
Halogenated benzene 3  
8 
 
19.5% 16 Halogenated 
dibenzodioxine 
1 
17 Indole-3-carbonyl 0 
18  
 
 
Peroxisome 
Proliferator 
 
 
Phenoxy herbicide 0  
 
 
4 
 
 
 
9.8% 
19 Substituted  phenoxyacid 1 
20 Substituted  N-
alkylcarboxylic acid 
2 
21 Phthalate 2 
22 Perflourooctanoic acid 
(PFOA) 
0 
23 Tri and tetraflouro 
ethylene 
3 
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Figure 2.11. Percentage of structural alerts flagged on non-genotoxic carcinogenic chemicals 
based on their mechanism of action. 
Table 2.7. List of 109 out of 150 experimentally non-genotoxic carcinogens which were not 
identified by the ISS genotoxic rule base structural alerts for non-genotoxic carcinogenicity. 
Number Chemical Name SMILES String 
1 acetaldehyde CC=O 
2 acetamide CC(=O)N 
3 N-(4-hydroxyphenyl)acetamide C1(=CC=C(C=C1)O)NC(C)=O 
4 acrylamide NC(=O)C=C 
5 
2-amino-4,6-dimethyl-3-oxo-N,N'-
bis[(6S,9R,10S,13R,18aS)-2,5,9-trimethyl-
6,13-bis(1-methylethyl)-1,4,7,11,14-
pentaoxohexadecahydro-1H-pyrrolo[2,1-
i][1,4,7,10,13]oxatetraazacyclohexadecin-
10-yl]-3H-phenoxazine-1,9-dicarboxamide 
C12C(OC3=C(N=1)C(=CC=C3C)C(N[C@@H]4C(N[C@@H](C(N5[C@@
H] 
(CCC5)C(N(CC(N([C@H](C(O[C@H]4C)=O)C(C)C)C)=O)C)=O)=O)C(C)
C)=O)=O)=C(C(C(=C2C(N[C@@H]6C(N[C@@H](C(N7[C@@H](CCC7)
C(N(CC(N([C@H](C(O[C@H]6C) 
=O)C(C)C)C)=O)C)=O)=O)C(C)C)=O)=O)N)=O)C 
6 allyl 3-methylbutanoate O=C(CC(C)C)OCC=C 
7 1H-1,2,4-triazol-3-amine C1(N=CNN=1)N 
8 11-aminoundecanoic acid OC(=O)CCCCCCCCCCN 
9 aniline hydrochloride NC1=CC=CC=C1[H]Cl 
10 2,2',3,3',4-pentachlorobiphenyl ClC2=C(C=CC(Cl)=C2Cl)C1=C(Cl)C(Cl)=CC=C1 
11 
6-chloro-N-ethyl-N'-isopropyl-1,3,5-triazine-
2,4-diamine 
ClC1=NC(=NC(=N1)NC(C)C)NCC 
12 benzene C1=CC=CC=C1 
13 1-benzofuran C1=COC2=C1C=CC=C2 
14 
2,2'-{[2-(5-nitro-2-thienyl)quinazolin-4-
yl]imino}diethanol 
C1=CC=C2C(=C1)N=C(N=C2N(CCO)CCO)C3=CC=C(S3)[N+]([O-])=O 
15 2-methylpropan-2-ol CC(C)(C)O 
16 benzyl butyl phthalate C1(=C(C=CC=C1)C(OCCCC)=O)C(OCC2=CC=CC=C2)=O 
46%
24%
20%
10%
Total hits out of 150 substances
Hormonal Imbalance
Oxidative Stress
Preoxisome Proliferator
Aryl Hydrocarbone Agonist-
Antagonist
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17 2-(1,1-dimethylethyl)-4-(methyloxy)phenol OC1=CC=C(C=C1C(C)(C)C)OC 
18 cadmium dichloride [Cl-].[Cd+2].[Cl-] 
19 (2E)-3-(3,4-dihydroxyphenyl)acrylic acid OC1=C(C=CC(=C1)/C=C/C(=O)O)O 
20 [(aminocarbonyl)(nitroso)amino]acetic acid N(C(=O)N)(N=O)CC(=O)O 
21 pyrocatechol OC1=C(C=CC=C1)O 
22 1,2,3,4,6,7,10-heptachlorododecane ClC(CC(Cl)C(Cl)CCC(Cl)CC)C(Cl)C(Cl)CCl 
23 2-chloro-1,1,1-trifluoroethane C(CCl)(F)(F)F 
24 chloro(methoxy)methane ClCOC 
25 3-(4-chlorophenyl)-1,1-dimethylurea O=C(N(C)C)NC1=CC=C(C=C1)Cl 
26 2-chlorobuta-1,3-diene C=C(Cl)C=C 
27 2,4,5,6-tetrachloroisophthalonitrile ClC1=C(C(=C(C(=C1C#N)Cl)Cl)Cl)C#N 
28 
(2E)-3-phenylprop-2-en-1-yl 2-
aminobenzoate 
NC1=C(C=CC=C1)C(=O)OC/C=C/C2=CC=CC=C2 
29 
(3S,4R)-8-hydroxy-3,4,5-trimethyl-6-oxo-
4,6-dihydro-3H-isochromene-7-carboxylic 
acid 
CC1=C2C(=CO[C@H]([C@@H]2C)C)C(=C(C1=O)C(=O)O)O 
30 
4-(2,2-dimethylhydrazino)-4-oxobutanoic 
acid 
O=C(CCC(=O)O)NN(C)C 
31 4,4'-sulfonyldianiline O=S(=O)(C1=CC=C(C=C1)N)C2=CC=C(C=C2)N 
32 2,2'-oxydiethanol OCCOCCO 
33 4,4'-(3E)-hex-3-ene-3,4-diyldiphenol OC2=CC=C(C=C2)/C(CC)=C(CC)/C1=CC=C(O)C=C1 
34 chroman-2-one O=C1OC2=C(C=CC=C2)CC1 
35 dimethyl methylphosphonate CP(=O)(OC)OC 
36 dimethyl morpholin-4-ylphosphonate P(=O)(OC)(OC)N1CCOCC1 
37 N,N-dimethylaniline CN(C1=CC=CC=C1)C 
38 1,4-dioxane C1COCCO1 
39 
N,N-dimethyl-2-(1-phenyl-1-pyridin-2-
ylethoxy)ethanamine succinate 
C(CC(=O)O)C(=O)O.C(OCCN(C)C)(C)(C1=CC=CC=C1)C2=CC=CC=N2 
40 
6',7',10,11-tetramethoxyemetan 
dihydrochloride 
[C@@]12(C3=C(C=C(OC)C(=C3)OC)CCN1C[C@H](CC)[C@H](C2)C[C
@@]4(C5=C(C=C(OC)C(=C5)OC)CCN4)[H])[H].[H]Cl.[H]Cl 
41 
4-[(1R)-1-hydroxy-2-
(methylamino)ethyl]benzene-1,2-diol 
hydrochloride 
C1(=C(C=CC(=C1)[C@H](CNC)O)O)O.[H]Cl 
42 
(17beta)-17-ethynylestra-1(10),2,4-triene-
3,17-diol 
[H][C@]14[C@@]([C@]3([H])CC[C@@](O)(C#C)[C@](C)3CC4)([H])CC
C2=CC(O)=CC=C12 
43 S-ethyl-L-homocysteine N[C@@H](CCSCC)C(=O)O 
44 S-ethylhomocysteine NC(CCSCC)C(=O)O 
45 1-(4-ethoxyphenyl)urea NC(NC1=CC=C(C=C1)OCC)=O 
46 ethyl acrylate O=C(OCC)C=C 
47 ethanol CCO 
48 ethylbenzene CCC1=CC=CC=C1 
49 furan C1=COC=C1 
50 2-furylmethanol C1=C(CO)OC=C1 
51 glycine NCC(O)=O 
52 
(6aR,11bS)-7,11b-dihydroindeno[2,1-
c]chromene-3,4,6a,9,10(6H)-pentol 
OC1=C(O)C=C4C(C[C@](COC2=C3C=CC(O)=C2O)([C@@]34[H])O)=C
1 
53 hexachlorobenzene ClC1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl 
54 
N,N,N',N',N'',N''-hexamethylphosphoric 
triamide 
CN(C)P(=O)(N(C)C)N(C)C 
55 hydroquinone OC1=CC=C(C=C1)O 
56 2-methylprop-1-ene CC(C)=C 
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57 3,5,5-trimethylcyclohex-2-en-1-one CC1(CC(=CC(=O)C1)C)C 
58 isoprene CC(=C)C=C 
59 lead(2+) diacetate C([O-])(C)=O.[Pb+2].[O-]C(C)=O 
60 
(4R)-1-methyl-4-(1-
methylethenyl)cyclohexene 
CC(=C)[C@@H]1CCC(=CC1)C 
61 sodium (1E)-3-oxoprop-1-en-1-olate C(=C/C=O)\[O-].[Na+] 
62 1,3,5-triazine-2,4,6-triamine NC1=NC(=NC(=N1)N)N 
63 1,3-benzothiazole-2-thiol SC1=NC2=C(C=CC=C2)S1 
64 
N,N-dimethyl-N'-pyridin-2-yl-N'-(2-
thienylmethyl)ethane-1,2-diamine 
hydrochloride 
CN(C)CCN(CC2=CC=CS2)C1=NC=CC=C1.Cl 
65 4-methoxyphenol COC1=CC=C(C=C1)O 
66 1,1-dimethylethyl methyl ether CC(OC)(C)C 
67 methyl carbamate NC(=O)OC 
68 1-phenylethanol C1=CC=C(C(O)C)C=C1 
69 4-methylbenzene-1,2-diol OC1=C(C=CC(=C1)C)O 
70 4-allyl-1,2-dimethoxybenzene O(C)c1cc(CC=C)ccc1OC 
71 
(3R,4R,5R,13aR,13bR)-4,5-dihydroxy-
3,4,5-trimethyl-4,5,8,10,12,13,13a,13b-
octahydro-2H-
[1,6]dioxacycloundecino[2,3,4-
gh]pyrrolizine-2,6(3H)-dione 
O=C1O[C@@H]3CCN2C\C=C(\COC(=O)[C@](C)(O)[C@](C)(O)[C@H]1
C)[C@@H]23 
72 
1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-
naphthyridine-3-carboxylic acid 
O=C1C2=C(N=C(C=C2)C)N(C=C1C(=O)O)CC 
73 naphthalene C1=C2C(=CC=C1)C=CC=C2 
74 2,2',2''-nitrilotriacetic acid OC(=O)CN(CC(=O)O)CC(=O)O 
75 trisodium 2,2',2''-nitrilotriacetate hydrate N(CC(=O)[O-])(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Na+].O 
76 nitrobenzene O=[N+](C1=CC=CC=C1)[O-] 
77 nitromethane [O-][N+](C)=O 
78 
2,6-dimethyl-4-nitroso-1-
(phenylcarbonyl)piperazine 
N1(CC(N(C(C1)C)C(C2C=CC=CC=2)=O)C)N=O 
79 N-nitroso-N-phenylaniline O=NN(C1=CC=CC=C1)C2=CC=CC=C2 
80 4-[methyl(nitroso)amino]butanoic acid O=C(CCCN(C)N=O)O 
81 1-methyl-2-nitrobenzene [N+](=O)([O-])c1ccccc1C 
82 1-methyl-4-nitrobenzene O=N(=O)c1ccc(C)cc1 
83 
N-{[(3R)-5-chloro-8-hydroxy-3-methyl-1-
oxo-3,4-dihydro-1H-isochromen-7-
yl]carbonyl}-L-phenylalanine 
O=C(O[C@H](C)C2)C1=C2C(Cl)=CC(C(N[C@@H](CC3=CC=CC=C3)[C
@@](O)=O)=O)=C1O 
84 
17-Hydroxy-2-(hydroxymethylene)-17-
methyl-5-alpha-17-beta-androst-3-one 
O=C3C[C@@H]4CC[C@@H]1[C@H](CC[C@]2(C)[C@@](C)(O)CC[C
@@H]12)[C@@]4(C)C\C3=C\O 
85 
1,5-dimethyl-2-phenyl-1,2-dihydro-3H-
pyrazol-3-one 
CN1N(C2=CC=CC=C2)C(=O)C=C1C 
86 
3-[(E)-phenyldiazenyl]pyridine-2,6-diamine 
hydrochloride 
NC1=CC=C(/N=N/C2=CC=CC=C2)C(N)=N1.Cl 
87 
(3β)-cholest-5-en-3-yl {4-[bis(2-
chloroethyl)amino]phenyl}acetate 
O=C(O[C@@H]5CC([C@@](CC5)(C)[C@]([H])3CC4)=CC[C@@]3([H])[
C@@]2([H])[C@@]4(C)[C@]([C@H](C)CCCC(C)C)([H])CC2)CC1=CC=
C(N(CCCl)CCCl)C=C1 
88 
sodium 5-ethyl-4,6-dioxo-5-phenyl-1,4,5,6-
tetrahydropyrimidin-2-olate 
C1(C2=CC=CC=C2)(C(NC(=NC1=O)[O-])=O)CC.[Na+] 
89 
3,3-bis(4-hydroxyphenyl)-2-benzofuran-
1(3H)-one 
O=C1OC(C2=C1C=CC=C2)(C3=CC=C(C=C3)O)C4=CC=C(C=C4)O 
90 4-butyl-1,2-diphenylpyrazolidine-3,5-dione O=C1N(C2=CC=CC=C2)N(C3=CC=CC=C3)C(=O)C1CCCC 
91 
(11β)-11,17,21-trihydroxypregna-1,4-diene-
3,20-dione 
[C@]13([C@@](C(=O)CO)(CC[C@H]1[C@@H]2CCC=4[C@@]([C@H]2
[C@H](C3)O)(\C=C/C(C=4)=O)C)O)C 
92 
N-(1-methylethyl)-4-[(2-
methylhydrazino)methyl]benzamide 
CNNCC1=CC=C(C=C1)C(=O)NC(C)C 
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93 
N-(1-methylethyl)-4-[(2-
methylhydrazino)methyl]benzamide 
hydrochloride 
CNNCC1(=CC=C(C=C1)C(=O)NC(C)C).[H]Cl 
94 pyridine N1=CC=CC=C1 
95 
disodium 3-hydroxy-4-[(E)-(2,4,5-
trimethylphenyl)diazenyl]naphthalene-2,7-
disulfonate 
CC1=CC(C)=C(/N=N/C2=C(C(S([O-])(=O)=O)=CC3=C2C=CC(S([O-
])(=O)=O)=C3)O)C=C1C.[Na+].[Na+] 
96 
trisodium 3-hydroxy-4-[(Z)-(4-
sulfonatonaphthalen-1-
yl)diazenyl]naphthalene-2,7-disulfonate 
C12(C(=CC(=C(C=1/N=N/C3=C4C(=C(C=C3)S(=O)(=O)[O-
])C=CC=C4)O)S(=O)(=O)[O-])C=C(C=C2)S(=O)(=O)[O-
]).[Na+].[Na+].[Na+] 
97 
methyl (3β,16β,17α,18β,20α)-11,17-
bis(methyloxy)-18-({[3,4,5-
tris(methyloxy)phenyl]carbonyl}oxy)yohim
ban-16-carboxylate 
O=C(C4=CC(OC)=C(OC)C(OC)=C4)O[C@@H]1C[C@@]3([H])[C@@](
C[C@](N5C3)([H])C2=C(CC5)C(C=C6)=C(C=C6OC)N2)([H])[C@H]([C
@](OC)=O)[C@H]1OC 
98 tetrahydrofuran C1CCCO1 
99 toluene CC1=CC=CC=C1 
100 2-methylbenzenesulfonamide CC1=C(C=CC=C1)S(=O)(=O)N 
101 tributyl phosphate CCCCOP(=O)(OCCCC)OCCCC 
102 2,4,6-trichlorophenol OC1=C(C=C(C=C1Cl)Cl)Cl 
103 tris(2-chloroethyl) phosphate O=P(OCCCl)(OCCCl)OCCCl 
104 pyrimidine-2,4(1H,3H)-dione O=C1NC(=O)NC=C1 
105 vinyl acetate CC(=O)OC=C 
106 4-vinylcyclohexene C=CC1CCC=CC1 
107 1-vinylpyrrolidin-2-one O=C1N(C=C)CCC1 
108 m-xylene CC1=CC=CC(C)=C1 
109 zinc ethane-1,2-diylbis(dithiocarbamate) S=C([S-])NCCNC([S-])=S.[Zn+2] 
 
 
 
2.4: Conclusions:  
The aim of Chapter 2 was to assess the currently available structural alerts for both genotoxic 
and non-genotoxic carcinogenicity, focussing on the main mechanisms of action of both 
genotoxic and non-genotoxic carcinogenicity. An existing database of information (i.e. the 
CPDB) was downloaded and the data curated and cleaned. From this, 240 genotoxic 
carcinogens and 150 non-genotoxic carcinogens were identified. A well-used rule base for ISS 
carcinogenicity in Toxtree version 2.6.13 was utilised to investigate the usefulness of the alerts. 
Out of the 240 genotoxic carcinogens, the true positive rate of the genotoxic carcinogens was 
92% with 223 predicted correctly. The majority of genotoxic carcinogens were associated with 
aromatic amines and nitro aromatics, with 51 and 40 hits respectively. These substances 
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become carcinogenic through the aminoaryl DNA adduct formation as an indirect acting agent. 
This high positive predictivity is due to the clear mechanistic information of the molecular 
initiating event (MIE) which can be used as structural alert and gives a more accurate result. 
For non-genotoxic carcinogens, the alerts only identified 41 of 150 non genotoxic substances 
correctly, giving a true positive rate of 27%. The most influential alerts were for hormonal 
imbalance and oxidative stress mechanism, which accounted for more than 71% of the positive 
hits, as compared to peroxisome proliferators and aryl hydrocarbon agonists and antagonists 
with lower hit rates. It was also shown that the structural alert for metals was poorly defined 
and not able to identify other metals that caused carcinogenicity through oxidative stress e.g. 
lead, zinc and cadmium. Therefore, better definition of existing alerts, and greater coverage 
with new alerts is needed. More detailed assessment of individual structural alerts for both 
genotoxic and non-genotoxic carcinogens will be undertaken in the next chapters. 
 
 
 Chapter 3: Assessment of current profilers and structural alerts for mutagenicity provided in 
the OECD QSAR Toolbox. 
 
3.1 Introduction 
Assessment of the mutagenic potential of the ingredients used in cosmetic products and 
preparations is one of the priorities of the safety assessment process. Safety assessment is based, 
in part, on regulatory requirements. For instance, the SCCS Notes of Guidance for the Testing 
of Cosmetic Ingredients and their Safety Evaluation (10th revision, SCCS/1602/18), indicate 
that mutagenicity refers to the induction of permanent transmissible changes in the amount or 
structure of the genetic material of cells or organisms. These changes may involve a single 
gene or gene segment, a block of genes or whole chromosomes. Effects on whole chromosomes 
may be structural and/or numerical. Genotoxicity, on the other hand, is a broader term and 
refers to processes which alter the structure, information content or segregation of DNA and 
are not necessarily associated with mutagenicity (SCCNFP, 2003).   
As stated in the SCCS “Notes of Guidance for Testing of Cosmetic Ingredients for their Safety 
Evaluation” (9th revision, SCCS/1564/15), the safety evaluation procedure refers to the 
ingredients in the Annexes III, IV, VI and VII of Directive 76/768/EEC as summarised in Table 
3.1. The ingredients listed in Annexes III-VII may pose a risk to human health because their 
use in cosmetic products may lead to high exposure of the consumer because of potentially 
extensive and routine use over a long period of the time. These Annex ingredients, therefore, 
require detailed toxicological information, including studies on the mutagenicity potential.  
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Table 3.1. Ingredients in cosmetic products that require safety evaluation by the Scientific 
Committee on Cosmetic Product and Nonfood Product (SCCNFB) under Directive 
76/768/EEC 
 
As stated in section 1.7, a mutagenic effect can take place via several different mechanisms 
(Hsu et al., 2016). For instance, a compound's reactivity toward DNA can result in the 
formation of DNA adducts or base deletions, which distort the structure and function of DNA. 
Non-reactive compounds may also be converted to DNA-reactive metabolites through enzyme-
catalysed metabolic activation (Plošnik, Vračko and Dolenc, 2016). DNA distortion can also 
be caused by intercalation, a process of reversible, non-covalent fixation of a molecule into the 
DNA (SCCNFP, 2003). For example, compounds with an aromatic polycyclic backbone can 
intercalate, that is, insert themselves between, or parallel to, base pairs of the DNA double helix, 
thus form π stacking interactions (Garrett and Grisham, 1995). The distortion of the structure 
of DNA through DNA reactivity and/or intercalation can disrupt enzymatic DNA repair and 
replication, which increases the chances of erroneous base replacements or deletions or 
insertions of base pairs, in other terms mutations (Garret and Grisham, 1995).  
In section 2.1, a brief explanation was given about definition and use of the Ames test. The 
Ames test has become one of the standard tests for mutagenicity determinations as it is 
relatively simple, fast and inexpensive. Ames tests use a histidine-free medium with an 
engineered strain of the Salmonella typhimurium bacterium that can only proliferate into 
colonies after certain mutations restore its ability to synthesise histidine (Mortelmans and 
 
Annex III 
list of substances which cosmetic products must not contain except 
subject to restrictions and conditions laid down 
Annex IV list of colouring agents allowed for use in cosmetic products 
Annex VI list of preservatives which cosmetic products may contain 
Annex VII list of UV filters which cosmetic products may contain 
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Zeiger, 2000). A chemical is considered Ames positive when its addition to the assay causes a 
significant increase in the number of bacterial colonies with respect to a control experiment. A 
metabolic activation mixture termed “S9”, generally comprising (rat) liver microsomes, can be 
added to this test to mimic in vivo metabolism (Benigni and Bossa, 2008). The term Ames test 
does not, however, refer to a single unique assay, as evidenced by the different standardised 
experimental methods, bacterial strains and metabolic activation mixtures that are available 
(Mortelmans and Zeiger, 2000). 
 
Several factors can limit the reproducibility of the Ames test, such as the purity of the tested 
chemicals, the variation in the interpretation of dose-response curves, differences in the 
methodology employed and the materials used (bacterial strains and mixtures for metabolic 
activation) as well as interference from other toxic side effects, including cytotoxicity (Kazius 
et al., 2006). It has been determined that average inter-laboratory reproducibility for a series of 
Ames tests is around 85% (Benigni and Bossa, 2011). The Ames test has also been applied to 
predict rodent carcinogenicity because of the high predictive power of the positive Ames that 
ranges from 77% to 90% depending on the various factors discussed (Kazius et al., 2006). This 
predictive performance makes it superior to any other in vitro genotoxicity assay, all of which 
have lower performance in terms of predicting genotoxicity (Kazius et al., 2006). One of the 
main databases that contains a large number of chemical records with mutagenicity test results 
is the Chemical Carcinogenicity Research Information System (CCRIS) database. This 
database contains Ames test data for approximately 7,000 compounds and mixtures that have 
been curated and evaluated in terms of their validity. These high-quality data for the Ames test 
has been reviewed by experts in mutagenesis. The National Cancer Institute (NCI) has 
developed this database from various studies cited in primary journals, NCI reports and current 
awareness tools (TOXNET, 2019). 
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An important research focus of predictive toxicology has been on the identification of the 
chemicals that are able to bind covalently to DNA (Benigni and Bossa, 2008). Recent 
legislation such as REACH and the Cosmetics Regulation in the European Union is intended 
to ensure that all chemicals either manufactured or imported (some of which may be used in 
cosmetic products) at significant tonnage must have appropriate information relating to safety 
to human health and environment (EC, 2003, 2006). It is well established that there is a 
significant ethical responsibility and a high cost when using animal testing to gather the 
required toxicological information to perform a risk assessment for regulatory purposes (van 
der Jagt et al., 2004). Alternative means for filling the data gaps in the available toxicological 
information have therefore been sought, including in silico models and tools for developing 
chemical categories (van Leeuwen et al., 2009; Enoch and Cronin, 2010).  
Based on the assumption that chemicals that have similar structures are likely to have similar 
toxicological profiles (Enoch et al., 2008, 2009a), the chemical category principle can be used 
to predict a range of toxicological endpoints when populated with suitable data through the so-
called process of “read-across”. Utilising a common mechanism of action is one of the most 
powerful methods to group chemicals on the basis of structural/functional similarities, which 
is the key step in the process of developing chemical categories (EC, 2007; OECD, 2007). In 
order to group chemicals, the mechanism of action needs to be defined in relation to chemical 
structure.  
Mutagenicity mechanisms involve the formation of a covalent adduct between an exogenous 
chemical and biological macromolecule such as DNA, RNA or proteins; the covalent 
interaction may be defined as the MIE.  It is important to note that other factors can also 
determine whether the chemical is mutagenic or not, in addition to those that are defined by an 
AOP. These factors include any biological repair mechanisms e.g. within the genetic DNA. 
Therefore, placing a chemical into a mechanistic category, such as those derived from MIEs 
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for the ability to bind covalently with DNA, or other biological macromolecule, does not 
necessarily mean that the chemical will be toxic. The read-across of an adverse outcome is, as 
such, a skilled procedure which involves the compilation of information and expert judgment 
to form an overall weight of evidence.  
The first compilation of covalently reactive structural alerts based on the analysis of 
mutagenicity data by Ashby and Tennant (1988) defined a board range of reactive structural 
features responsible for the formation of DNA adducts. Ashby and Tennant (1988) also defined 
a hypothetical 'super molecule' which was the first attempt to define the potential MIE for 
genotoxicity (see Figure 3.1). Additional structural alerts for covalent binding to DNA have 
been suggested by other workers (Benigni and Bossa, 2008; Kazius et al., 2005, 2006), and 
Enoch and Cronin, (2010) who compiled the alerts into a single, mechanistically based, profiler 
describing the chemistry associated with binding to DNA. 
 
Figure 3.1. Super molecule suggested by Ashby and Tenant (1988) for structurally reactive 
features that may bind covalently with DNA. 
. 
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It is important to know that, aside from structural features, other factors may also contribute to 
the potential of a compound to be mutagenic and/ or carcinogenic. For example, some 
cosmetics ingredients may contain one or more structural alerts associated with toxicity; 
however, the compound may be metabolically inactive. Metabolic inactivity may be caused by 
the compound’s molecular weight, solubility, reactivity, stability and state of matter, or the 
geometry of the chemical structure, amongst other factors (Plošnik, Vračko and Dolenc, 2016). 
Elucidation of the mechanism for electrophilic reactions with biological nucleophiles is 
founded on basic substitution, conjugation and addition reactions that are characterised by the 
reaction between electron-deficient and electron-rich moieties. Enoch and Cronin (2010) 
categorised genotoxic carcinogenic structural alerts according to chemistry into the main 
known mechanistic domains of organic reaction chemistry. The six main organic chemistry 
mechanisms relevant to toxicology are Michael addition (MA), acylation (AC), Schiff base 
formation (SB) and nucleophilic domain reactions (SN) which include unimolecular aliphatic 
nucleophilic substitution (SN1), bimolecular aliphatic nucleophilic substitution (SN2) and 
aromatic nucleophilic substitution (SNAr). The key genotoxic structural alerts linked to 
chemically mechanistic domains are depicted in Table 3.2. The definition of the chemistry 
associated with the mechanisms has enabled the grouping of electrophiles depending on their 
potential to bind covalently with DNA (and hence potential mutagenicity). Some of the aspects 
of chemistry associated with the mechanisms are illustrated in Table 3.3.  
 
One of the most beneficial computational toxicology applications that has been used by 
regulators, industry, researchers and many others is OECD QSAR Toolbox (or simply referred 
to as the ‘Toolbox’). This software package was developed by the Organisation for Economic 
Cooperation and Development (OECD) and has now reached its 10th anniversary              
(Schultz et al., 2018). The Toolbox has number of advantages over the other QSAR prediction 
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tools including that it is freely available, continuously updated and mainly designed to assess 
the safety of organic substances (Nicolotti, 2018). The Toolbox was designed to offer a 
comprehensible and transparent predictions including ‘read-across’ for the user (Cronin and 
Madden, 2011).   
The Toolbox, and other computational toxicology applications, can identify structural 
analogues by providing the information on chemicals in standardised, structure-searchable files 
that are associated with chemical and toxicity data. Toxicity assessment and testing methods 
are changing and improving through time, which raises the need of computational toxicology 
software, such as the Toolbox, to integrate new datasets, e.g. the next generation of in vitro 
tests (Nicolotti, 2018). 
Fundamentally, grouping substances into chemical categories and using the data from tested 
chemicals to fill the gaps of untested chemicals was considered as a long-term goal of the 
Toolbox, thus ensuring its usefulness in regulatory assessment. In order to be useful in a 
regulatory setting, the Toolbox user must be confident that the predictions coming from this 
tool are reliable, consistent and correct. This can be achieved by ensuring accuracy in chemical 
and biological information and, when appropriate, adding statistical assurance. Unlike other 
QSAR-based software which failed to achieve regular regulatory use, the Toolbox used a 
unique approach that provided mechanical understanding and high transparency through the 
category approach and read-across. For other QSARs using descriptors and modelling 
approaches, putting statistics ahead of chemistry and biology often resulted in “black box” 
predictions which did not give a mechanical understanding to the user. 
The Toolbox predictions are based on the category approach (OECD, 2007). In this approach, 
one or more chemicals are grouped based on their similarity which is not only defined in terms 
of their chemical structure and physiochemical properties but also includes similarity in 
mechanism of interaction with different biomolecular targets (e.g., DNA, protein),  as well as 
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similarity in toxicokinetic and toxicodynamic properties. The available experimental data for 
one or more members of the category, the source substances, are used to fill the data gap(s) of 
other unknown chemical substances of the category, the target substances. 
The six modules in the Toolbox are based on the category approach that guide the user through 
a logical workflow (OECD, 2009). These six modules (i.e., Chemical Input, Profiling, 
Endpoints, Category Definition, Filling Data Gap, and Report) are employed in a sequential 
workflow as suggested by the Toolbox guidance (Dimitrov et al., 2016).  
A number of in silico profilers are available in the Toolbox for various toxicological endpoints. 
Of these profilers, the following are relevant to the investigation of mutagenicity in this chapter:  
1. DNA binding by OASIS v1.4. This profiler is a mechanistic profiler developed from an 
analysis of Ames mutagenicity data. It contains 85 structural alerts that have been 
separated into eight mechanistic domains. Each of the mechanistic domains comprises 
mechanistic alerts that have been shown to be related to established electrophilic 
reaction chemistry known to be important in covalent DNA binding. (Mekenyan et al. 
2004; Serafimova et al. 2007). 
2. DNA binding by OECD. This profiler is based on structural alerts for the electrophilic 
reaction chemistry associated with covalent DNA binding (Enoch and Cronin 2010). 
The profiler is made up of 60 structural alerts that contain electrophilic centres or those 
that can be metabolically activated to electrophiles. 
3. Carcinogenicity (genotoxic and non-genotoxic) alerts by ISS. This profiler is based on 
a list of 55 structural alerts from the Toxtree software (http://toxtree.sourceforge.net/). 
Approximately 20 of the alerts are for non-genotoxic carcinogenicity, and the 
remainder for genotoxic carcinogenicity (mutagenicity). 
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4. DNA alerts for AMES, MN and CA by OASIS v.1.1. This is a refinement of the DNA 
binding by OASIS profiler described above. The profiler is based on the 85 structural 
alerts responsible for interaction of chemicals with DNA extracted from chromosomal 
aberrations data. There is a slight difference between DNA alerts in the in vitro Ames 
and CA models justified by the different local training set chemicals in both models. 
The scope of this profiler is to investigate the presence of alerts within the target 
molecules responsible for interaction with DNA related to chromosomal aberration and 
micronucleus tests. 
5. In vitro mutagenicity (Ames test) alerts by ISS. The present list of structural alerts is a 
subset of the original Toxtree list, obtained by eliminating the structural alerts for non-
genotoxic carcinogenicity and is a refinement of the Carcinogenicity (genotoxic and 
non-genotoxic) alerts by ISS profiler. 
6. In vivo mutagenicity (Micronucleus) alerts by ISS. This profiler is based on the ToxMic 
rule-base within the Toxtree software. This rule-base provides a list of 35 structural 
alerts for a preliminary screening of potential in vivo mutagens. These structural alerts 
are molecular functional groups or substructures that are known to be linked to the 
induction of effects in the in vivo micronucleus assay. 
 
A number of statistical analyses are appropriate to evaluate the predictive performance of the 
in silico profilers against the experimental data. Key amongst these are the Cooper statistics 
and Mathews Correlation Coefficient. The Cooper statistics (Cooper et al., 1979) are useful to 
assess the predictions against the experimental values given in the databases, by calculating the 
sensitivity, specificity, positive predictivity and accuracy of the alert triggers. Sensitivity is 
defined as the percentage of correctly classified positive predictions among the total number 
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of positive instances. Specificity is the percentage of correct negative predictions compared to 
the total number of negatives. Accuracy (concordance or “Q”) is defined as the total number 
both positive and negatives correctly predicted among the total number of compounds. The 
positive predictive value (PPV) or precision is defined as the as the proportion of positives or 
toxic chemicals that are correctly predicted (see Table 3.4; Pradeep et al., 2016) and can be 
considered as an estimate of the likelihood that following a positive prediction (i.e., the 
presence of a structural alert), that the substance will truly be positive (Eriksson et al., 2003). 
The Matthews Correlation Coefficient (MCC) is a weighted value that overcomes any 
imbalance in the data classes which might lead to over optimistic values of Q (Matthews, 1975). 
An MCC value of 1 indicates that the model can predict the data classes of unknown 
compounds perfectly, whilst a MCC value of 0 indicates that the predictions are no better than 
random guessing, and a MCC value of -1 indicates total disagreement between the predicted 
data and the actual data. 
Since there have been few, or no, attempts to evaluate the statistical performance of the in silico 
profilers, the aim of this chapter was to provide a detailed analysis for positive prediction of 
each structural alert in six mutagenicity profilers within the OECD QSAR Toolbox against 
experimental mutagenicity data from the CCRIS dataset. Analysis of the results from this 
investigation aimed to increase the reliability and accuracy of mutagenicity predictions by these 
profilers. 
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Table 3.2. A selection of structural alerts which belong to reactive electrophilic mechanistic 
domains relating to mutagenicity (Enoch and Cronin, 2010). 
Mechanism domain Structural alert 
 
 
 
 
SN2 
• Alkyl esters of either phosphonic or sulphonic acids 
• Monohaloalkenes 
• S- or N- mustards 
• Propiolactones and propio sulphones 
• Epoxides and arizidines 
• Aliphatic halogens 
• Alkyl nitriles 
 
 
 
SN1 
• Aromatic nitro groups 
• Alkyl hydrazines 
• Alkyl and aryl N-nitroso groups 
• Aliphatic N-nitro groups 
• Aromatic nitroso groups 
• Aromatic amines and hydroxyl amine 
• Halogenated polycyclic aromatic hydrocarbons 
• Halogenated dibenzodioxins 
 
Acylation 
• Aromatic diazo groups 
• Acyl halides 
Schiff base 
formation 
• Simple aldehydes 
• N-methylol derivative 
 
Michael addition 
• Quinones 
• Aromatic N-oxides 
SNAr • Aromatic mono and dialkylamino groups 
• Halogenated benzenes 
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Table 3.3.  Mechanisms of covalent binding to cellular nucleophiles (DNA, proteins) *Nu- 
nucleophilic site of molecule and how this may be translated into usable structural fragments 
(Enoch and Cronin, 2010) 
Type of 
reaction 
illustration 
 
 
SN2 
reaction 
 
  
 
 
 
 
SN1 
reaction 
 
  
 
 
 
 
 
Acylation 
  
 
 
 
 
Michaels 
addition 
 
 
 
 
 
SNAR 
  
 
 
 
Schiff 
base 
formation 
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3.2 Methods 
3.2.1 Dataset used 
The main resource to obtain data for this study was the Chemical Carcinogenicity Research 
Information System (CCRIS) database which was available uploaded in the Leadscope 
Personal software Version 4.4 (Leadscope.com, 2018). The version of CCRIS used in this study 
was updated in 2011 and it has not been updated since that time. CCRIS provides historical 
information from 1985 – 2011 and contains Ames test data for approximately 7,000 compounds 
and mixtures, the results of which have been curated and evaluated in terms of their validity. 
The compounds were identified with a CAS registry number and/or chemical name(s). 
Additional mutagenicity data, although fewer in number, were available from other public 
toxicity databases, including CPDB, GENETOX, National Toxicology Program Dataset NTP 
and the genetic activity profile dataset (EPA/ IARC). Compounds whose CCRIS data showed 
contradictory categorisations with the NTP data were removed from the dataset. In total, a 
dataset of 8,130 compounds with corresponding molecular structures and toxicity 
categorisations (3,838 mutagens and 2,861 non-mutagens) was constructed. The chemical 
structures of the dataset were obtained as in the SDF file format using the Leadscope software 
so that they may be used in the OECD QSAR Toolbox. 
 3.2.2 The OECD QSAR Toolbox 
For this study, version 4.1 (downloaded in April 2018) of the OECD QSAR Toolbox was used 
throughout for the profiling process. The Toolbox is freely available and downloaded from 
qsartoolbox.org.  
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3.2.3 Data analysis:  
 
The following workflow was implemented in order to assess and evaluate the accuracy of the 
following six mutagenicity profilers as implemented in the OECD QSAR Toolbox (details on 
the profilers is given in Section 3.1). 
 
1. DNA binding by OASIS v1.4  
2. DNA binding by OECD  
3. Carcinogenicity (genotoxic and non-genotoxic) alerts by ISS 
4. DNA alerts for AMES, MN and CA by OASIS v.1.1 
5. In vitro mutagenicity (Ames test) alerts by ISS 
6. In vivo mutagenicity (Micronucleus) alerts by ISS 
 
The workflow below allowed for detailed analysis of the positive predictivity for each 
structural alert within each profiler.    
 
 
Step 1 – Within the Leadscope personal version 4.4 software, the latest (2011) high-quality 
version of the CCRIS database was selected. The database was searched to identify and extract 
all experimental results for each substance. A screenshot of this process is shown in Figure 3.2. 
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Figure 3.2. Screenshot from Leadscope database with the CCRIS mutagenicity database 
uploaded. 
Step 2 - Bacterial mutagenicity and Salmonella experimental results were identified for each 
chemical substance in the database, the file containing these data was exported as molecular 
spreadsheet sheet as shown in Figure 3.3. 
 
Figure 3.3. Screenshot from the Leadscope software showing the list of substances from the 
CCRIS database with experimental mutagenicity data. 
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Step 3 – A SDF version of CCRIS database was profiled through the OECD QSAR Toolbox 
using the six mutagenic profilers noted above. The results of this profiling were exported as an 
excel spreadsheet. A screenshot of the profiling in the Toolbox is shown in Figure 3.4. 
Step 4 – The data from the Leadscope software and predictions from the OECD QSAR Toolbox 
were merged into a single spreadsheet so that experimental data and the profiling results for 
each structural alert triggered could be compared. A screenshot of the spreadsheet is shown in 
Figure 3.5.  
 
Figure 3.4. Screenshot showing the profiling of a list of 8,210 substances from the CCRIS 
database. 
 
Step 5 – A separate column for each of the six Toolbox profilers assessed was created in the 
merged spreadsheet. If the structural alert was triggered, the compound was given a score of 1, 
if no alerts were triggered, a score of 0 was allocated. The results were compared with the 
assigned binary activity for mutagenicity from the CCRIS database (positive=1, negative=0). 
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Figure 3.5. Final excel spreadsheet where both profiling and experimental results for each 
substance from CCRIS database were merged in one single file. 
 
Step 6 - The results from the six profilers within the OECD QSAR Toolbox were assessed 
statistically against the experimental results value given in CCRIS database. This was 
performed by calculating sensitivity, specificity, accuracy, precision, negative predictive value, 
false positive rate, false negative rate, false discovery rate, false omission rate, F1 score, 
informedness, markedness, and the Mathews correlation coefficient (MCC) of each alert. These 
statistical parameters are described in Section 3.1 and their definitions provided in Table 3.4. 
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Table 3.4. 13 statistical assessment parameters of the results from six profilers within the 
OECD QSAR Toolbox against the experimental results value given in CCRIS database. 
Sensitivity (True positive rate)  = TP/ TP+FN 
Specificity (True negative rate)       =     TN/TN+FP 
Accuracy    =     (TN+TP)/(TN+FP+FN+TP) 
PPV (Positive predictive value) or (precision)    =          TP/ TP+FP 
NPV (negative predictive value)              =           TN/TN+FN 
FNR (false negative rate) or (miss rate)   =           1- sensitivity 
FPR (false positive rate) or (fall out) =           1- specificity 
FDR (false discovery rate)                         =           1- PPV 
FOP (false omission rate)                          =           1- NPV 
F1 score                                                      =          2 x (PPV x TPR) / (PPV +TPR) 
Informedness (BM)                                       =          TPR+TNR -1 
Markedness (MK)          =            PPV + NPV -1 
MCC =  (TPxTN)-(FPxFN)/√(TP+FN)(TP+FP)(TN+FN)(TN+FP) 
Where TP=True positive, TN=True negative, FP=False positive, FN=False negative 
 
Step 7 - A detailed analysis of the positive predictivity value (PPV) for each structural alert 
within each profiler were conducted. Only substances with one structural alert triggered were 
assessed, this was to avoid any interference of other structural alerts in cases of substances with 
multiple structural alerts triggered.  
Step 8 - Structural alerts that were triggered in more than 10 substances and showed less than 
0.5 positive predictivity were considered to be of limited significance. 
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3.3: Results and Discussion 
The aim of Chapter 3 was to evaluate the performance of six commonly used in silico profilers 
for mutagenicity from the OECD QSAR Toolbox with a view to identifying strongly 
performing alerts and those in need of more refinement or development. 
3.3.1 Data Collection  
A dataset of 8,130 compounds with corresponding molecular structures and toxicity 
categorisations (3,838 mutagens and 2,861 non-mutagens) was constructed. The dataset 
included data from four mutagenicity tests for each chemical substance, namely bacterial 
mutation, Salmonella, female rat and male rat. No information about metabolism was available 
for any chemical substance. The major uses for these chemicals varied from drugs (anti-
infectives and anti-viral), pesticides (herbicides and plant growth regulators), intermediates 
(dyes), analytical reagents and solvents. The chemical structures for use in the OECD QSAR 
Toolbox were obtained as a SDF file from the Leadscope software.  
 
3.3.2 Evaluation of the overall performance of the six in silico profilers for mutagenicity.  
The results of the assessment of the profilers against the measured values for mutagenicity are 
shown in Table 3.5 and Figure 3.6 respectively.  
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Table 3.5. Performance statistics for the six mutagenicity profilers provided within the OECD 
QSAR Toolbox against experimental data. 
Profiler Genotox and 
nongenotox 
alerts by ISS 
DNA alerts 
for AMES, 
MN and CA 
by OASIS 
Ames test 
alerts by 
ISS 
Micronucleus 
alerts by ISS 
DNA 
binding by 
OASIS 
v.1.4 
DNA 
binding by 
OECD 
CCRIS database 
Sensitivity  0.84 0.52 0.83 0.90 0.71 0.70 
Specificity  0.60 0.91 0.69 0.37 0.73 0.62 
Accuracy (Q) 0.74 0.69 0.77 0.67 0.72 0.67 
Precision (PPV) 0.73 0.88 0.78 0.65 0.77 0.71 
Negative predictive value (NPV) 0.74 0.59 0.75 0.74 0.66 0.61 
False positive rate (FPR) 0.40 0.09 0.31 0.63 0.27 0.38 
False negative rate (FNR) 0.16 0.48 0.17 0.10 0.29 0.30 
False omission rate (FOR) 0.26 0.41 0.25 0.26 0.34 0.39 
False discovery rate (FDR) 0.27 0.12 0.22 0.35 0.23 0.29 
F1 score 0.78 0.65 0.8 0.76 0.74 0.7 
Informedness (BM) 0.44 0.43 0.52 0.27 0.44 0.32 
Markedness (MK) 0.47 0.47 0.53 0.39 0.43 0.32 
MCC 0.46 0.45 0.52 0.33 0.43 0.32 
Sensitivity = True positive rate; Specificity = True negative rate; MCC = Matthews Correlation Coefficient;  
__= MCC below 0.33;  __= High sensitivity or specificity ;  __= Low sensitivity or specificity  
 
Table 3.5 shows that the accuracy (Q) (percentage of positives and negatives correctly 
predicted) of the mutagenicity profilers varies for the profilers from 67% to 77%. Clearly, a 
profiler with an accuracy of 67% has a significant margin of error that may affect the profiler's 
ability to predict adequately, whereas 77% is a more acceptable level of prediction that is in 
line with the experimental error level in the measured data. These accuracy of the profilers 
reflects the known average interlaboratory reproducibility of Ames tests, which is known to be 
at least 15%. As such it was concluded that these profilers can be applied to risk assessment 
processes and can guide the design of chemical libraries for hit and lead optimisation (Kazius 
et al., 2005).  
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Considering individual profilers in more detail, the true positive rate (sensitivity) was relatively 
high for Micronucleus alerts with a low specificity (true negative rate) which indicates an over 
prediction of mutagenicity. In contrast, the true negative rate for DNA-binding alerts for the 
Ames, MN and CA profiler was high (91%) but with a poor ability to distinguish positive 
mutagenicity results (52%). The sensitivity rates of the other four profilers ranged from 70% 
to 84%, which is an acceptable. However, two profilers (genotoxicity and non-genotoxicity 
alerts (ISS) and OECD DNA binding profilers) failed to adequately predict the non-mutagenic 
compounds with a true negative rate of only 60%. The positive prediction value (PPV), which 
measures the ability of the alerts to predict mutagenic compounds, was high (88%) for the 
“DNA alerts for AMES” profiler, however this profiler showed the lowest Negative predictive 
value (NPV) of 59%. The PPV and NPV of the other five mutagenicity profilers ranged from 
65% -78% and 61%-75% respectively. 
The Mathews correlation coefficient (MCC) is more informative than other confusion matrix 
measures (such as F1 score and accuracy) in evaluating binary classifications. This is because 
it takes into account the balanced ratios of the four confusion matrix categories (true positives, 
true negatives, false positives and false negatives). MCC did not exceed 0.52 for any of the six 
profilers for mutagenicity and the lowest MCC value was 0.32 for the “DNA binding profiler 
by OECD” and 0.33 for “Micronucleus alerts by ISS”. The Ames alerts was the only profiler 
that showed a MCC value greater than 0.5, which indicates that the performance is independent 
of skewed sample categories. The statistics for individual profilers, and any weak predictive 
alerts within them, are discussed below. 
Whilst good predictivity is desirable, it is should not be expected that any profiler is able to 
predict all mutagenic compounds. The profilers considered in this analysis are likely to have 
limited predictive capability for a number of different reasons. Firstly, they are not profilers for 
mutagenicity in its entirety, but for different aspects (i.e. mechanisms or modes) of it. Secondly, 
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some or all of the profilers were not designed to be predictive but for grouping allowing for 
read-across. For a predictive profiler, the desired level of predictivity would be in line with the 
error level seen in measured data. When this level of predictivity is achieved and demonstrated, 
these profilers can be considered a more valid substitute for experimental studies. With this in 
mind, this study seeked to refine those structural alerts that have lower predictivity by analysing 
which compounds they hit erroneously. Ultimately, such analyses and knowledge will lead to 
increased reliability and confidence in the predictive ability of these profilers. 
155 chemicals, known to be mutagenic experimentally were not identified by any of the six 
mutagenicity profilers. Of these, 43 chemicals, which represent 30% of these non-identified 
mutagens, were inorganic chemical substances such as cadmium chloride, manganese 
dichloride, selenium sulfide, titanium chloride etc. The remaining 112 mutagenic substances 
were varied organic chemicals that did not have any unifying characteristics for grouping or 
that could be used to formulate a new rule for a new chemical structural alert. The list of all 
155 mutagens that were not identified, including both inorganic and organic chemicals, is 
available in Appendix I. 
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Figure 3.6. Column chart of the sensitivity and specificity rates for each of the six mutagenicity 
profilers in the OECD QSAR Toolbox when compared against experimental results taken from 
the CCRIS database. 
Carcinogenicity
(genotox and
nongenotox)
alerts by ISS
DNA alerts for
CA and MNT by
OASIS
in vitro
mutagenicity
(Ames test)
alerts by ISS
in vivo
mutagenicity
(Micronucleus)
alerts by ISS
DNA binding by
OASIS
DNA binding by
OECD
True Negative 1722 2599 1964 1051 2079 1783
Flase positve 1139 262 897 1810 782 1078
Flase negative 605 1804 635 361 1086 1128
True positive 3124 1925 3094 3368 2643 2601
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 3.3. Evaluation of individual structural alerts within the six in silico profilers for mutagenicity 
Further detailed analysis was conducted on each structural alert within the six mutagenicity 
profilers. The purpose here was to identify structural alerts that are over-predictive i.e. when 
the precision or PPV is lower than 0.5. These over-predictive structural alerts were excluded 
to increase the sensitivity and overall accuracy of the profiler and are listed in Tables 3.6 - 3.11 
respectively. The results for the individual profilers are described in more detail below and a 
final list of 28 structural alerts with low predictivity, obtained from the six mutagenicity 
profilers, is summarised in Table 3.12. 
3.3.1 Genotox and Nongenotox alerts by ISS profiler:  
The sensitivity and accuracy of this profiler were fairly acceptable (see Table 3.6) with a 84% 
true positive rate and 74% accuracy. The analysis of positive predictivity of the alerts within 
this profiler revealed that eight alerts showed low predictivity for positive mutagens; five were 
non-genotoxic carcinogenicity (1,3-benzodioxoles, benzenesulfonic ethers, halogenated 
benzene, substituted n-alkylcarboxylic acids and thiocarbonyl) and three were genotoxic 
carcinogenicity structural alerts (alkenylbenzenes, α,β-unsaturated carbonyls and simple 
aldehydes).  As shown in Table 3.6, the alert for α,β-unsaturated carbonyls was the highest 
triggered alert being found in 187 substances with 102 false positives and hence a low PPV of 
45%. The alert for substituted n-alkylcarboxylic acids had the lowest PPV value (12%) with 
23 false positive result out of 26 substances triggered. Halogenated benzenes and simple 
aldehydes alerts were flagged in 82 and 74 substances respectively, but they were over 
predictive amongst negative substances with PPVs of 23% and 38% respectively. This 
indicates that they may be not suitable to be used to predict mutagenic substances. The 
remaining four alerts with low PPV ranged in their predictivity from 23% for benzenesulfonic 
ethers to 42% for 1,3-benzodioxoles. However, Table 3.6 shows some of the alerts in the 
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profiler showed high positive predictivity values for many positive mutagens including the 
alert for nitroso-aromatic with 82% of 395 substances and that for Polycyclic Aromatic 
Hydrocarbons with 91% among 271 mutagenic substances. 
Table 3.6. Positive prediction analysis (PPV) for each structural alert within the 
“Carcinogenicity (genotox and nongenotoxic) alerts by ISS” profiler. 
alert TOTA
L 
TP FP PP
V 
N
on
 g
en
ot
ox
ic
 c
ar
ci
no
ge
n 
str
uc
tu
ra
l a
le
rt 
(Poly) Halogenated Cycloalkanes  14 2 12 0.1
4 
1,3-Benzodioxoles  12 5 7 0.4
2 
Alkyl halides  17 13 4 0.7
6 
Benzenesulfonic ethers, methylation  13 3 10 0.2
3 
Halogenated benzenes  82 19 63 0.2
3 
Halogenated dibenzodioxins 4 1 3 0.2
5 
Imidazoles, benzimidazoles  37 17 20 0.4
6 
Indole-3-carbinols 1 1 0 1.0
0 
Metals, oxidative stress  51 27 24 0.5
3 
o-Phenylphenols  13 6 7 0.4
6 
Pentachloro phenols  2 1 1 0.5
0 
Quercetin type flavonoids  5 3 2 0.6
0 
Substituted n-alkylcarboxylic acids  26 3 23 0.1
2 
Thiocarbonyls  17 6 11 0.3
5 
Trichloro (or fluoro) ethylenes and Tetrachloro (or fluoro) ethylenes 
(Nongenotox)  
10 9 1 0.9
0 
   
   
   
   
ge
no
to
xi
c 
ca
rc
in
og
en
 st
ru
ct
ur
al
 
l
t 
Acyl halides  17 12 5 0.7
1 
Aliphatic azo and azoxys  21 20 1 0.9
5 
Aliphatic halogens  214 162 52 0.7
6 
Aliphatic N-nitro groups  13 11 2 0.8
5 
Alkenylbenzenes  17 4 13 0.2
4 
Alkyl (C<5) or benzyl ester of sulphonic or phosphonic acid  49 31 18 0.6
3 
Alkyl and aryl N-nitroso groups  96 83 13 0.8
6 
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Alkyl carbamate and thiocarbamates 17 8 9 0.4
7 
Alkyl nitrites  7 7 0 1.0
0 
α,β-Unsaturated aliphatic alkoxy groups  16 14 2 0.8
8 
α,β-Unsaturated carbonyls  187 85 10
2 
0.4
5 
Aromatic diazos 74 41 33 0.5
5 
Aromatic mono-and dialkylamines  52 31 21 0.6
0 
Aromatic N-acyl amines  42 23 19 0.5
5 
Aromatic nitroso groups  23 23 0 1.0
0 
Aromatic ring N-oxides  9 3 6 0.3
3 
Azide and triazene groups  52 51 1 0.9
8 
Coumarins and Furocoumarins  22 16 6 0.7
3 
Epoxides and aziridines  235 186 49 0.7
9 
Heterocyclic Polycyclic Aromatic Hydrocarbons  98 82 16 0.8
4 
Hydrazines  50 34 16 0.6
8 
Isocyanate and isothiocyanate groups  3 3 0 1.0
0 
Monohaloalkenes  10 6 4 0.6
0 
Nitro-aromatics (Genotox) 395 322 73 0.8
2 
Polycyclic Aromatic Hydrocarbons  271 246 25 0.9
1 
Primary aromatic amine,hydroxyl amine and its derived esters  311 211 10
0 
0.6
8 
Propiolactones or propiosultones  5 4 1 0.8
0 
Pyrrolizidine alkaloids  4 4 0 1.0
0 
Quinones  111 82 29 0.7
4 
S or N mustards  19 15 4 0.7
9 
Simple aldehydes  74 28 46 0.3
8 
 TOTAL PPV 2818 196
4 
85
4 
0.7
0 
 GENOTOXIC CARCINOGEN PPV 2514 184
8 
66
6 
0.7
4 
 NON GENOTOXIC CARCINOGEN PPV 304 116 18
8 
0.3
8 
Total = number of  substances  flagged  by alert  , TP=  True positive  (mutagens identified positive by  alert) ,   
FP= False positive  (non-mutagens identified positive by alert) , PPV= Positive Predictivity value  
 3.3.2 DNA alerts for AMES, MN and CA by OASIS profiler: 
In contrast to other profilers, the DNA alerts for Ames profiler showed low true positive 
(sensitivity) and high true negative rates (see Table 3.7). This indicates that there is a lack of 
alerts that can predict mutagens and those that are available are unspecific and have a high 
number of false negatives (48%).  
 
Table 3.7. Positive predictivity analysis for each structural alert among the “DNA alerts for 
AMES, MN and CA by OASIS” profiler.  
DNA alerts for CA and MNT by OASIS TOTAL TP FP PPV 
AN2|AN2 >> Schiff base formation|AN2 >> Schiff base formation >> 
Dicarbonyl compounds 
15 11 4 0.73 
Non-covalent interaction|Non-covalent interaction >> DNA 
intercalation|Non-covalent interaction >> DNA intercalation >> DNA 
Intercalators with Carboxamide and Aminoalkylamine Side Chain 
3 2 1 0.67 
Non-covalent interaction|Non-covalent interaction >> DNA 
intercalation|Non-covalent interaction >> DNA intercalation >> Quinolone 
Derivatives 
17 10 7 0.59 
SN2|SN2 >> Alkylation, direct acting epoxides and related|SN2 >> 
Alkylation, direct acting epoxides and related >> Epoxides and Aziridines 
181 166 15 0.92 
SN2|SN2 >> Alkylation|SN2 >> Alkylation >> Alkylphosphates, 
Alkylthiophosphates and Alkylphosphonates 
47 19 28 0.40 
SN2|SN2 >> Coordination with nucleoside bases|SN2 >> Coordination with 
nucleoside bases >> Short-Chain Alkyltin and Alkylgermanium Halides 
7 1 6 0.14 
Total = number of substances  flagged  by alert  , TP=  True positive  (mutagens identified positive by  alert) ,   
FP= False positive  ( non-mutagens identified positive by alert) , PPV= Positive Predictivity value  
 
 
The only alert that showed low PPV was the (SN2| Alkylphosphates, Alkylthiophosphates and 
Alkylphosphonates) alert which was incorrectly predicted 28 mutagenic substances out of 47 
substances with 40% PPV. On the other hand, as illustrated in Table 3.7, the alert for epoxides 
and aziridines ( SN2|SN2 >> Alkylation, direct acting epoxides and related|SN2 >> Alkylation, 
 
 
Chapter 3 
 
      Page 106  
direct acting epoxides and related >> Epoxides and Aziridines) was accurate as it correctly 
detected 166 mutagenic substances out of 181 with 91% PPV. DNA alkylation of epoxides is 
caused by the epoxidation reaction when three-membered epoxide ring opened with 
nucleophilic DNA centre via substituted nucleophilic reaction SN2 (Figure 3.7). Epoxidation 
is a common ring-opening reaction leading to DNA alkylation (Sawatari, 2001). Importantly, 
reactive epoxides can be produced after the metabolism of a range of alkenes, resulting in DNA 
reactivity. Overall, the predictive power of this profiler showed that there should be a high 
confidence in a hit from this profiler for mutagenicity.  
 
 
Figure 3.7. Epoxide ring opening reaction (Enoch and Cronin, 2010) 
 
3.3.3 In vitro mutagenicity (Ames test) alerts by ISS profiler: 
In the ISS profiler the true positive and true negative rates were reasonably good at 83% and 
69% respectively. Compared to the other profilers for mutagenicity, the Ames test alerts had 
the highest MCC value, which was greater than 0.5 which is a good indicator for predicting 
both positive and negative mutagens. The positive prediction of mutagenicity for the structural 
alerts in this profiler was acceptable (78%) and well balanced with the negative prediction 
value (75%). Four structural alerts were over-predictive and showed false positive results in 
more than 60% of triggered substances. Three of these four alerts with low PPV values were 
analogous to poorly performing alerts in the genotoxic and non-genotoxic by ISS profiler. 
These four alerts were alkenyl benzenes, α,β-unsaturated carbonyls, aromatic ring N-oxide and 
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simple aldehydes. The highest error rate was for the α,β−unsaturated carbonyl alerts with only 
44% positive predicated substances among 192 substances as shown in Table 3.8. 
 
Table 3.8. PPV analysis for each structural alert among “in vitro mutagenicity (Ames test) 
alerts by ISS” profiler. 
In vitro mutagenicity (Ames test) alerts by ISS TOTAL TP FP PPV 
Acyl halides 22 16 6 0.73 
Aliphatic halogens 224 166 58 0.74 
Aliphatic N-nitro groups 12 10 2 0.83 
Alkenylbenzenes 21 3 18 0.14 
Alkyl (C<5) or benzyl ester of sulphonic or phosphonic acids 55 36 19 0.65 
Alkyl and aryl N-nitroso groups 98 84 14 0.86 
Alkyl carbamate and thiocarbamates 20 10 10 0.50 
Alkyl hydroperoxides 10 9 1 0.90 
α,β-Unsaturated aliphatic alkoxy groups 2 0 2 0.00 
Alkyl nitrites 7 7 0 1.00 
α,β-Unsaturated carbonyls 192 84 108 0.44 
Anthrones 3 1 2 0.33 
Aromatic diazos 78 44 34 0.56 
Aromatic mono-and dialkylamines 53 32 21 0.60 
Aromatic N-acyl amines 45 22 23 0.49 
Aromatic ring N-oxides 10 4 6 0.40 
Azide and triazene groups 55 54 1 0.98 
Coumarins and Furocoumarins 22 16 6 0.73 
Epoxides and aziridines 219 165 54 0.75 
Flavonoids 5 3 2 0.60 
Heterocyclic Polycyclic Aromatic Hydrocarbons 107 88 19 0.82 
Hydrazines 50 33 17 0.66 
Hydroxamic acid derivatives 9 8 1 0.89 
Monohaloalkenes 10 6 4 0.60 
N-aryl-N-acetoxyacetaamides 4 3 1 0.75 
Nitro-aromatics 427 347 80 0.81 
Polycyclic Aromatic Hydrocarbons 287 258 29 0.90 
Primary aromatic amine,hydroxyl amine and its derived esters 340 227 113 0.67 
Propiolactones or propiosultones 5 4 1 0.80 
Quinones 35 18 17 0.51 
S or N mustards 24 17 7 0.71 
Simple aldehydes 80 29 51 0.36 
Steroidal estrogens 5 0 5 0.00 
Xanthones, Thioxanthones, Acridones 31 24 7 0.77 
Total = number of substances  flagged  by alert  , TP=  True positive  (mutagens identified positive by  alert) ,   
FP= False positive  ( non-mutagens identified positive by alert) , PPV= Positive Predictivity value  
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In contrast, other structural alerts in this profiler showed high and accurate precision (PPV) e.g. 
the alerts for nitro-aromatics, Polycyclic Aromatic Hydrocarbons as shown in Table 3.8. The 
mechanism of mutagenicity of compounds containing aromatic amine, nitro, nitroso or 
hydroxylamine moieties can be explained by partially overlapping metabolic activation 
pathways (Cronin, 2010). Although an aromatic nitro group requires enzymatic reduction 
(catalysed by both cytosolic and microsomal enzymes) to form an aromatic hydroxylamine 
intermediate, the analogous reduction of an aromatic nitroso group is probably non-enzymatic. 
An aromatic amine moiety, on the other hand, requires enzymatic oxidation to form the same 
aromatic hydroxylamine intermediate. Subsequent activation of aromatic hydroxylamine 
intermediates by O-acetylation, O-sulfation, or O-protonation is suggested to form electrophilic 
intermediates that covalently bind to DNA as shown in Figure 3.8 (Enoch and Cronin, 2010). 
This shows that the performance of the structural alerts is better when the chemical relationship 
that explains the mutagenicity is clear and well known. 
 
Figure 3.8. Metabolic conversion of aniline to the electrophilic nitrenium ion (Enoch and 
Cronin, 2010). 
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3.3.4 In vivo mutagenicity (Micronucleus) alerts by ISS: 
The results of the analysis of the “in vivo mutagenicity (Micronucleus) alerts by ISS” profiler 
are provided in Table 3.9 and show an imbalance between true positive rate (sensitivity) 90% 
and true negative rate (specificity) 37%. Five alerts in this profiler are over-predictive, namely 
H-acceptor-path3-H-acceptor, 1-phenoxy-benzene, α,β-unsaturated carbonyls, aromatic N-
acyl amine and simple aldehydes. The majority of false positive results were from the H-
acceptor-path3-H-acceptor alert among non-mutagenic substances. This alert was triggered in 
1114 substances and incorrectly predicts 791 non-mutagenic substances as mutagenic with a 
PPV of only 29%. This also explains the high value of true positive rate (sensitivity) caused by 
this alert. This alert explores the possibility that a chemical interacts with DNA and/or proteins 
via non-covalent binding, such as DNA intercalation or groove-binding (Snyder et al. 2006) 
which may not be relevant to Ames test data, however, it suggests that this alert should go 
under detailed further investigation using Micronucleus data (this was undertaken in Chapter 
5). Clearly, this alert significantly affects the performance of the profiler’s ability to predict the 
mutagenicity, as the profiler has the lowest MCC value (0.33) of the six profilers considered. 
This indicates removing this alert from the profiler would improve the overall performance of 
the profiler. The unsaturated carbonyl and simple aldehyde alerts also showed low positive 
predictivity, 47% and 18% respectively, confirming the similar conclusion from the genotoxic 
and nongenotoxic profilers and Ames test by ISS profiler. The alert for “Simple aldehydes” is 
based on the theory that all compounds containing an aldehydic group can potentially undergo 
Schiff base formation with a primary amine. They are to be considered potentially genotoxic, 
as demonstrated by their ability to react in vivo with nucleobases, without metabolic activation, 
forming adducts, interbase cross-links (both intra and inter-strand) and DNA-protein crosslinks. 
The carbon chain length of aliphatic aldehydes and, in general, molecular size can strongly 
modulate the formation of every type of cross-link and even the accessibility of the DNA 
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nucleobases. DNA-protein crosslinks have been reported as the primary DNA damage induced 
by formaldehyde (Speit et al. 2007). Thus, the overall analysis has indicated that the alert for 
simple aldehdyes, whilst valid mechanistically, requires further and detailed definition to 
enable it for use. On the other hand, alerts for primary aromatic amines, nitro aromatics, 
epoxides and aziridines had high mutagenicity predictivity with PPV ranging from 75% to 90%. 
Table 3.9. Positive predictivity analysis for each single structural alert within the in vivo 
mutagenicity (Micronucleus) alerts by ISS profiler. 
in vivo mutagenicity (Micronucleus) alerts by ISS TOTAL TP FP PPV 
H-acceptor-path3-H-acceptors 1114 323 791 0.29 
1,3-dialkoxy-benzenes 2 1 1 0.50 
1-phenoxy-benzenes 14 3 11 0.21 
Acyl halides 21 15 6 0.71 
Aliphatic azo and azoxys 9 9 0 1.00 
Aliphatic halogens 173 131 42 0.76 
Aliphatic N-nitro groups 5 4 1 0.80 
Alkyl (C<5) or benzyl ester of sulphonic or phosphonic acids 47 33 14 0.70 
Alkyl and aryl N-nitroso groups 30 27 3 0.90 
Alkyl carbamates and thiocarbamates 12 7 5 0.58 
Alkyl nitrites 7 7 0 1.00 
α,β-unsaturated aliphatic alkoxy groups 7 5 2 0.71 
α,β-unsaturated carbonyls 60 28 32 0.47 
Aromatic diazos 8 6 2 0.75 
Aromatic mono- and dialkylamines 35 19 16 0.54 
Aromatic N-acyl amines 26 10 16 0.38 
Aromatic nitroso groups 17 17 0 1.00 
Aromatic ring N-oxides 6 2 4 0.33 
Azide and triazene groups 22 21 1 0.95 
Carbodiimides 2 1 1 0.50 
Coumarins and Furocoumarins 5 1 4 0.20 
Epoxides and aziridines 140 103 37 0.74 
Heterocyclic Polycyclic Aromatic Hydrocarbons 71 62 9 0.87 
Hydrazines 15 12 3 0.80 
Isocyanate and isothiocyanate groups 3 3 0 1.00 
Monohaloalkenes 6 6 0 1.00 
Nitro-aromatics 218 174 44 0.80 
Polycyclic Aromatic Hydrocarbons 247 221 26 0.89 
Primary aromatic amine, hydroxyl amine and its derived esters 174 123 51 0.71 
Propiolactones or propiosultones 5 4 1 0.80 
S or N mustards 15 11 4 0.73 
Simple aldehydes 33 6 27 0.18 
Total = number of substances  flagged  by alert  , TP=  True positive  (mutagens identified positive by  alert) ,   
FP= False positive  ( non-mutagens identified positive by alert) , PPV= Positive Predictivity value  
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3.3.5 DNA binding by OASIS v.1.4 Profiler: 
The DNA binding by OASIS profiler showed reasonably acceptable overall sensitivity and 
specificity values, 71% and 73% respectively. Accuracy was also good (72%), but MCC was 
still low at 0.43. Table 3.10 shows three alerts had a low PPV (19%, 43% and 30% respectively), 
namely: carboxamides and aminoalkylamines via non covalent interaction, thiols via a radical 
mechanism and alkylphosphates, alkylthiophosphates and alkylphosphonates via alkylation. 
The structural alert for alkylphosphates was triggered in 69 substances with only 21 true 
positives predicted. This alert is based on the theory that some of the organophosphorus 
fragments are known to be strongly electrophilic (mainly phosphonic and phosphoric acid 
derivatives). Two chemo-toxicological mechanisms have been suggested: phosphorylation and 
alkylation of the biological macromolecules. Compared to the carbon atom of the alkyl group, 
the phosphorus atom is more electron-deficient and susceptible to attack by nucleophiles 
(Braun et al., 1982). This mechanism may be not relevant to the Ames test which could explain 
the low predictivity of this alert. Other alerts in this profiler, such as those for epoxides and 
aziridines showed high PPVs for a large proportion of substances (92% of 181 substances were 
identified correctly). 
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Table 3.10. Positive predictivity analysis (PPV) for each structural alert with the DNA binding by OASIS profiler. 
 Total = number of substances  flagged  by alert  , TP=  True positive  (mutagens identified positive by  alert) ,   FP= False positive  ( non-mutagens identified positive by 
alert) , PPV= Positive Predictivity value  
DNA binding by OASIS TOTAL TP FP PPV 
AN2|AN2 >> Michael-type conjugate addition to activated alkene derivatives|AN2 >> Michael-type conjugate addition to activated 
alkene derivatives >> Alpha-Beta Conjugated Alkene Derivatives with Geminal Electron-Withdrawing Groups 
2 0 2 0 
AN2|AN2 >> Schiff base formation|AN2 >> Schiff base formation >> Dicarbonyl compounds 17 12 5 0.71 
Non-covalent interaction|Non-covalent interaction >> DNA intercalation|Non-covalent interaction >> DNA intercalation >> DNA 
Intercalators with Carboxamide and Aminoalkylamine Side Chain 
32 6 26 0.19 
Non-covalent interaction|Non-covalent interaction >> DNA intercalation|Non-covalent interaction >> DNA intercalation >> 
Quinolone Derivatives 
23 15 8 0.65 
Radical|Radical >> Radical mechanism by ROS formation (indirect) or direct radical attack on DNA|Radical >> Radical 
mechanism by ROS formation (indirect) or direct radical attack on DNA >> Organic Peroxy Compounds 
34 28 6 0.82 
Radical|Radical >> Radical mechanism via ROS formation (indirect)|Radical >> Radical mechanism via ROS formation (indirect) 
>> Anthrones 
3 1 2 0.33 
Radical|Radical >> Radical mechanism via ROS formation (indirect)|Radical >> Radical mechanism via ROS formation (indirect) 
>> Thiols 
23 10 13 0.43 
SN2|SN2 >> Alkylation, direct acting epoxides and related|SN2 >> Alkylation, direct acting epoxides and related >> Epoxides and 
Aziridines 
280 223 57 0.80 
SN2|SN2 >> Alkylation|SN2 >> Alkylation >> Alkylphosphates, Alkylthiophosphates and Alkylphosphonates 69 21 48 0.30 
SN2|SN2 >> Coordination with nucleoside bases|SN2 >> Coordination with nucleoside bases >> Short-Chain Alkyltin and 
Alkylgermanium Halides 
7 1 6 0.14 
SN2|SN2 >> Direct acting epoxides formed after metabolic activation|SN2 >> Direct acting epoxides formed after metabolic 
activation >> Quinoline Derivatives|SN2 >> SN2 at an activated carbon atom|SN2 >> SN2 at an activated carbon atom >> 
Quinoline Derivatives 
85 47 38 0.55 
SN2|SN2 >> Direct acylation involving a leaving group|SN2 >> Direct acylation involving a leaving group >> Acyl Halides 20 16 4 0.80 
SN2|SN2 >> DNA alkylation|SN2 >> DNA alkylation >> Vicinal Dihaloalkanes|SN2 >> Internal SN2 reaction with aziridinium 
and/or cyclic sulfonium ion formation (enzymatic)|SN2 >> Internal SN2 reaction with aziridinium and/or cyclic sulfonium ion 
formation (enzymatic) >> Vicinal Dihaloalkanes 
34 19 15 0.56 
SN2|SN2 >> SN2 at sulfur atom|SN2 >> SN2 at sulfur atom >> Sulfonyl Halides 2 0 2 0.00 
 3.3.6 DNA binding by OECD profiler: 
The true negative rate (specificity) for the “DNA binding by OECD” profiler was, to some 
extent, less than acceptable at 62%. The poorer performance was also reflected in the MCC 
value of 0.32 which was the second lowest value amongst the six profilers. Six alerts in this 
profiler showed low PPV including one through the acylation mechanism (1,1-dihaloalkanes), 
three alerts for the Michael addition mechanism (furan, α,β−unsaturated ester, α,β-unsaturated 
ketone), one Schiff base former mechanism (mono aldehyde) and two alerts for unimolecular 
aliphatic nucleophilic substitution SN1 reactions (aromatic phenyl urea and aliphatic tertiary 
amines). Of the six alerts with low PPV, that for aliphatic tertiary amines was the most triggered 
hitting 218 substances. However, this alert falsely predicted 149 positives out of 218 with only 
30% PPV, as shown in Table 3.11. The alert for aliphatic tertiary amines was described in this 
profiler as relating to a mechanism of action whereby P450 metabolism converts the aliphatic 
tertiary amine to a reactive iminium species. This has been suggested as a potential pathway to 
DNA adducts via an SN1 mechanism, the reaction shown in Figure 3.9 (Kalgutkar and Soglia, 
2005). The relatively unspecific nature of the chemical relationship supporting this structural 
alert seems to be broad, this results in many false positive predictions and eventually lower 
accuracy of the overall profiler. 
 
Figure 3.9. DNA adduct formation mechanism of aliphatic tertiary amine (Kalgutkar and 
Soglia,  2005) 
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Table 3.11. Positive predictivity analysis for DNA binding by OECD profiler 
DNA binding by OECD TOT
AL 
T
P 
FP PP
V 
Acylation|Acylation >> Direct Addition of an Acyl Halide|Acylation >> Direct 
Addition of an Acyl Halide >> Acyl halide 
18 16 2 0.9 
Acylation|Acylation >> Isocyanates and Isothiocyanates|Acylation >> Isocyanates 
and Isothiocyanates >> Isocyanates 
11 7 4 0.6 
Acylation|Acylation >> Isocyanates and Isothiocyanates|Acylation >> Isocyanates 
and Isothiocyanates >> Isothiocyanates 
2 2 0 1.0 
Acylation|Acylation >> P450 Mediated Activation to Acyl Halides|Acylation >> 
P450 Mediated Activation to Acyl Halides >> 1,1-Dihaloalkanes 
16 4 12 0.3 
Acylation|Acylation >> P450 Mediated Activation to Isocyanates or 
Isothiocyanates|Acylation >> P450 Mediated Activation to Isocyanates or 
Isothiocyanates >> Formamides 
7 5 2 0.7 
Michael addition|Michael addition >> P450 Mediated Activation of Heterocyclic 
Ring Systems|Michael addition >> P450 Mediated Activation of Heterocyclic Ring 
Systems >> Furans 
20 7 13 0.4 
Michael addition|Michael addition >> P450 Mediated Activation to Quinones and 
Quinone-type Chemicals|Michael addition >> P450 Mediated Activation to 
Quinones and Quinone-type Chemicals >> 5-alkoxyindoles 
4 1 3 0.3 
Michael addition|Michael addition >> P450 Mediated Activation to Quinones and 
Quinone-type Chemicals|Michael addition >> P450 Mediated Activation to 
Quinones and Quinone-type Chemicals >> Alkyl phenols 
41 23 18 0.6 
Michael addition|Michael addition >> P450 Mediated Activation to Quinones and 
Quinone-type Chemicals|Michael addition >> P450 Mediated Activation to 
Quinones and Quinone-type Chemicals >> Arenes 
119 55 64 0.5 
Michael addition|Michael addition >> P450 Mediated Activation to Quinones and 
Quinone-type Chemicals|Michael addition >> P450 Mediated Activation to 
Quinones and Quinone-type Chemicals >> Hydroquinones 
87 42 45 0.5 
Michael addition|Michael addition >> P450 Mediated Activation to Quinones and 
Quinone-type Chemicals|Michael addition >> P450 Mediated Activation to 
Quinones and Quinone-type Chemicals >> Methylenedioxyphenyl 
8 2 6 0.3 
Michael addition|Michael addition >> P450 Mediated Activation to Quinones and 
Quinone-type Chemicals|Michael addition >> P450 Mediated Activation to 
Quinones and Quinone-type Chemicals >> Polycyclic (PAHs) and heterocyclic 
(HACs) aromatic hydrocarbons-Michael addition 
51 47 4 0.9 
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Michael addition|Michael addition >> Polarised Alkenes-Michael addition|Michael 
addition >> Polarised Alkenes-Michael addition >> Alpha, beta- unsaturated 
aldehydes 
23 15 8 0.7 
Michael addition|Michael addition >> Polarised Alkenes-Michael addition|Michael 
addition >> Polarised Alkenes-Michael addition >> Alpha, beta- unsaturated 
amides 
4 1 3 0.3 
Michael addition|Michael addition >> Polarised Alkenes-Michael addition|Michael 
addition >> Polarised Alkenes-Michael addition >> Alpha, beta- unsaturated esters 
55 9 46 0.2 
Michael addition|Michael addition >> Polarised Alkenes-Michael addition|Michael 
addition >> Polarised Alkenes-Michael addition >> Alpha, beta- unsaturated 
ketones 
24 9 15 0.4 
Michael addition|Michael addition >> Polarised Azo Compounds|Michael addition 
>> Polarised Azo Compounds >> Azocarbonamides 
1 1 0 1.0 
Michael addition|Michael addition >> Quinones and Quinone-type 
Chemicals|Michael addition >> Quinones and Quinone-type Chemicals >> 
Quinones 
16 14 2 0.9 
Schiff base formers|Schiff base formers >> Chemicals Activated by P450 to 
Glyoxal |Schiff base formers >> Chemicals Activated by P450 to Glyoxal  >> 
Ethanolamines (including morpholine)|Schiff base formers >> Chemicals 
Activated by P450 to Glyoxal  >> Ethylenediamines (including piperazine) 
1 1 0 1.0 
Schiff base formers|Schiff base formers >> Chemicals Activated by P450 to 
Glyoxal |Schiff base formers >> Chemicals Activated by P450 to Glyoxal  >> 
Ethanolamines (including morpholine) 
4 0 4 0.0 
Schiff base formers|Schiff base formers >> Direct Acting Schiff Base 
Formers|Schiff base formers >> Direct Acting Schiff Base Formers >> Alpha-beta-
dicarbonyl 
10 7 3 0.7 
Schiff base formers|Schiff base formers >> Direct Acting Schiff Base 
Formers|Schiff base formers >> Direct Acting Schiff Base Formers >> Mono 
aldehydes 
35 15 20 0.4 
SN1|SN1 >> Carbenium Ion Formation|SN1 >> Carbenium Ion Formation >> 
Aliphatic N-Nitro 
11 10 1 0.9 
SN1|SN1 >> Carbenium Ion Formation|SN1 >> Carbenium Ion Formation >> 
Allyl benzenes 
6 3 3 0.5 
SN1|SN1 >> Carbenium Ion Formation|SN1 >> Carbenium Ion Formation >> 
Polycyclic (PAHs) and heterocyclic (HACs) aromatic hydrocarbons-SN1 
110 10
3 
7 0.9 
SN1|SN1 >> Iminium Ion Formation|SN1 >> Iminium Ion Formation >> Aliphatic 
tertiary amines 
218 69 149 0.3 
SN1|SN1 >> Nitrenium Ion formation|SN1 >> Nitrenium Ion formation >> 
Aromatic azo 
30 14 16 0.5 
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SN1|SN1 >> Nitrenium Ion formation|SN1 >> Nitrenium Ion formation >> 
Aromatic N-hydroxylamines 
27 24 3 0.9 
SN1|SN1 >> Nitrenium Ion formation|SN1 >> Nitrenium Ion formation >> 
Aromatic nitro 
481 39
6 
85 0.8 
SN1|SN1 >> Nitrenium Ion formation|SN1 >> Nitrenium Ion formation >> 
Aromatic phenylureas 
10 2 8 0.2 
SN1|SN1 >> Nitrenium Ion formation|SN1 >> Nitrenium Ion formation >> 
Aromatic nitroso 
21 21 0 1.0 
SN1|SN1 >> Nitrenium Ion formation|SN1 >> Nitrenium Ion formation >> 
Primary (unsaturated) heterocyclic amine 
66 53 13 0.8 
SN1|SN1 >> Nitrenium Ion formation|SN1 >> Nitrenium Ion formation >> 
Primary aromatic amine 
265 18
9 
76 0.7 
SN1|SN1 >> Nitrenium Ion formation|SN1 >> Nitrenium Ion formation >> 
Secondary (unsaturated) heterocyclic amine 
11 1 10 0.1 
SN1|SN1 >> Nitrenium Ion formation|SN1 >> Nitrenium Ion formation >> 
Secondary aromatic amine 
34 16 18 0.5 
SN1|SN1 >> Nitrenium Ion formation|SN1 >> Nitrenium Ion formation >> 
Tertiary aromatic amine 
59 36 23 0.6 
SN2|SN2 >> Direct Acting Epoxides and related|SN2 >> Direct Acting Epoxides 
and related >> Aziridines 
36 35 1 1.0 
SN2|SN2 >> Direct Acting Epoxides and related|SN2 >> Direct Acting Epoxides 
and related >> Epoxides 
184 14
4 
40 0.8 
SN2|SN2 >> Direct Acting Epoxides and related|SN2 >> Direct Acting Epoxides 
and related >> Sulfuranes 
3 1 2 0.3 
SN2|SN2 >> Episulfonium Ion Formation|SN2 >> Episulfonium Ion Formation >> 
1,2-Dihaloalkanes 
27 23 4 0.9 
SN2|SN2 >> Epoxidation of Aliphatic Alkenes|SN2 >> Epoxidation of Aliphatic 
Alkenes >> Halogenated polarised alkenes 
14 8 6 0.6 
SN2|SN2 >> SN2 at an sp3 Carbon atom|SN2 >> SN2 at an sp3 Carbon atom >> 
Aliphatic halides 
103 80 23 0.8 
SN2|SN2 >> SN2 at an sp3 Carbon atom|SN2 >> SN2 at an sp3 Carbon atom >> 
Phosphonic esters 
5 0 5 0.0 
 Total = number of  substances  flagged  by alert  , TP=  True positive  (mutagens identified positive by  alert) ,   
FP= False positive  ( non-mutagens identified positive by alert) , PPV= Positive Predictivity value  
 3.4. Conclusion 
This chapter provides detailed analysis of the positive predictions of each structural alert in six 
mutagenicity profilers within the OECD QSAR Toolbox, as compared to experimental 
mutagenicity data from the CCRIS dataset. The analysis of the results from this investigation 
aimed to increase the reliability and accuracy of mutagenicity predictions by these profilers. 
All six mutagenicity profilers showed reasonably acceptable overall sensitivity and specificity 
ranging from the excellent predictive performance of the “Ames test alert by ISS” profiler to 
an acceptable predictive performance with the remaining five mutagenicity profilers. The 
OECD QSAR Toolbox mutagenicity profilers play an important role in read-across from the 
expermintal data to predict mutagenicity for untested compounds. Knowing and investigating 
the accuracy and senstivity of these profilers will highlight which strucutral alerts need to be 
kept or ignored, to improve the overall preformance of the profilers.  
As this study has shown, 28 strucutural alerts were found to be too inaccurate to be used as an 
indicator for mutagenicity and need more refinment and evaluation, these are summarised in 
Table 3.12. The alert “Hacceptor-path3-Hacceptor” in the micronucleus profiler was the 
highest triggered alert amongst the total 28 alerts for 1114 subsatances. The positive 
predicitvity of this alert was too low (30%) and removing this alert may improve the overall 
preformence of the profiler. Similarly, aliphatic tertiary amines in the DNA binding profiler by 
OECD was the second highest alert to be triggered among the 28 alert list. This alert was 
triggered in 219 substances and correctly predicts only 30% of the substances, which raises the 
need to remove it to improve the overall accuracy of the profiler in addition to the other low 
PPV alerts suggested in each profiler in Table 3.12. 
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Table 3.12. A list of 28 structural alerts showing low mutagenicity predictivity among the six 
mutagenicity profilers within the OECD QSAR Toolbox. 
ALERT TOTAL TP FP PPV 
genotox and nongenotox alerts by ISS 
1,3-Benzodioxoles  12 5 7 0.42 
Benzenesulfonic ethers, methylation  13 3 10 0.23 
Halogenated benzenes  82 19 63 0.23 
Substituted n-alkylcarboxylic acids  26 3 23 0.12 
Thiocarbonyls  17 6 11 0.35 
Alkenylbenzenes  17 4 13 0.24 
α,β-unsaturated carbonyls  187 85 102 0.45 
Simple aldehydes 74 28 46 0.38 
DNA alerts for AMES, MN and CA by OASIS 
SN2| Alkylphosphates, Alkylthiophosphates and Alkylphosphonates 47 19 28 0.40 
in vitro mutagenicity (Ames test) alerts by ISS 
Alkenylbenzenes 21 3 18 0.14 
alpha,beta-unsaturated carbonyls 192 84 108 0.44 
Aromatic ring N-oxides 10 4 6 0.40 
Simple aldehydes 33 6 27 0.18 
in vivo mutagenicity (Micronucleus) alerts by ISS 
H-acceptor-path3-H-acceptors 1114 323 791 0.29 
1-phenoxy-benzenes 14 3 11 0.21 
alpha,beta-unsaturated carbonyls 60 28 32 0.47 
Aromatic N-acyl amines 26 10 16 0.38 
Simple aldehydes 33 6 27 0.18 
DNA binding by OASIS v.1.1 
Non-covalent interaction| DNA Intercalators with Carboxamide and Aminoalkylamine Side Chain 32 6 26 0.19 
Radical|Radical >> Radical mechanism via ROS formation (indirect)| Thiols 23 10 13 0.43 
SN2|SN2 >> Alkylation| Alkylphosphates, Alkylthiophosphates and Alkylphosphonates 69 21 48 0.30 
DNA binding by OECD 
Acylation >> P450 Mediated Activation to Acyl Halides| 1,1-Dihaloalkanes 16 4 12 0.3 
Michael addition| >> P450 Mediated Activation of Heterocyclic Ring Systems| Furans 20 7 13 0.4 
Michael addition| >> Polarised Alkenes| Alpha, beta- unsaturated esters 55 9 46 0.2 
Michael addition| >> Polarised Alkenes-| Alpha, beta- unsaturated ketones 24 9 15 0.4 
Schiff base formers >> Direct Acting Schiff Base >> Mono aldehydes 35 15 20 0.4 
SN1|SN1 >> Iminium Ion Formation| Aliphatic tertiary amines 218 69 149 0.3 
SN1|SN1 >> Nitrenium Ion formation| Aromatic phenylureas 10 2 8 0.2 
 Total = number of  substances  flagged  by alert  , TP=  True positive  (mutagens identified positive by  alert) ,   FP= False 
positive  ( non-mutagens identified positive by alert) , PPV= Positive Predictivity value  
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Overall Chapter 3 confirms the need, and value derived from, the study of the suitability and 
merits of each of the alerts within the profilers in the OECD QSAR Toolbox. This is equally 
applicable to other in silico toxicity platforms e.g. knowledge-based expert systems for 
predictive toxicology. These analysis are important to identify possibilities to improve the 
performance of the profilers, as well as to provide estimates of confidence in the alerts. This 
will, by implication, also improve the reliability of chemical read-across and 
grouping/categorisation for classification, labelling and risk assessment.   
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Chapter 4: Identification of the core structural features of genotoxic and non-genotoxic 
carcinogens in cosmetic ingredients using scaffold analysis. 
 
 
4.1. Introduction:  
As described in Chapter 1, safety of cosmetics in Europe is regulated under the Cosmetic 
Regulation (EC) No 1223/2009. The Regulation prohibits the use of any carcinogenic, 
mutagenic and reproductive toxicant (CMR) substances in cosmetic products. The CMR 
classifications can be summarised as follows (see Section 1.4 for more details): 
Carcinogenic 
• Cat. 1A: Known to have carcinogenic potential for humans 
• Cat. 1B:  Presumed to have carcinogenic potential for humans 
• Cat. 2:  Suspected human carcinogen  
 
Mutagenic 
• Cat. 1A:  Substance known to induce heritable mutations in the germ cells of humans 
• Cat. 1B:  Substance to be regarded as if it induces heritable mutations in the germ cells 
of humans 
• Cat. 2:  Substance which causes concern for humans owing to the possibility that it 
may induce heritable mutations in the germ cells of humans 
 
Reproductive toxicants 
• Cat. 1A:  Known human reproductive toxicant 
• Cat. 1B:  Presumed human reproductive toxicant 
• Cat. 2:  Suspected human reproductive toxicant 
 
.As a consequence of the regulatory pressures and ethical considerations discussed in Chapter 
1, the use of alternative testing methods, such as computational toxicology and QSAR 
modelling, have considerably increased for the assessment of toxic hazards (Nendza et al., 
2013; Plošnik, Zupan and Vračko, 2015). At the same time, the incidence of cancer has 
increased by 70% during the last two decades and this has put cancer as the second leading 
cause of mortality worldwide (Stewart and Wild 2017). The use of any carcinogenic chemical 
ingredient in a cosmetic product is considered as of high concern as all personal products 
provide direct exposure to the consumer and a route of emission to the environment. In order 
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to develop in silico models, a mechanistic basis is strongly encouraged. As discussed the 
preceding Chapters 1 and 2, two mechanisms that can initiate cancer – these are based around 
genotoxic and non-genotoxic pathways and these need to be considered for modelling 
purposes.  
In this chapter, the word “scaffold” is used primarily to describe the core structure of 
compounds. This chapter focused mainly on the identification of the core structural “scaffold” 
through which the potential of other (untested) carcinogenic chemical agents may be assessed. 
This chapter encompassed chemical substances with either genotoxic or non-genotoxic 
carcinogenic mechanisms of action. In accordance with the European Cosmetic Regulation, the 
emphasis of this study was to explore QSARs as an alternative (non-animal) method for 
assessment of the potential carcinogenicity for the chemicals that are intended to be used as 
cosmetic ingredients. The QSAR field has seen much progress in the past couple of decades, 
and a number of high quality in silico models, expert systems and read-across tools based on 
both Ames test and experimental rat carcinogenicity test data are now available (Mostrag-
Szlichtyng et al., 2010). In addition to the predictivity (from chemical structure) of the in silico 
models and tools, they also provide very useful information in regard to mechanistic pathways 
or structure-activity relationships (Cronin and Madden, 2011). 
Various structural alerts have also been derived for mutagenicity/carcinogenicity. For example, 
the Benigni-Bossa rules are utilised by various expert systems i.e. Derek Nexus and Toxtree to 
predict the carcinogenicity or mutagenicity of unknown chemicals (Benigni, 2008). On the 
other hand, QSAR based approaches illustrate the relationship between the carcinogenicity of 
the chemicals and physicochemical properties of the molecules such as lipophilicity, electron 
density, etc by linear or non-linear models (Schultz et al., 2006). One of the main examples of 
programmes that use the QSAR approach is Leadscope Model Applier (LSMA) which has been 
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used in this study to generate the main structural scaffolds for grouping of the chemicals 
according to mutagenic/carcinogenic potential. 
A major limitation in using QSAR or structural alerts to predict carcinogenicity is that neither 
of the approaches (structural alerts or QSAR) can link a core structural “scaffold” with the 
ability of a chemical substance to be carcinogenic. Structural alerts mainly depict the outcomes 
of an evaluation linked to functional group(s), whereas QSAR approaches derive estimates 
from a series of similar (analogous) chemicals in their properties and their activity (Kho et al., 
2005). As a result, neither of the approaches can precisely flag the carcinogenic potency when 
it arises from a certain core structural feature (scaffold). Different carcinogenic chemicals may, 
however, share one or more structural features (i.e. the scaffold) contained within the functional 
groups or side chains and the scaffold analysis approach was therefore investigated in this 
Chapter to seek clues to find a link between a compound's chemical structure and potential 
carcinogenicity. For this, the relationship between scaffolds of a range of diverse compounds 
and carcinogenicity (both genotoxic and non-genotoxic) was analysed using a dataset of Ames 
assay for 10,543 compounds from the SAR genotoxicity database, and carcinogenicity data for 
2,870 compounds from the SAR carcinogenicity database both within the Leadscope® 
database (Leadscope.com, 2018). The scaffold generation feature in Leadscope® was utilised 
to generate hierarchical relationships of scaffolds between these compounds and the activities. 
Through analysis of scaffold relationships, lists of the scaffolds with potential mutagenicity or 
carcinogenicity were established. These scaffolds can be used as the basis for predicting the 
carcinogenic potency of new chemicals planned to be used in cosmetic product which helps to 
prevent using potentially carcinogenic chemicals. The knowledge of scaffolds implicated in 
carcinogenic effects may also make it possible to redesign some of the compounds by replacing 
them with non-carcinogenic scaffolds. 
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4.2. Materials and Methods: 
4.2.1: Leadscope SAR carcinogenicity and genotoxicity databases:  
Leadscope SAR carcinogenicity and genotoxicity databases are high-quality data resources that 
can be used to build a predictive model and for the 'read-across' of data for other chemicals to 
determine their potential to be carcinogenic or mutagenic. Both databases contain summarised 
data for in vitro and in vivo cancer and mutagenicity endpoints along with chemical structures. 
These databases are used by the Leadscope program to build predictive models. To ensure 
high-quality data for SAR, analyses of various salt forms of chemical compounds and their 
respective toxicity data have also been carried out to derive an overall endpoint for the active 
portion of the chemical. Several sources of experimental test results have been included in these 
databases, such as from FDA, NTP, CCRIS, CPDB and other primary sources. All chemical 
structures have been provided in SAR in the neutral and, if appropriate, tested form and 
confirmed for accuracy.  
The SAR carcinogenicity database contains 1,948 SAR structures. The database includes 3,598 
compounds with 11,538 test results and provides carcinogenicity study endpoints for male and 
female rats (1,774 and 1,725 compounds respectively) and male and female mice (1,640 and 
1,675 compounds respectively). The SAR genotoxicity database provides compound-level 
calls for 46 genetic toxicity endpoints. These include 32 bacterial mutagenicity endpoints, 4 in 
vitro mammalian, 5 in vitro chromosomal aberration and 6 in vivo micronucleus results. An 
overview of the datasets is presented in Table 4.1. 
 
 
 
  
 
 
Chapter 4 
 
      Page 124  
Table 4.1. An overview of the number of compounds and the endpoints total results for both 
SAR genetox and SAR carcinogenicity databases. * = (Number of tests) 
SAR genotoxic database  (10543)* Mutagenic (positive) Non-mutagenic (negative) 
Bacterial mutation 4530 4173 
Salmonella 4235 4180 
In vivo micronucleus 274 912 
SAR carcinogenic database (2870)* carcinogenic (positive) Non-carcinogenic (negative) 
Male rat 745 869 
Female rat  686 892 
 
4.2.2 Scaffold generation feature in Leadscope: 
The scaffold analysis feature for a large dataset of bioactivity values in the Leadscope personal 
Ver 4.4 programme was used in this study to generate hierarchical structuring and visualisation 
of the main carcinogenic scaffolds covering both genotoxic and non-genotoxic mechanisms. 
This feature was also used to navigate and explore the chemical space of different complex 
structures in both the SAR carcinogenicity and SAR genotoxicity databases. The carcinogenic 
scaffolds were extracted by removing all side chains except the linking double bonds and 
exocyclic groups to generate chemically meaningful compound scaffolds. Using the scaffold 
generating parameters, the level of quality of the extracted scaffolds from the database was 
selected by choosing the minimum compounds per scaffold and the minimum atoms per 
scaffold. Choosing higher numbers yields lower number of scaffolds but of higher quality. In 
this study, the criteria used were that a carcinogenic scaffold has to cover at least 10 compounds 
and therefore the minimum compounds number per one scaffold was set to 10, and the same 
number was set for the minimum number of atoms per scaffold.  
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The scaffold generation feature in Leadscope has another advantage in that it arranges scaffolds 
to form a tree of “virtual scaffolds” that are constructed in silico. This tree is built in hierarchical 
arrangement of parent and child scaffolds (see Figure 4.1). The smaller size scaffold (parent), 
which covers a larger number of compounds, yields bigger sized (child) scaffolds that cover 
fewer compounds but have more specificity in terms of activity. Child scaffolds that share the 
same substructure of parent scaffold are usually termed as sibling scaffolds since they are all 
linked to one parent scaffold. 
 
Figure 4.1. A screenshot of the Leadscope program which shows the virtual scaffolds tree in 
hierarchical arrangement of parent and child carcinogenic scaffolds. 
 
In this study, the scaffold generation feature in Leadscope was used to construct a scaffold tree 
of both carcinogenic and mutagenic scaffolds extracted from the SAR carcinogenicity and 
genotoxicity databases. This approach also helped to illustrate any relationship(s) between 
carcinogenicity and mutagenicity scaffolds since visual analysis of the structural relationship 
between parent and child scaffolds was easier using the hierarchical arrangement tree. 
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4.2.3 Cut-offs for Selecting Carcinogenic and Mutagenic Scaffolds: 
Carcinogenicity and mutagenicity values were assigned to each scaffold within a scaffold tree. 
In the case of the SAR carcinogenicity database, this value was defined as the ratio of 
carcinogenic compounds to the total compounds that are contained in that scaffold. While in 
the SAR genotoxicity database, this value was defined as the ratio of mutagenic compounds to 
the total compounds that are contained in that scaffold. Cut-off values were then specified in 
order to select the representative carcinogenicity or mutagenicity scaffold. If the value of 
mutagenicity or carcinogenicity of any scaffold was equal or greater than the cutoff value, it 
was considered as a representative active scaffold (carcinogenicity or mutagenicity) whereas 
the scaffolds less than the cut-off value were defined as non-active (non-carcinogenic or non-
mutagenic). In addition, each scaffold had to cover at least 10 compounds to be selected to the 
scaffold group. The main goal of adjusting the cut-off value was to select the minimum number 
of carcinogenicity and mutagenicity scaffolds that would cover the largest possible number of 
carcinogenic and mutagenic compounds. The ratio of activity (carcinogenicity or mutagenicity) 
(C1/S), where C1 represent total active compounds (carcinogenic or mutagenic) and S 
represent the number of active compounds that contain this scaffold, was adjusted to be 0.7 
based on selection criteria discussed above. All the values between 0.7-0.3 were considered 
equivalent while values below 0.3 were considered as non-active scaffolds (non-
carcinogenicity or non-mutagenicity). 
On the other hand, the non-active compounds’ ratio was also adjusted to select the minimum 
number of non-active (non-carcinogenicity or non-mutagenicity) scaffolds that would cover 
maximum number of non-active compounds. The ratio of non-activity (C2/S), where C2 
represent the total non-active compounds (non-carcinogenic or non-mutagenic) and S  
represent the number of non-active compounds that contain this scaffold, was adjusted to be 
0.7 based on selection criteria discussed above, which is equal to 0.3 in ratio of activity.  
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All scaffolds that were equal or more than the activity ratio (0.7) in carcinogenicity and equal 
or more than activity ratio (0.7) in mutagenicity and covered more than 10 structures were 
classified as genotoxic carcinogenicity scaffolds. On the other hand, all scaffolds that are more 
than or equal to activity ratio (0.7) in carcinogenicity and less than or equal to non-activity ratio 
(0.3) in mutagenicity were classified as non-genotoxic carcinogenicity scaffolds. 
4.3. Results and Discussion: 
The aim of the study presented in this chapter was to investigate the relationship between 
structural scaffolds and carcinogenicity or mutagenicity for diverse chemical substances using 
experimental data from the SAR carcinogenicity and genotoxicity database. A scaffold is 
defined as “fixed part of a molecule, on which functional group or other side chain can be 
substituted or changed” (Hsu et al., 2016). The experimental toxicity data on which this 
analysis was based included the results of both genotoxic and non-genotoxic carcinogenicity 
studies.  
Through application of stringent selection criteria, 17 carcinogenicity scaffolds (C/S scores 
greater than or equal to 0.7), 21 mutagenicity scaffolds (C/S scores greater than or equal to 0.7), 
and 7 non-mutagenicity scaffolds (C/S scores lower than or equal to 0.3) were identified. Each 
scaffold has two values: score-1 for carcinogenicity obtained from the SAR carcinogenicity 
database and score-2 for mutagenicity obtained from the SAR genotoxicity database. Some 
scaffolds showed a high carcinogenicity score with the absence of a mutagenicity scaffold(s) 
obtained from SAR genotoxicity database confirming that the mode of action was non-
genotoxic carcinogen.   
To determine the main structural features for carcinogenicity the structure-activity 
relationships for the 17 carcinogenic scaffolds were examined. Any structural similarity or 
common features in the carcinogenic scaffolds were grouped together and a scaffold tree was 
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build. Of the 17 carcinogenic scaffolds, 12 scaffolds shared the same structural feature(s) and 
were categorised into three groups 1) phenanthrenes, 2) 9H- fluorene and 3) nitronaphthalene. 
The other five carcinogenic scaffolds were listed as a separate (fourth) group.  
All children scaffolds listed under these three main groups met the selection criteria - i.e. they 
had carcinogenicity scores equal or greater than 0.7, and covered more than 10 compounds. 
The fourth group, which contained five parent scaffolds with no children scaffolds, comprised 
anthracene-9,10-dione, benzidine, 1-methylnaphthalene, estradiol and 5-methylbenzodioxole. 
The statistics concerning the carcinogenicity value and the number of compounds covered by 
the scaffold are shown in Table 4.1. The analysis demonstrated that it is highly probable that 
any chemical structure containing one of these carcinogenic scaffolds would induce 
carcinogenicity regardless of the attached functional group or side chain to the scaffold.  
In the following section, the structural feature(s) of all of the carcinogenicity scaffolds are 
discussed in detail and their classification based on mode of action (genotoxic or non-genotoxic) 
is presented at the end of the chapter. 
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4.3.1 Major carcinogenicity scaffold (1): Phenanthrene:  
In the SAR carcinogenicity database, more than 70% of compounds containing phenanthrene 
as the main core structure were carcinogenic. 86% of these compounds (in 108/125) were tested 
carcinogenic in female rat. Phenanthrene was, therefore, considered one of the major 
carcinogenic scaffolds. The scaffold tree for phenanthrene consists of six child scaffolds 
(shown in Table 4.2). These were: (2) tetraphene, (3) benzo[pqr] tetraphene, (4) chrysene, (5) 
3a,5a-dihydropyrene, (6) 1,2,2a,3a,tetrahydrochryseno[3,4-b]oxirene and (7) methyl-
phenantherene. All of the child scaffolds were considered as major carcinogenic scaffolds 
because all compounds containing these scaffolds were carcinogenic with a carcinogenicity 
value more than 0.7. From the total of 48 compounds containing tetraphene, 100%, were 
carcinogenic in both female and male rats. For the other compounds containing scaffolds the 
carcinogenicity value were as follows:  benzo[pqr] tetraphene (100%, 16/16) , chrysene (100%, 
37/37),   3a,5a dihydropyrene (100%, 43/43), tetrahydrochryseno oxirene (100%, 11/11) and 
methyl phenantherene (100%, 12/12). 
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Table 4.2. First major carcinogenic scaffolds (phenanthrene) with six child scaffolds identified 
from the SAR carcinogenicity database (includes both genotoxic and nongenotoxic 
mechanisms) that are equal or more than 0.7 c/s ratio.*F: female rat M: male rat. 
Phenanthrene 
Frequency: 125   C/S:  M:0.7, F:0.86 
 
Frequency: 48 
C/S: M:1, F:1 
Frequency: 16 
C/S: M:1 , F:1 
Frequency: 37 
C/S: M:1 , F:1 
Frequency: 43 
C/S : M:1 , F:0.7 
 
tetraphene 
 
benzo[pqr] tetraphene 
 
chrysene  
3a,5a dihydropyrene 
Frequency: 11 
C/S : M:1 , F:1 
Frequency: 12 
C/S : M:1 , F:1 
 
1,2,2a,3a,tetrahydrochryseno[3,4-b]oxirene 
 
 
4 methylphenanthene 
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The differences between the parent scaffold of phenantherene and its children scaffolds were: 
three of the children scaffold, tetraphene, chrysene and 3a,5a dihydropyrene, have an additional 
benzene ring compared to the parent scaffold. The fourth child scaffold, benzo[pqr]tetraphene, 
has additional two benzene rings, the fifth child scaffold, tetrahydrochryseno oxirene, has an  
additional oxirene group, and the sixth child scaffold methyl phenantherene had an additional 
methyl group compared to the parent scaffold. 
Phenanthrene and chrysene have been found in some cosmetic ingredients such wood tar 
(SCCNFP, 2003). They have also been used by ship-builders and sailors for a long period of 
time as wood preservative because they have disinfectant properties (SCCNFP, 2003). A 
typical wood tar preparation contains polyaromatic hydrocarbons (PAHs) such as phenanthrene 
and chrysene that are classified as highly genotoxic compounds and classified as Category 3 
mutagens in the EU i.e. substances that cause concern for human health owing to possible 
mutagenic effects (EU, 2002).  According to the EU Scientific Committee on Cosmetic and 
Non-Food Products (SCCNFP), using wood tar in cosmetic products can pose a high risk to 
the consumer health because of the highly genotoxic carcinogen compounds such as 
phenanthrene, chrysene and other polycyclic aromatic hydrocarbons (PAHs). It has also been 
found that wood tar and its preparations could present a high risk of skin cancer in humans 
because they may form a DNA adduct in the skin. In addition, wood tar and its preparations 
may induce benign and malignant tumours in mouse skin (SCCNFP, 2003).  
However, wood tar preparation is also used as a psoriasis treatment and different types of wood 
tar, based on different sources, may show differing genotoxicity activity (SCCNFP, 2003). For 
example, juniper tar (cade oil) was found to form DNA adduct by covalent binding in both 
human and mouse skin. This was found both in human biopsy samples from psoriasis treated 
patients with juniper tar, and in skin and lung cells of mice treated with juniper tar. On the other 
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hand, pine tar resin has not been found to be genotoxic in the Ames test and did not induce any 
mutations in S. typhimurium (SCCNFP, 2003). 
4.3.2 Major carcinogenicity scaffold (2): 9H-Fluorene  
This study considered 9H-fluorene as the second major carcinogenicity scaffold on the basis 
of analysis of SAR carcinogenicity database as more than 70% of fluorene containing 
compounds, from a total of 22 compounds, were positive in the carcinogenicity test. The 9H-
fluorene parent scaffold consists of two carcinogenic child scaffolds that were found in more 
than 10 compounds and were carcinogenic in more than 70% of these compounds. In Table 
4.3, the structural relationship between the parent 9H-fluorene scaffold and the two 
carcinogenic children scaffold is shown. The first of those two carcinogenicity child scaffolds, 
9H-fluorene-2amine was present in 16 compounds and 100% of these compounds were 
carcinogenic. It can be observed that 9H-fluorene-2-amine has an added amino group compared 
to the parent scaffold 9H-fluorene. Interestingly, the addition of an amino group led to 25% 
increase of carcinogenicity compared to the parent scaffold 9H-fluorene. 100% of compounds 
containing the other carcinogenicity child scaffold, fluoranthene, in 16 compounds were 
carcinogenic. Fluoranthene has an added benzene ring compared to the parent scaffold 9H- 
fluorene. The addition of a benzene group increases the carcinogenicity rate by 30% compared 
to 70% in parent scaffold 9H-fluorene. Fluorene containing compounds, such as like coal tar, 
are prohibited to be used in cosmetic products according to European regulation (EC) No 
1223/2009. 
The Chronic Exposure of 9H-fluorene in rats was evaluated . A group of 18 female Buffalo 
strain rats, 0.9 months of age, were fed 0.05% fluorene in the diet for 18 months (total average 
intake, 2553 mg/rat), and surviving animals were killed at 20.1 months; the average age /at/ 
autopsy was 19 months. Tumours reported were one uterine carcinosarcoma, one uterine 
fibrosarcoma, one granulocytic leukemia, and four pituitary adenomas (IARC, 1983). In a 
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control group of 18 rats, 3.5 months of age, fed a basal diet for an average of 15.5 months, one 
uterine adenocarcinoma, two uterine fibro-epithelial polyps, five adrenal cortical adenomas, 
six pituitary adenomas, and one inguinal region fibroma were reported (IARC, 1983). 
Table 4.3. Second major carcinogenic scaffolds (9H-Fluorene) with two child scaffolds 
identified from the SAR carcinogenicity database (includes both genotoxic and nongenotoxic 
mechanisms) that are equal or more than 0.7 c/s ratio.*F: female rat M: male rat. 
9H-Fluorene 
Frequency: 22 C/S : M:0.7F:0.7 
 
 
Frequency: 13 
C/S : M:1 , F:1 
Frequency: 16 
C/S: M:1, F:1 
 
9H-fluorene- 2amine 
 
Fluoranthene 
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4.3.3 Major carcinogenicity scaffold (3): Nitronaphthalene:  
The third major carcinogenicity scaffold was 2-nitronaphthalene, 80% of the total 28 
compounds with the nitronaphthalene core structure were carcinogenic. This high probability 
of carcinogenicity of any compound with nitronaphthalene as its core structure means it should 
be avoided in any cosmetic product intended to be manufactured. 2- Nitronaphthalene is a by-
product of the commercial preparation of 1-nitronaphthalene which is synthesised by the action 
of a mixture of nitric and sulfuric acids on finely ground naphthalene (Verschueren, 1985). 1,6-
Dinitopyrene and 5-nitro-1,2-dihydroacenthylene are two examples of structures containing 
the 2-nitronaphthalene scaffold as part of their structure. These two compounds were positive 
in carcinogenicity tests in both male and female rats.  
Carcinogenic aromatic amines and nitro compounds are metabolised to “activated” 
intermediates generally believed to be responsible for producing tissue alterations (Miller and 
Miller, 1969). N-Oxidation of l- and 2-naphthylamine and nitro reduction of l- and 2-
nitronaphthalene may lead to identical N-oxy intermediates which have been shown to be 
carcinogenic and/or mutagenic in several in vitro and in vivo studies (Crabtree et al., 1991). 
The nitronaphthalene scaffold consists of one carcinogenicity child scaffold, namely 
nitropyrene (see Table 4.4). Nitropyrenes were present in 13 compounds and have a 
carcinogenicity rate of 0.8 in female rats. The nitropyrene has additional two benzene rings 
attached to the parent nitronaphthalene scaffold. The additional two benzene rings in child 
nitropyrene scaffold did not change the carcinogenicity level compared to the parent 
nitronaphthalene scaffold since the carcinogenicity level were still 80% in female rat. 
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Table 4.4. Major carcinogenic scaffold (nitrophthalene) with one child scaffold identified from 
the SAR carcinogenicity database (includes both genotoxic and nongenotoxic mechanisms) 
that are equal or more than 0.7 c/s ratio.*F: female rat M: male rat. 
Nitronaphthalene 
Frequency: 28 C/S : M:0.8, F:0.6 
 
 
Frequency: 13 
C/S: M:0.5, F:0.8 
 
Nitropyrene 
 
 
4.3.4 Major carcinogenicity scaffold (4): five groups without child scaffolds:  
The fourth major carcinogenicity group consisted of five carcinogenic scaffolds with no child 
scaffold (see Table 4.5). These five scaffolds were anthraquinone, benzidine, 1-methyl 
naphthalene, estradiol and methylbenzodioxole.  
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Table 4.5. Main 5 carcinogenic scaffolds with no child scaffold identified from the SAR 
carcinogenicity database (includes both genotoxic and nongenotoxic mechanisms) that are 
equal or more than 0.7 C/S ratio.*F: female rat M: male rat. 
 
Other carcinogenic scaffolds with no child scaffolds 
Frequency: 16 
C/S: M:0.7, F:0.8 
Frequency: 24 
C/S: M:0.7, F:0.7 
Frequency: 42 
C/S: M:0.8, F:1 
Frequency: 18 
C/S: M:0.8, F:0.8 
 
 
Anthraquinone 
 
 
benzidine 
 
1-methyl naphthalene 
 
(Estradiol) 
3methyl-decahydro-
cyclopenta-phenanthrene 
Frequency: 10 
C/S: M: 0.8, F:1 
 
 
5-methylbenzodioxole 
 
 
 
 
 
4.3.4.1: Anthraquinone carcinogenic scaffold :  
The anthraquinone scaffold was present in 16 compounds as part of their structure with a 
carcinogenicity rate of 70% and 80% in male and female rat respectively. 1-Amino-2-
methylanthraquinone (C.I disperse orange 11) and (C.I. disperse blue 1) are two examples of 
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compounds that contain the anthraquinone scaffold in SAR carcinogenicity database as the 
main core structure and were positive in carcinogenicity tests in both male and female rats. In 
cosmetic products, anthraquinone hair dyes are used mainly within semi-permanent and 
temporary hair dyes. Acid blue 62 is one example of a chemical with the anthraquinone moiety 
used as a temporary hair dye that can cause a wide range of toxicities including increase in 
kidney weight, increased aminotransferase and decrease body weight (SCCP, 2005). Table 4.6 
lists the most used hair dyes that contain anthraquinone as a core structure along with a list of 
side effects in male and female rat that have been noted in the SCCP Opinions.  
The International Agency for Research on Cancer (IARC, 2013) stated that anthraquinone 
increased the incidence of both benign and malignant neoplasms in rat in a 2 year study. In 
female rats treated with anthraquinone the tumours were noted as renal tubular adenoma of 
kidney, hepatocellular adenoma, and urinary bladder papilloma of transitional epithelial cell. 
In experimental animal tests, kidney and urinary bladder tumours and hepatoblastoma are rare. 
The metabolism of anthraquinone has been investigated mainly in rat and there are insufficient 
data in humans (IARC, 2013). The absorption of anthraquinone occurred completely after oral 
administration and distributed systemically with no sign of accumulation in any specific organ. 
The most important metabolites of anthraquinone in rodents relevant to mechanistic 
considerations for anthraquinone (parent molecule) are 1-and 2-hydroxyanthraquinones.  
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Table 4.6. The main anthraquinone hair dyes and SCCS opinions on carcinogenicity and the 
maximum allowed limit in hair dyes. ↑ = elevation (increase in level), ↓ = (lowering), ♀ = 
female , ♂ = male 
 Structure Compound 
Name 
Adverse effects used to derive LO(A)EL within SCC(NF)P 
and SCCS opinions 
1 
N H 2
N H 2
O
O
 
Disperse 
Violet 1 
↑ Centrilobular/Midzonal hepatocyte hypertrophy↑ 
Triglycerides (♀)↑ Cholesterol↓ Motor activity 
Based on the information provided, the SCCS is of the 
opinion that the use of Disperse Violet 1 in semi-permanent 
hair dye formulations at a maximum concentration of 0.5% 
does not pose a risk to the health of the consumer, apart 
from its moderate skin sensitising potential. 
2 
S
O
O
O H
N
O
O
N
S
O
O
OH
 
Acid Green 
25 
↑ Kidney weight 
Acid Green 25 is proposed for use in semi-permanent hair 
dye formulations as a direct dye at a maximum 
concentration of 0.3% in the finished cosmetic product. 
The SCCS is of the opinion that the use of Acid Green 25 as 
a non-oxidative hair dye with a maximum on head 
concentration of 0.3% does not pose a risk to the health of 
the consumer. 
3 
O
O N H 2
NH
S
O
O
O H
 
Acid Blue 62 ↑ Kidney weight ↑ Liver weight↑ Ptyalism↑ Tubular 
nephrosis↑ Centrilobular hepatocyte hypertrophy↑ Blood 
Urea↑ Albumin↑ Cholesterol↑ AAT↓ Body weight↓ 
Glucose 
The SCCS opinion is not available 
4 
N
+
C H
3
O
–
O
O
NH
O  
Hydroxyanthr
aquinone 
Aminopropyl 
Methyl 
Morpholinium 
Methosulfate 
↓ Absolute thymus weight (♀)↓ Body weight (♂)↓ Relative 
thymus weight 
The SCCS is of the opinion that the use of 
Hydroxyanthraquinone aminopropyl methyl 26 
morpholinium methosulfate with a maximum concentration 
of 0.5% in non-oxidative hair 27 dye formulations does not 
pose a risk to the health of the consumer, apart from its 28 
sensitising potential. 
5 
C H
3
O H
O
O
NH
S
O
O
OH
 
Acid Violet 
43 
↑ PT ↑ APTT 
The SCCP is of the opinion that the information submitted 
is inadequate to assess the safe use of the substance as a hair 
dye. 
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In mutagenicity tests, anthraquinone itself showed conflicting results. In early studies, neither 
anthraquinone nor its metabolites showed any genotoxicity in the Salmonella mutagenicity test 
(Salamone et al., 1979). I However, in later studies, anthraquinone was shown to be mutagenic 
in the Salmonella bacterial mutagenicity test (Zeiger et al., 1988). The conflicting results in 
negative studies were due to the variable amounts of contaminants resulting from the 
production method, the contaminants included 9-nitroanthracene, anthrone and phenanthrene 
and it was concluded that they were non mutagenic or weakly mutagenic (NTP, 2005). On the 
other hand, the major anthraquinone urinary metabolite (2-hydroxyanthraquinone) was clearly 
mutagenic, and another major metabolite, 1-hydroxyanthraquinone, was carcinogenic in rats 
(Mori et al., 1990). 
The mechanism by which anthraquinone can cause carcinogenicity is not clearly recognised. 
However, in male and female rats treated with anthraquinone, it has been noted in kidney and 
urinary bladder that there was an increased cell proliferation and cytotoxicity. An accumulation 
of hyaline droplets, which is indicator for nephropathy, in male rat kidney has been observed, 
with less severe effects in female rats (IARC working group, 2013). 
There is some recent evidence that genotoxicity may play a role in the mechanism of action for 
anthraquinone-induced cancer (NTP, 2005).  
4.3.4.2: Benzidine carcinogenicity scaffold: 
The second non-child scaffold carcinogenicity within the fourth group was benzidine (see 
Figure 4.2) that was present in 24 compounds. The carcinogenicity rate for benzidine was 70% 
in both male and female rats. 
Benzidine is known to be a human carcinogen based on sufficient evidence of carcinogenicity 
from studies in humans (NTP, 2016a).  All benzidine based azo dyes, 4,4'-diarylazobiphenyl 
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dyes, with the exception of those specified elsewhere in Annex I to Directive 67/548/EEC, are 
prohibited to be used in cosmetic product in Europe. 
 
Figure 4.2. Chemical structure of benzidine  
 
A strong relationship between the occupational exposure to benzidine and urinary bladder 
cancer has been reported (IARC, 2010). The association has been reported by different research 
workers in different labs, as well as by a number of epidemiological studies that include both 
case reports and cohort studies (IARC, 2010). Additionally, epidemiological studies have 
shown that when measures were taken to reduce exposure to benzidine in the workplace, there 
was a decrease in the number of cases of bladder cancer amongst the workers (IARC, 1972, 
1982, 1987, 2010). 
Although there are few studies on exposure to benzidine in occupational environments where 
workers were not exposed simultaneously to other types of chemicals, some studies indicate 
that increases in the percentage of urinary bladder cancer are associated with increased length 
of exposure to benzidine (IARC, 1982). There is limited and inconclusive evidence from other 
studies on the possibility of benzidine causing other types of cancer in tissues other than urinary 
bladder, such as cancers of liver, kidney, oral cavity, central nervous system, oesophagus, 
larynx, stomach and gall bladder (Choudhary, 1996). Benzidine was listed and reviewed by 
IARC as a carcinogen in the first annual report of the agency (IARC, 2010). 
At the level of laboratory experiments on animals, there is sufficient evidence that there is a 
link between cancer and exposure to benzidine. The type of cancer is different depending on 
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the type of animal and the method of laboratory injection. For example, injection of animals 
with benzidine under the skin causes liver cancer in mice and Zymbal-gland tumours in rats. 
When the animals were exposed orally to benzidine, female rats were diagnosed with 
mammary gland cancer, liver cancer in rats and urinary bladder cancer in dogs. Rats injected 
with benzidine into the peritoneum membrane were diagnosed with Zymbal-gland tumours and 
mammary gland cancer (NTP, 2016a). 
The mechanism of benzidine to cause cancer has been studied in detail. It includes formation 
of electrophilic compounds that bind through covalent bond to DNA after the metabolism of 
benzidine by cytochrome P450 (via N oxidation) (Choudhary, 1996). Benzidine also caused 
DNA mutations in various experimental test system both in vivo and in vitro. The exception to 
this was for cultured rodent cells where benzidine gave conflicting results, it causes DNA 
mutation in bacteria, plants, yeast, cultured human and rodents exposed in vivo. The damage 
caused by benzidine to DNA includes DNA strand break, micronucleus formation, 
chromosomal aberration and mitotic gene conversion (in yeast). In humans, according to the 
National Toxicology Program (NTP 2016a), the chromosomal aberration rate in white blood 
cells in workers that were exposed to benzidine or dyes that contain benzidine as main 
constituent was relatively higher than those who were not exposed.  
4.3.4.3: Methyl naphthalene carcinogenicity scaffold: 
The third non-child carcinogenicity scaffold was methyl naphthalene. Methyl naphthalene was 
present in 40 compounds as part of the structure. The carcinogenicity rate for methyl 
naphthalene was 80% and 100% in male and female rat respectively. The National Toxicology 
Program (NTP, 2000) concluded that there was clear evidence of carcinogenic activity of 1-
methylnaphthalene in male and female F344/N rats based on increased incidences of 
respiratory epithelial adenoma and olfactory epithelial neuroblastoma of the nose. Nearly all 
rats in all exposure groups showed nonneoplastic nasal lesions in both olfactory and respiratory 
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epithelia, including atypical hyperplasia in olfactory epithelium, hyaline degeneration in 
olfactory and respiratory epithelia, and Bowman’s gland hyperplasia (NTP, 2000). 
 
4.3.4.4: Estradiol carcinogenicity scaffold : 
The fourth non-child carcinogenicity scaffold was estradiol. Estradiol was present in 18 
compounds for which the carcinogenicity rate was 80% in both male and female rats. 
Studies have shown that the natural estradiol hormone, known as 17β-estradiol (E2), can induce 
tumours in humans, including breast and uterine cancer (Patisaul and Jefferson, 2010). The 
risks of breast and uterine cancer are increased by either endogenous elevation of estradiol 
level, or by external sources that increase the estradiol level, such as oestrogen medication or 
cosmetic products that contain oestrogen as an ingredient or contaminant. Tumour induction 
by estradiol has been shown in different organs of rats, mice and hamsters (Liehr, 2000).   
Compounds that mimic the estradiol hormone in both steroidal and non-steroidal forms have 
been found in different cosmetic products such as creams and shampoos (Kurzer and Xu, 1997). 
Most of these oestrogens are phytoestrogens derived from plants such as soya. Phytoestrogens 
have certain health benefits in terms of lowering the risk of heart disease, lowering the 
menopausal symptoms and osteoporosis in women. However, many of these compounds are 
also considered as endocrine disruptors and could be a possible source of adverse health effects. 
For those people who are using oestrogen containing compounds for long periods of time, or 
in case of children, these compounds may increase the risk of certain cancers due to increase 
in the endogenous oestrogens than the normal levels (Patisaul and Jefferson, 2010). 
In September 1993, the US FDA issued a decision that all hormone containing products used 
on the skin or topically, and sold over the counter (OTC) without a prescription, are not fully 
safe and effective (Accessdata.fda.gov, 1993). 
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The estradiol mechanism of causing carcinogenicity is considered to be a non-genotoxic 
mechanism (epigenetic) as these compounds show negative results in mutagenicity tests in 
bacterial cells i.e. the Ames test and mammalian cell assays. It has been proposed that there is 
a dual role of oestrogen to induce carcinogenicity which includes the stimulation of cell 
proliferation and induction of genetic damage as a pro-carcinogen (Feigelson and Henderson, 
1996). Oestrogen is metabolically converted by catalysation of 4-hydroxylase (CYP1B1) to 4-
hydroxyestradiol and then further activated to yield a reactive intermediates 
semiquinone/quinone that can initiate tumours. All these substances, oestrogen, 4-
hydroylestradiol and quinone induce DNA damage by a free radical mediated mechanism, 
directly and indirectly, and this has been shown both in in vitro or in vivo cell systems (Li and 
Li, 1990). Other chromosomal and genetic damage can also be caused by oestrogen which 
includes chromosomal aberration, microsatellite instability, gene amplification and aneuploidy 
in both in vitro and in vivo cell systems (Jackson, Chen and Loeb, 1998; Tsutsui and Barrett, 
1997; Liehr, 2000). 
Estradiol is classified as carcinogen based on biological studies in animal and epidemiological 
studies in humans. In a small group of animals, it was noticed that the tumours were induced 
after using pharmacological dose of estradiol. In humans, the risk of breast and uterine cancer 
was increased due to the elevation of circulating estradiol level caused either by elevation of 
endogenous production or by therapeutic medication (IARC,1999). 
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4.3.4.5: Methylbenzodioxole carcinogenicity scaffold : 
The fifth non-child carcinogenicity scaffold was methyl benzodioxole. Methyl benzodioxole 
was present in 10 compounds with a carcinogenicity rate of 80% and 100% in male and female 
rat respectively. Examples of structures containing methyl benzodioxole scaffold are safrole 
and isosafrole (as shown in Figure 4.3). 
 
 
Figure 4.3. Isosafrole structure is an example of a positive carcinogenic compound in rat that 
contains methylbenzodioxole as the core structure 
 
Safrole has been used in cosmetics such as soaps and perfumes, it also has been used as 
flavoring agent in drug manufacturing and as preservative in mucilages. In the food industry, 
oil of sassafras has been used as flavouring agent in some beverages such as root beer (IARC 
1972, 1976; HSDB 2009). In 1960, the US FDA banned any use of safrole in food and listed it 
as a carcinogen in the Second Annual Report on Carcinogens. Liver tumours are reported to be 
caused by safrole by two different methods of administration in two rodent species. The 
administration of safrole through diet caused liver cancer in male mice and both rat sexes. Oral 
gavage of safrole followed by dietary exposure was shown to cause liver cancer in mice of both 
sexes. Infant male mice were shown to have liver cancer when injected with safrole 
subcutaneously (NTP, 2016b).  
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4.3.5: Major genotoxic and non-genotoxic scaffolds: 
A molecular scaffold analysis was carried out to classify all 17 previously identified 
carcinogenicity scaffolds as to whether they are genotoxic or non-genotoxic using the 
structures within the Leadscope SAR Genetox Database. The Leadscope SAR Genetox 
Database comprises the results for 10,543 mutagenicity tests. In addition, the SAR Genetox 
Database provides mutagenicity test results for 46 genetic toxicity endpoints, which includes 
32 bacterial mutagenicity, 4 in vitro mammalian, 5 in vitro chromosomal aberration and 6 in 
vivo micronucleus endpoints. The scaffold analysis of the SAR Genetox Database identified in 
28 main mutagenicity scaffolds and 7 main non-mutagenicity scaffolds. The resulting scaffolds 
met the cut-off criteria - i.e. the C/S ratio greater than or equal to 0.7 and present in at least 10 
compounds. For scaffolds associated with mutagenicity, the mutagenicity ratio criterion was 
set to be more than or equal to 0.7, whilst for non-mutagenicity scaffolds the mutagenicity ratio 
not to exceed 0.3 (in other word the non-mutagenicity ratio should be more than or equal to 
0.7) as shown in Tables 4.7 and 4.8. The selection from those mutagenicity and non-
mutagenicity scaffolds was only for those scaffolds that are cross-referenced with the previous 
17 carcinogenicity scaffolds to confirm whether the carcinogenicity scaffolds were related to 
mutagenicity or non-mutagenicity pathways. If a scaffold (mutagenicity or non-mutagenicity) 
resulting from the SAR Genetox Database did not match one of the previous 17 carcinogenic 
scaffolds, then it was not added to the final list of scaffolds (genotoxic carcinogenic and non-
genotoxic carcinogenic scaffolds). For those carcinogenic scaffolds that are not cross- 
referenced with mutagenic scaffolds, a further manual scaffold search within the SAR Genetox 
database experimental results was conducted (shown in Table 4.7). The cut-off in Leadscope 
was set at 70% as to whether it was related to genotoxicity or non-genotoxicity. The 
mutagenicity scaffold also had to cover at least 10 compounds, the minimum compounds 
number per one scaffold was assigned to 10 and the same number was assigned for the 
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minimum number of atoms per scaffold.  
Of the 28 scaffolds associated with mutagenicity, five matched with  carcinogenicity scaffolds 
group automatically by Leadscope. These were chrysene, 9H-fluorene, anthraquinone, 2-
nitronaphthalene and phenanthrene. The mutagenicity C/S scores for these five scafolds were 
0.96 out of 124 compounds for chrysene, 0.85 out of 72 compounds for 9H-fluorne, 0.86 out 
of 159 compounds for anthracene-9,10-dione, 0.96 out of 132 compounds for 2-
nitronaphthalene and 0.95 out of 579 compounds for phenenethrene. This implied that these 
were scaffolds related to genotoxic carcinogenicity. The five mutagenic scaffolds that matched 
carcinogenicity scaffolds are highlited in blue in Table 4.7. The analysis showed 18 
mutagenicity scaffolds did not overlap with carcinogenicity scaffolds but were highly 
significant as mutagenicity scaffolds. Conversely, the scaffold analysis for the absence of 
mutagenicity resulted in only seven non-mutagenic scaffolds. Only one carcinogenicity 
scaffold matched with this group, which was for estradiol, and that was also negative in the 
mutagenicity tests for all of 21 related compounds with a mutagenicity score of 0 as shown in 
Table 4.8. The previous scaffold analysis was performed in the Leadscope software in 
automatic mode which can miss some of the muagenicity scaffolds that may not be present in 
large enough number of compounds. Therefore, a manual check for mutagenicity scaffolds in 
the expermintal mutagenicity results was performed to further ensure that there was no missing 
scaffold that was not detected. The manual check resulted in six additional mutagenicity 
scaffolds that matched with the 17 carcinogenic scaffold list. These scaffolds are highlighted 
in yellow in Table 4.7. The scaffolds are 1-methyl naphthalene, tetraphene, 3a,5a-
dihydropyrene, methylphenanthene, benzidine and a new additional mutagenic carcinogenicity 
scaffold - diethylaniline. The mutagenicty score for these scaffolds were 0.84 out of 992 
compounds for 1-methylnaphthalene, 0.93 out of 139 compounds for tetraphene, 0.71 out of 
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21 compounds for 3a,5a-dihydropyrene, 0.87 out of 64 compounds for methylphenanthene, 
0.93 out of 87 compounds for benzidine and 0.7 out of 100 compounds for diethylaniline.  
 
4.4 : Conclusions:  
The main findings and conclusions of this study showed that a total 17 molecular scaffolds 
associated with carcinogenicity could be identified from the available databases (Tables 4.2, 
4.3, 4.4 and 4.5). Of these, 11 were genotoxic carcinogenicity related and included structures 
such as anthraquinone, phenanthrene, benzidine, 2- nitronaphthalene, 9H-fluorene, chrysene, 
diethylaniline, 1-methylnaphthalene, tetraphene, 3a,5a-dihydropyrene and 
methylphenanthrene. The single non-genotoxic carcinogenicity related scaffold that could be 
identified through this study was estradiol, whilst other six carcinogenicity scaffolds did not 
have supporting experimental data for mutagenicity. All of the children carcinogenicity 
scaffolds that were derived from the three major groups of parent carcinogenicity scaffolds 
were also related to carcinogenicity. The parent carcinogenic scaffolds were phenanthrene, 9H 
fluorene, 2-nitronaphthalene. The fourth scaffolds had no child scaffold.  These findings will 
be useful in identifying the presence of any carcinogenicity related scaffold in a cosmetic 
ingredient or drug candidate compound and will provide the opportunity to replace them with 
a safer moiety at early stages of the lead optimisation and further development. A new scaffold 
based profiler which includes these 17 carcinogenic scaffolds as a starting point is suggested. 
This new suggested profiler should be in the form of molecular scaffolds since it is supported 
by animal data.  
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Table 4.7. The most significant 28 mutagenic scaffolds from the Leadscope SAR Genetox 
database (      =scaffolds matched carcinogenic list and its mutagenicity score obtained by 
Automatic generation from the software),      = scaffolds matched carcinogenic list and its 
mutagenicity score obtained by manual search through the SAR genotoxicity database) 
Frequency: 10 
C/S: Mutagen:1 
Frequency: 16 
C/S: Mutagen:1  
Frequency: 23 
C/S: Mutagen:1 
Frequency: 11 
C/S: Mutagen:1 
 
1-nitroanthracene 9,10-dione 
 
 
Dihydrobenzoacephenanthrylene 
 
 
Dihydrobenzo pyrene  
9H-thioxy-9-one 
Frequency: 25 
C/S: Mutagen:1 
Frequency: 10 
C/S: Mutagen:1 
Frequency: 27 
C/S: Mutagen:1 
Frequency: 38 
C/S: Mutagen:1 
 
imidazoquinoxaline 
imidazoquoline 
 
phenazine 
 
 
aceanthrylene 
Frequency: 38 
C/S: Mutagen:1 
Frequency: 152 
C/S: Mutagen:1 
Frequency: 266 
C/S: Mutagen: 0.9 
Frequency: 124 
C/S: Mutagen: 0.96 
 
acenaphthylene 
 
Acridine  anthracene 
 
Chrysene 
 
 
Frequency: 72 
C/S: Mutagen:0.85 
Frequency: 38 
C/S: Mutagen:1 
Frequency: 38 
C/S: Mutagen:1 
Frequency: 1129 
C/S: Mutagen:0.8 
 
 
9H-fluorene 
 
 
 
1,4 dioxacycloudecane-5,11dione 
 
 
nitrobenzene 
 
Naphthalene 
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Frequency: 100 
C/S: Mutagen:0.7 
*C/S: Carcinogen: 0.7 of 17 
substance 
Frequency: 38 
C/S: Mutagen:1 
Frequency: 159 
C/S: Mutagen:0.86 
Frequency: 38 
C/S: Mutagen:1 
 
 
diethylaniline 
 
 
 
quinoxaline 
 
anthraquinone 
 
1-benzylaziridine 
Frequency: 159 
C/S: Mutagen:0.86 
Frequency: 132 
C/S: Mutagen:0.96 
Frequency: 579 
C/S: Mutagen:0.95 
Frequency: 992 
C/S: Mutagen:0.85 
 
tetrahydophenanthrooxirene 
 
 
2-nitronaphthalene 
 
 
phenanthrene  
1-methyl naphthalene 
Frequency: 139 
C/S: Mutagen:0.93 
Frequency: 21 
C/S: Mutagen:0.71 
Frequency: 64 
C/S: Mutagen:0.87 
Frequency: 87 
C/S: Mutagen:0.93 
tetraphene 
 
3a,5a dihydropyrene  
methylphenanthene 
 
 
benzidine 
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Table 4.8. The most 7 significant non-mutagenic scaffolds from SAR Genetox database: 
(      =scaffolds matched carcinogenic list and its mutagenicity score obtained by Automatic 
generation from the software) 
Frequency: 21 
C/S: Mutagen: 0 
Frequency: 38 
C/S: Mutagen:0.1 
Frequency: 12 
C/S: Mutagen:0.1 
Frequency: 38 
C/S: Mutagen:0.86 
 
Estradiol) 
3methyl-decahydro-
cyclopenta-phenanthrene 
 
 
dimethylhexanediamine 
 
 
1-methyl-
4(trifluromethyl)benzene 
 
 
 
N-methyl-3-(trifluromethyl) 
aniline 
Frequency: 10 
C/S: Mutagen:0.1 
Frequency: 41 
C/S: Mutagen:0.09 
Frequency: 68 
C/S: Mutagen:0.1 
 
 
dodecahydrophenanthrene 
 
 
octahydophenanthrene 
 
 
 
Trifluromethyl benzene 
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Table 4.9. The molecular scaffolds of the major genotoxic and non-genotoxic carcinogens 
groups  
The scaffold structures of major genotoxic carcinogens scaffold groups 
 
Anthraquinone  phenanthrene 
 
benzidine 
 
2-nitronaphthalene  
9H-fluorene 
 
 
 
 
 
Chrysene 
 
 
 
diethylaniline 
 
1-methyl naphthalene 
 
tetraphene 
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3a,5a-dihydropyrene 
 
 
methylphenanthene 
 
The scaffold structures of major non-genotoxic carcinogens scaffold groups 
 
Estradiol 
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Chapter 5: Assessment of the Profilers Provided in the OECD QSAR Toolbox for Category 
Formation of Carcinogenic Chemicals 
 
5.1 Introduction 
In the previous chapters, several methods for searching and evaluating structural alerts for non-
genotoxic carcinogens were reviewed. This chapter will focus on the performance of the 
profilers provided in the OECD QSAR Toolbox for category formation on the basis of the 
mutagenic, carcinogenic and skin sensitisation potential of chemical substances. In this regard, 
the use of in silico methods based on read-across (i.e. from the properties and effects of a group 
of structurally and/or functionally similar substances to an untested compound) will be 
discussed.  
Under most regulatory frameworks, tests for carcinogenicity are only required when there is 
either a positive in vitro mutagenicity/gentoxicity test, or there are indications of carcinogenic 
effects from long-term in vivo tests. The ban on animal testing under the EU Cosmetic 
Regulation, and the absence of appropriate alternative methods, make it is likely that the 
potential carcinogenic effects of non-genotoxic carcinogens will not be the identified in the 
current risk assessment scheme. This is where in silico methods, including (Q)SAR modelling 
and read-across, can play a major role in relation to grouping/categorisation of chemicals to 
identify potential NGCs. The concept behind the grouping approach is based on the notion that 
'similar substances usually have similar effects'. Based on the number of substances used for 
read-across, different terms are used to describe the process - e.g. a category approach is used 
when a large number of substances within a group has been used for read-across, whereas an 
analogue approach is used where limited number (usually one-to-one) of substances have been 
used (EChA, 2017). The grouping approach aims to identify substances that are similar in terms 
of chemical structure, and/or effects with (where possible) high quality data for a given 
physiochemical, toxicological, or environmental endpoint. At the physicochemical level, the 
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factors considered for grouping could be the similarities in chemical structure, functional 
group(s); (metabolic) degradation profiles, or other parameters such as log P, protein binding, 
etc. When sufficient 'similarity' criteria are met in a set of chemical substances that follow a 
regular pattern, it can be considered a 'category' of substances. 
The European Chemicals “REACH” Regulation encourages the use of grouping and 
categorisation of chemicals for classification, risk assessment and labelling purposes. Some of 
the data gaps in this regard can be filled using read-across, which aims to interpolate 
experimental data from tests conducted on a one or more 'similar' substances termed as 
reference substances(s) or source substances(s) to other untested substances termed as target 
substances(s). The data for the endpoint in question for the target substance(s) are predicted 
using the experimental data for the same endpoint of the source substance(s). Since each 
endpoint has a different set of complexities, e.g. with regard to the biological target site or other 
key parameter(s), it is essential to consider read-across on an endpoint-by-endpoint basis 
(EChA, 2017). 
There is a growing body of knowledge regarding how to undertake and report read-across 
assessment, with many learnings taken from well-established case studies (Ball et al. 2016; 
Schultz and Cronin 2017). There are several strong themes that run through the use of read-
across for data gap filling. For instance, scientific justification and documentation for read-
across is fundamentally required to strengthen its use in chemical grouping/categorisation. The 
structural or other similarities between the target and the source substances need to be described 
clearly to justify the read-across. Explanation of the rationale for the prediction of target 
substance properties/effects from the data on source substance(s) also needs to be provided for 
each specific endpoint. For a valid read-across for regulatory purposes, it is essential to provide 
accurate information on the substance identity and chemical composition (including impurity 
profile) to assist the evaluation of the similarities within the group of substances. The activity 
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or toxicity of substances may also differ for different forms or phases of substances (e.g. 
different valence, crystalline or particulate forms), and this requires evidence to show that the 
substance used in the read-across are representative of the structure/activity aspects used a basis 
for grouping, categorisation and risk assessment. In the first place, each substance used in read-
across needs to have a specific chemical identity, as well as sufficient characterisation data in 
relation to purity/ impurity profiles to allow derivation of a meaningful read-across.  
Furthermore, similarity(ies) between target and source substances are not necessarily 
represented by structural similarity alone. Other aspects of chemistry (and biology) also need 
to be assessed to build a robust read-across case. Such aspects include the presence of common 
functional groups, similarities in the core structure, bonding patterns, structural alerts for a 
particular activity, stereoisomerism, potential difference that may arise from steric hindrance 
or specific reactivity, etc (Cronin, 2013). It is also essential for a read-across argument that 
differences in structure and properties are defined and understood. 
Certain physicochemical properties of both target and source substances that are relevant to the 
endpoint (e.g. log P, molecular weight, vapour pressure) also need to be clearly understood as 
they may play an important role in the read-across of a specific toxicological endpoint (EChA, 
2013; Cronin, 2013). Chemical read-across is generally consolidated using data from all 
available sources, including from the scientific literature and predictive QSAR models. 
Information on the mode of action can be established from the mechanistic data or other 
methods (e.g. data from omics methods). In order to rationalise the recording of properties and 
effects, templates have been created for their storage that can act as a guide for developers as 
well as allowing for the easy assessment of a read-across (Schultz et al. 2015). 
It needs to be highlighted that read-across is not only used for positive prediction of toxicity. 
The approach can also be used to predict the absence of toxicity, however a negative prediction 
may require more proof to support the level of confidence as compared to positive predictions. 
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The proof is required to ensure that the absence of toxicity of the source substances implies the 
absence of toxicity of the target substance(s). The reduction of uncertainties to allow for the 
prediction of “no or low” toxicity needs to be considered and addressed to avoid the potential 
underestimation of the positive toxicity of target substances. The use of read-across, along with 
other in silico methods, such as SAR/QSAR modelling, is also increasingly used in a “weight 
of evidence” approach that may further incorporate information from Adverse Outcome 
Pathways (AOPs). Thus, all elements relating to interaction of a chemical with the exposed 
biological system are included in the analysis. Schultz et al. (2017) demonstrated that increased 
evidence was required for the read-across of the toxicity of compounds – in this case n-alkanols 
– that were considered to be of low toxicity and utilising various sources of information could 
reduce uncertainty.  
As the use of read-across has become more mainstream, the definition of 'similarity' has 
evolved to include physicochemical, structural, mechanistic and/or metabolic similarity 
(Schultz and Cronin, 2017). In order for read-across to be valid, a robust category of analogues 
must be derived from the available datasets. A valuable tool for achieving this is the OECD 
QSAR Toolbox, which is a freely available multifunctional platform that allows the users to 
make informed decisions about toxicity predictions for a range of (eco)toxicological endpoints 
(Schultz et al., 2018). As part of the process of identifying a set of analogues for read-across, 
the Toolbox allows the user to apply structural alerts as in the form of computational “profilers”. 
For many relevant toxicological endpoints, there are one or more profilers that are designed to 
aid this process – these may be based around chemistry e.g. covalent binding to DNA or be 
mechanistically or toxicologically derived. The target compound is first subjected to profiling, 
and then the profile(s) is used to screen for compounds in the databases with the same or similar 
mechanistic, toxicological and/or structural profiles. The analogues found this way are reduced 
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to those that have measured values for the specific endpoint(s) of interest and therefore provide 
a basis prediction of the endpoint value of the target compound.  
The OECD QSAR Toolbox is widely used platform for chemical grouping/categorisation and 
estimation of chemical toxicity by in silico methods and read-across. Despite the increasing 
reliance of risk assessors on the Toolbox, attempts have only recently started to assess the 
reliability and limitations of the profilers provided in the system (Devillers et al., 2011; 
Mombelli, 2012; Yordanova et al., 2019). As part of the current study, it was felt that such an 
assessment of the profilers was necessary to understand the usefulness and limitations of their 
use in screening databases for analogous compounds that can be used subsequently for read-
across or development of (Q)SAR models. The aim of this chapter, therefore, was to investigate 
the OECD QSAR Toolbox profilers for mutagenicity, carcinogenicity and skin sensitisation 
potential of chemical substances, in the context of how reliably they report both positive and 
negative compounds contained within the databases for these endpoints. 
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5.2: Materials and Methods 
 
5.2.1 The OECD QSAR Toolbox 
The OECD QSAR Toolbox (referred to herein as the “Toolbox”) is a software application 
intended to be used to fill gaps in toxicity and ecotoxicity data needed for to assess the hazards 
of chemicals. The Toolbox incorporates databases on chemical data (e.g. properties), 
experimental toxicological and ecotoxicological data, estimated values from a large range of 
QSAR tools, together with incorporated QSAR models, built within an informatics chassis 
designed for regulatory application. The Toolbox therefore allows the user to perform a number 
of functions (OECD 2008): 
• Identification  of analogues for a chemical, retrieval of experimental results available 
for those analogues and data gap filling by read-across or trend analysis; 
• Categorisation of large inventories of chemicals according to mechanisms or modes of 
action; 
• Filling of data gaps for a chemical by using appropriate model(s) from the collection of 
QSAR models; 
• Evaluation of the robustness of a potential analogue for read-across; 
• Evaluation of the appropriateness of a (Q)SAR model for filling a data gap for a 
particular target chemical; and 
• The capability of building QSAR models. 
For this study version 3.1 of the Toolbox was used throughout. The version of the Toolbox 
used had been augmented with a number of extra publicly available databases (as detailed 
below). 
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5.2.2. Profilers 
 
The following profilers in the Toolbox (version 3.1) were applied to the datasets described in 
Section 5.2.3. 
 
5.2.2.1 Mutagenicity profilers 
 
5.2.2.1.1. DNA binding by OASIS v1.1. This profiler is a mechanistic profiler developed from 
an analysis of Ames mutagenicity data. It contains a number of structural alerts that have been 
shown to be related to established electrophilic reaction chemistry known to be important in 
covalent DNA binding (Mekenyan et al. 2004; Serafimova et al. 2007). 
 
5.2.2.1.2 DNA binding by OECD. This profiler is based on structural alerts for the electrophilic 
reaction chemistry associated with covalent DNA binding (Enoch and Cronin 2010). The 
profiler returns a range of structural alerts that contain electrophilic centres or those that can be 
metabolically activated to electrophiles. 
 
5.2.2.1.3 Carcinogenicity (genotox and nongenotox) alerts by ISS. This profiler is based on a 
list of 55 structural alerts from the Toxtree software (http://toxtree.sourceforge.net/). About 20 
of the alerts are for non-genotoxic carcinogenicity, and the remainder for genotoxic 
carcinogenicity (mutagenicity). 
 
5.2.2.1.4 DNA alerts for AMES, MN and CA by OASIS v.1.1 is a refinement of 2.2.1.1 above. 
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5.2.2.1.5 In vitro mutagenicity (Ames test) alerts by ISS. The list of structural alerts is a subset 
of the original Toxtree list, obtained by eliminating the structural alerts for non-genotoxic 
carcinogenicity and is a refinement of 2.2.1.3 above. 
 
5.2.2.1.6 In vivo mutagenicity (Micronucleus) alerts by ISS. This profiler is based on the 
ToxMic rule-base of the software Toxtree. This rule-base provides a list of 35 structural alerts 
(SAs) for a preliminary screening of potentially in vivo mutagens. These SAs are molecular 
functional groups or substructures that are known to be linked to the induction of effects in the 
in vivo micronucleus assay. 
 
5.2.2.2 Carcinogenicity profilers 
5.2.2.2.1. DNA binding by OASIS v1.1. As above. 
5.2.2.2.2. DNA binding by OECD. As above. 
5.2.2.2.3 Carcinogenicity (genotox and nongenotox) alerts by ISS. The SAs for carcinogenicity 
are molecular functional groups or substructures known to be linked to the carcinogenic activity 
of chemicals. As one or more SAs embedded in a molecular structure are recognised, the 
system flags the potential carcinogenicity of the chemical. 
5.2.2.2.4. OncoLogic Primary Classifier. This profiler consists of molecular definitions derived 
by the Toolbox developers to mimic the structural criteria of chemical classes of potential 
carcinogens covered by the U.S. Environmental Protection Agency’s OncoLogic™ Cancer 
Expert System for Predicting the Carcinogenicity Potential 
(www.epa.gov/oppt/sf/pubs/oncologic.htm). 
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5.2.2.3 Skin Sensitisation profilers 
5.2.2.3.1 Protein binding by OASIS.  
These profilers have been developed to indicative of skin sensitisation potential and consist of 
85 structural alerts relating to 11 reactions, or chemical interactions, which are known to be 
associated with skin sensitisers. 
 
5.2.2.3.2. Protein Binding by OECD 
The protein binding by OECD profiler contains 16 mechanistic alerts covering 52 structural 
alerts. These data are supported by mechanistic chemistry and references to the scientific 
literature (the meta data). They represent a parallel approach to those of the OASIS profiler 
and capture mechanistic features of target compounds. 
 
5.2.2.3.3 Protein binding potency 
This profiler is developed on the basis of empirical data for thiol reactivity expressed by the in 
chemico RC50 value. All the chemicals have two common electrophilic mechanisms of 
interaction with GSH – interaction via SN2 and interaction via Michael addition (MA) 
mechanism. The profiler contains 49 MA and 46 SN2 categories 
 
5.2.2.3.4 Keratinocyte gene expression 
This profiler is built in relation to the database derived from the KeratinoSens assay, which 
examines the potential for chemicals to induce the expression of a luciferase reporter gene 
under control of a single copy of the ARE element of the human AKR1C2 gene stably inserted 
into immortalised human keratinocytes. Relevance to skin sensitisation is inferred from the 
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relationship of Keap1-Nrf2-ARE regulatory pathway and its detection of electrophilic 
chemicals to sensitisation. The profiler contains 22 categories. 
 
5.2.2.3.5 Protein binding alerts for skin sensitisation by OASIS 
This profiler seems to be much the same as the one at 2.2.3.1 above though there are some 
minor differences. 
 
5.2.2.3.6 DPRA Lysine peptide depletion 
This profiler is built on the basis of data derived from Direct Peptide Reactivity Assay (DPRA). 
The DPRA is a reactivity assay which evaluates the ability of chemicals to react with proteins. 
Model synthetic peptides containing either lysine or cysteine are used. The remaining 
concentration of cysteine- or lysine-containing peptide is measured after 24 hours incubation 
with the test chemical at 25±2.5ºC. The peptide reactivity is reported as percent peptide 
depletion. The relevance to skin sensitisation is the presence of cysteine and lysine residuals in 
the skin proteins.  
The profiler contains 24 structural alerts extracted from about 110 chemicals with 
experimentally measured lysine depletion values. 
 
5.2.2.3.7 DPRA Cysteine peptide depletion. 
As described above, this profiler contains 32 categories of alerts. 
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5.2.3. Databases 
A number of intrinsic Toolbox databases were examined using the profilers as well as some 
additional databases from publicly available sources. This involved running the compounds 
with known data and experimental values against the profilers and determining the hits. The 
following databases of experimental toxicity data were examined: 
 
5.2.3.1 Bacterial mutagenicity ISSSTY 
This database was donated to the OECD QSAR Toolbox by the Istituto Superiore di Sanità 
(ISS), Rome, Italy. The database comprises 41,634 Ames test data points for 7,367 compounds. 
The overall endpoint value (positive, negative, equivocal, inconclusive) outcome is determined 
as described in the help file:  
• Positive: at least one strain is positive (with or without metabolic activation);  
• Equivocal: no strain is positive, and at least one equivocal result is present in one of the 
following strains (with or without metabolic activation): TA1535, TA100, TA98, TA1538, 
TA1535, TA97;  
• Negative: no positive or equivocal results are present in any strain, and negative outcomes 
exist for: a) at least one strain from among TA1535 or TA100 or TA97 (with and without 
metabolic activation); and b) at least one strain from among TA1538 or TA98 or TA1537 
(with and without metabolic activation);  
• Inconclusive: If none of the above criteria are fulfilled. When more than one experiment in 
one strain was available, the number of reported positive and negative studies was counted, 
and the strain overall outcome was determined as follows: if the percentage of Positive 
studies is lower than 40 %, then outcome = Negative; if the percentage of Positive studies 
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is between 40 - 60 %, then outcome = Equivocal; if the percentage of Positive studies is 
higher than 60 %, then outcome = Positive. 
In order to record the data in a binary (positive/negative) form to allow for easy analysis of 
the profilers’ predictivity, only positive and negative outcomes were included. The 
equivocal outcomes, which were for 168 compounds, were excluded from the analysis. 
The number of compounds which showed an overall positive outcome in all strains was 
2,847 and the total number with negative outcomes was 4,352. 
 
5.2.3.2 Carcinogenicity and mutagenicity (ISSCAN) 
This database was also donated by the Istituto Superiore di Sanità (ISS), and comprises 6,979 
data points for 1,150 compounds. There are three endpoints for which data are presented; gene 
mutation, summary carcinogenicity, and TD50. The TD50 data were not used in this current 
study. Gene mutation data in Ames are reported in the same way as in the previous database, 
and a single datum point is available for each of the 832 compounds. Summary carcinogenicity 
data are represented as “positive”, “negative” or “equivocal”. Positives are carcinogenic in at 
least one experimental group; equivocal results are given to chemicals with equivocal results 
in at least one experimental group, together with negative results in the other experimental 
groups, and negatives are non-carcinogenic in all tests. Only positive and negative carcinogenic 
compounds were included in the analysis. Equivocal carcinogenic outcomes were excluded 
from the analysis.  
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5.2.3.3 Genotoxicity OASIS 
Donated by The Laboratory of Mathematical Chemistry, Bourgas, Bulgaria. 
The OASIS Genotox Database contains 7,500 compounds collected from seven sources. It 
contains data for mutagenic determined by the Ames test with and without metabolic activation. 
The database also includes chromosomal aberrations determined by in vitro tests using Chinese 
hamster lung cells (CHL, with and without S9). Micronucleus (MN) and mouse lymphoma 
gene mutation assay (MLA) were evaluated by Chinese hamster lung cells (CHL / IU) and by 
in vitro T-lymphoma cell lines, respectively. All endpoints were evaluated on a dichotomic 
scale, i.e.  yes (active) or no (inactive). Data used in this study were the Ames test data, and 
chromosomal aberration as the Toolbox has profilers for these endpoints. 
 
5.2.3.4 CRD-AGES 
Data from the UK Chemicals Regulatory Directorate and the Austrian Agency for Health and 
Food Safety, comprising 179 pesticides with mutagenicity data and 100 with carcinogenicity 
data (Worth et al. 2010). Mutagenicity data are binary active/inactive from Ames tests and 
carcinogenicity were also binary (active/inactive) from a range of tests. 
 
5.2.3.5 DSS Pesticide carcinogenicity 
Summary carcinogenicity data for 1,282 pesticide compounds from the US EPA National 
Center for Computational Toxicology, (http://www.epa.gov/ncct/dsstox/index.html). 
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5.2.3.6 SAR carcinogenicity and genotoxicity databases: 
These are high-quality data resources that can be used for building a predictive model, and for 
the 'read-across' of chemicals to find out their potential to be carcinogenic or mutagenic. Both 
databases contain summarised in vitro and in vivo cancer and mutagenicity endpoints along 
with chemical structures. These databases are used by Leadscope program to build predictive 
models. To ensure the high quality data for SAR, structure form, analysis of various salt forms 
of chemical compounds and their respective toxicity data have also been carried out to derive 
an overall endpoint for the active portion of the chemical. Several sources of experimental test 
results have been included in these databases, such as from FDA, NTP, CCRIS, CPDB and 
other primary sources. All chemical structures have been provided in SAR, neutral and tested 
form, and confirmed for accuracy.  
The SAR carcinogenicity database includes 3,598 compounds with 11,538 test results and 
provides carcinogenicity study endpoint for male and female rats (1,774 and 1,725 compounds 
respectively) and male and female mice (1,640 and 1,675 compounds respectively). The SAR 
genotoxicity database provides compound-level calls for 46 genetic toxicity endpoints for 
10,534 compounds. These include 32 bacterial mutagenicity endpoints, four in vitro 
mammalian, five in vitro chromosomal aberration and six in vivo micronucleus results.  
 
5.2.3.7 EFSA Pesticides Mutagenicity 
Ames test active/inactive classifications for 741 pesticides, compiled by, and downloaded from 
the European Food Safety Authority. 
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5.2.3.8. NISS mutagenicity database 
A database of 1,863 compounds with binary active/inactive Ames test data. Downloaded from 
the US National Institute of Statistical Sciences, (https://www.niss.org/) 
 
5.2.3.9. Inchemicotox Skin Sensitisation 
A version of the Cronin and Basketter dataset (Cronin and Basketter 1994) from the 
Inchemicotox project (http://www.inchemicotox.org/), comprising 322 compounds, with 
results taken from the Guinea Pig Maximisation Test. The classification is derived from the 
percentage of animals sensitised in the test: non-sensitiser = 0-9%, weak sensitiser = 10-29%, 
moderate sensitiser = 30-79%, strong sensitiser = 80-100%.  
In order to record the data in a binary (senstiser/non-senstiser) form to allow for easy analysis 
of the profilers’ predictivity, only strong senstiser (80-100%) and non-senstiser (0-9%) 
outcomes were included. The weak and moderate senstiser outcomes were excluded from the 
analysis. The number of compounds which were classified as strong senstisers was 200 and as 
non-senstisers was 122. 
 
 
5.2.3.10. CAESAR Skin Sensitisation 
209 compounds from the EU CAESAR project (www.caesar-project.eu). For developing 
classification models, this data set was subdivided in two classes, sensitiser (S) and non-
sensitisers (N), which gave a good distribution of the numbers of compounds in each class. The 
class S merges the first four ranges established by ECETOC: Extreme (EC3<0.1%), Strong 
(0.1%<EC3<1%), and Moderate (1%<EC3<10%) and Weak (EC3>10%) ranges; the class N 
regroups all compounds belonging to the non-sensitisers.  
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5.2.3.11. ECETOC Skin sensitisation 
39 compounds with experimental results on skin and respiratory sensitisation. The compounds 
were selected as known sensitisers and non-sensitisers for the assessment of novel test 
techniques (http://www.ecetoc.org/technical-reports). 
 
5.2.3.12 OECD Skin Sensitisation 
1,036 compounds from two databases and includes chemicals tested by Local Lymph Node 
Assay (LLNA) or Guinea Pig Maximisation Test (GPMT). Based on the observed skin 
sensitisation effect the chemicals are classified in three classes: - strong sensitisers, weak 
sensitisers or non-sensitisers.  
In order to record the data in a binary (senstiser/non-senstiser) form to allow for easy analysis 
of the profilers’ predictivity, only strong senstiser and non-senstiser (0-9%) outcomes were 
included. The weak outcomes were excluded from the analysis. The number of compounds 
which were classified as strong senstisers was 430 and as non-senstisers was 488. 
 
5.2.3.13 Lazar Opentox Rat Carcinogenicity  
Lazy Structure-Activity Relationships (LAZAR) is an open-source tool for the prediction of 
complex toxicological endpoints such as carcinogenicity (female/male, hamster/ 
mouse/rat/rodent) and Salmonella mutagenicity. The compounds were selected from database 
of experimental toxicity data. Carcinogenicity models are based on the CPDB, while the 
Salmonella mutagenicity model uses a dataset of 3,895 compounds determined in vitro  
(https://lazar.in-silico.de/predict). 
5.2.3.14 VEGA carcinogenicity 
 
 
Chapter 5 
 
      Page 169  
The VEGA platform serves to access a number of QSAR models for predicting mutagenicity 
and carcinogenicity. The compounds were selected from a set of 4,225 molecules tested in the 
Ames bacterial test and for carcinogenicity compounds were selected from a set of 805 
chemicals from the Carcinogenic Potency Database (CPDB). 
 
5.2.3.15 The Carcinogenic Potency Database (CPDB): 
Data relating to cancer causing chemicals were compiled from the Carcinogenic Potency 
Database (CPDB), which is freely available from (http://toxnet.nlm.nih.gov/cpdb/cpdb.html). 
This database is a widely used and unique international resource comprising the results of 6,540 
chronic, long-term animal carcinogenicity tests on 1,547 chemicals in rats, mice, dogs, 
hamsters and non-human primates.  
 
 
5.2.4 Data analysis 
The compounds in the databases (Section 5.2.3) were profiled using the appropriate profilers 
(Section 5.2.2). 
For each compound, if any alert was triggered, the compound was allocated a score of 1, if no 
alerts were triggered, a score of 0 was allocated. The results were compared with the assigned 
binary activities from the original database (positive=1; negative=0). 
Cooper statistics (Cooper et al., 1979) were used to assess the results against the experimental 
values given in the databases, by calculating the sensitivity, specificity and accuracy of the 
alert triggers as follows: 
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Sensitivity (True positive rate) = TP/ TP+FN 
Specificity (True negative rate)      =   TN/TN+FP 
Accuracy = (TN+TP)/(TN+FP+FN+TP) 
MCC = (TPxTN)-(FPxFN)/√(TP+FN)(TP+FP)(TN+FN)(TN+FP) 
PPV (Positive predictive value) or (precision) = TP/ TP+FP 
Where TP=True positive, TN=True negative, FP=False positive, FN=False negative 
 
Sensitivity is defined as the percentage of correctly classified positive predictions among the 
total number of positive instances. 
Specificity is the percentage of correct negative predictions compared to the total number of 
negatives. 
Accuracy (concordance or “Q”) is defined as the total number both positive and negatives 
correctly predicted among the total number of compounds. 
PPV (positive predictive value) is defined as the total number of correctly classified positive 
predictions among the total number of both negative and positive instance. 
MCC (Matthews correlation coefficient) is a weighted value that overcomes any imbalance in 
the data classes which might lead to over optimistic values of Q (Matthews, 1975). An MCC 
value of 1 indicates that the model can predict the data classes of unknown compounds 
perfectly, whilst a MCC value of 0 indicates that the predictions are no better than random 
guessing, and a MCC value of -1 indicates total disagreement between the predicted data and 
the actual data. 
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5.3: Results and discussion: 
The results of the assessment of the profilers against the experimental data for mutagenicity, 
carcinogenicity and skin sensitisation are shown in Tables 5.1, 5.2 and 5.3 respectively. Further 
detailed analysis was undertaken to identify over-predictive structural alerts in the 
carcinogenicity profilers i.e. the Precision or PPV (positive predictive value) is lower than 0.5. 
This analysis was performed to determine structural alerts with little information or predictive 
capability to increase the sensitivity and overall accuracy of the profiler. Detailed analysis of 
13 non-genotoxic carcinogenicity structural alert was conducted and is presented in Table 5.4. 
An additional analysis for the Oncologic Primary Classification carcinogenicity profiler was 
performed for 30 structural alerts included in the profiler. The purpose of this analysis was to 
assess which structural alerts had a precision PPV (positive predictive value) lower than 0.5. 
This analysis is presented in Table 5.5. 
The cut-off for value was set to be 0.5. This was to ensure that none of these profilers will have 
lower predictivity power as compared to Ames test. It is known that the Ames Test has been 
applied to predict rodent carcinogenicity. The high predictive power of a positive Ames ranges 
from 77% to 90% depending on the various factors. This makes it superior to any other in vitro 
genotoxicity assay, all of which have lower performance in terms of predicting genotoxicity 
(Kazius et al., 2006). 
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Table 5.1. Cooper statistics for the mutagenicity profilers in the Toolbox assessed against 
databases. 
Profiler DNA 
binding by 
OASIS v.1.1 
DNA 
binding by 
OECD 
genotox and 
nongenotox 
alerts by ISS 
DNA alerts 
for AMES, 
MN and CA 
by OASIS 
Ames test 
alerts by 
ISS 
Micronucleus 
alerts by ISS 
Bacterial mutagenicity  (ISSSTY) 
Sensitivity  0.76 0.76 0.87 0.64 0.84 0.95 
Specificity  0.65 0.59 0.55 0.77 0.63 0.28 
Accuracy (Q) 0.69 0.65 0.67 0.72 0.71 0.53 
MCC  0.56 0.45 0.56 0.62 0.66 0.32 
Micronucleus (OASIS) 
Sensitivity  0.56 0.58 0.69 0.41 0.58 0.89 
Specificity  0.58 0.53 0.42 0.71 0.57 0.18 
Accuracy (Q) 0.57 0.55 0.55 0.57 0.57 0.51 
MCC  0.16 0.12 0.12 0.13 0.16 0.10 
Micronucleus (ISSSTY) 
Sensitivity  0.51 0.54 0.61 0.36 0.50 0.78 
Specificity  0.62 0.55 0.50 0.79 0.68 0.21 
Accuracy (Q) 0.56 0.54 0.56 0.54 0.58 0.54 
MCC  0.13 0.08 0.11 0.16 0.18 -0.01 
Genotox OASIS (Ames) 
Sensitivity  0.76 0.74 0.85 0.62 0.82 0.95 
Specificity  0.63 0.56 0.52 0.78 0.62 0.22 
Accuracy (Q) 0.70 0.65 0.69 0.70 0.72 0.58 
MCC  0.51 0.38 0.50 0.53 0.59 0.27 
Genotox (OASIS CA) 
Sensitivity  0.59 0.62 0.70 0.44 0.58 0.83 
Specificity  0.66 0.61 0.50 0.80 0.66 0.28 
Accuracy (Q) 0.62 0.61 0.61 0.61 0.62 0.57 
MCC  0.28 0.25 0.22 0.28 0.26 0.13 
Mutagenicity (ISSCAN) 
Sensitivity  0.80 0.78 0.86 0.62 0.82 0.95 
Specificity  0.68 0.61 0.54 0.83 0.72 0.28 
Accuracy (Q) 0.74 0.69 0.69 0.73 0.76 0.59 
MCC  0.48 0.40 0.41 0.46 0.54 0.30 
SAR Gentox Database 
Sensitivity  0.70 0.70 0.83 0.51 0.81 0.90 
Specificity  0.69 0.55 0.57 0.85 0.66 0.33 
Accuracy (Q) 0.72 0.63 0.70 0.86 0.74 0.62 
MCC  0.39 0.26 0.41 0.38 0.48 0.27 
Sensitivity = True positive rate; Specificity = True negative rate; MCC = Matthews Correlation Coefficient,  
= Specificity below 0.5 
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Table 5.2. Cooper statistics for carcinogenicity profilers in the Toolbox assessed against 
databases. 
Profiler DNA binding by 
OASIS v.1.1 
DNA binding by 
OECD 
Carcinogenicity 
(genotox and 
nongenotox) alerts 
by ISS 
Oncologic Primary 
Classification 
DSS Pesticide Carcinogenicity 
Sensitivity  0.64 0.65 0.80 0.73 
Specificity  0.60 0.54 0.54 0.44 
Accuracy (Q) 0.62 0.60 0.68 0.60 
MCC  0.24 0.19 0.36 0.18 
CRD-AGES Carcinogenicity 
Sensitivity  0.45 0.42 0.68 0.66 
Specificity  0.67 0.58 0.49 0.30 
Accuracy (Q) 0.58 0.52 0.57 0.44 
MCC  0.12 0.00 0.17 -0.05 
VEGA Carcinogenicity 
Sensitivity  0.64 0.64 0.81 0.72 
Specificity  0.57 0.54 0.52 0.42 
Accuracy (Q) 0.61 0.59 0.68 0.59 
MCC  0.22 0.18 0.34 0.15 
ISSCAN Carcinogenicity 
Sensitivity  0.62 0.62 0.79 0.73 
Specificity  0.58 0.52 0.51 0.38 
Accuracy (Q) 0.60 0.57 0.64 0.54 
MCC  0.20 0.14 0.31 0.11 
CPDB Carcinogenicity 
Sensitivity  0.60 0.63 0.78 0.73 
Specificity  0.61 0.55 0.53 0.43 
Accuracy (Q) 0.61 0.58 0.64 0.57 
MCC  0.21 0.18 0.31 0.16 
LAZAR Carcinogenicity 
Sensitivity  0.63 0.65 0.76 0.70 
Specificity  0.65 0.55 0.57 0.46 
Accuracy (Q) 0.64 0.60 0.67 0.59 
MCC  0.28 0.20 0.34 0.17 
SAR carcinogenicity database 
Sensitivity  0.59 0.65 0.75 0.70 
Specificity  0.56 0.51 0.51 0.41 
Accuracy (Q) 0.58 0.60 0.67 0.60 
MCC  0.14 0.15 0.26 0.10 
Sensitivity = True positive rate; Specificity = True negative rate; MCC = Matthews Correlation Coefficient   
= Specificity below  0.5 
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Table 5.3. Cooper statistics for skin sensitisation profilers in the Toolbox assessed against 
databases. 
Profiler Protein 
binding 
OASIS 
DPRA 
Lysine 
peptide 
depletion 
Keratinocyte 
gene 
expression 
Protein 
binding 
potency 
Protein 
binding 
by 
OECD 
DPRA 
Cysteine 
peptide 
depletion 
Protein 
binding 
alerts 
OASIS 
v1.1 
Inchemitox skin sensitisation 
Sensitivity  0.53 0.12 0.19 0.12 0.47 0.22 0.50 
Specificity  0.74 0.94 0.89 0.93 0.79 0.91 0.86 
Accuracy (Q) 0.61 0.43 0.45 0.42 0.59 0.48 0.64 
MCC  0.27 0.10 0.10 0.08 0.25 0.17 0.36 
CAESAR 
Sensitivity  0.72 0.30 0.33 0.19 0.68 0.48 0.71 
Specificity  0.36 0.77 0.73 0.90 0.46 0.55 0.40 
Accuracy (Q) 0.54 0.54 0.54 0.55 0.56 0.52 0.55 
MCC  0.09 0.08 0.07 0.12 0.14 0.03 0.11 
ECETOC 
Sensitivity  0.60 0.30 0.43 0.20 0.63 0.37 0.60 
Specificity 0.80 0.80 0.80 1.00 0.80 0.80 0.80 
Accuracy (Q) 0.65 0.43 0.53 0.40 0.68 0.48 0.65 
MCC  0.35 0.10 0.21 0.24 0.38 0.15 0.35 
OECD Skin sensitisation 
Sensitivity  0.46 0.29 0.31 0.29 0.44 0.33 0.45 
Specificity  0.83 0.86 0.85 0.86 0.83 0.85 0.84 
Accuracy (Q) 0.67 0.58 0.59 0.58 0.66 0.61 0.68 
MCC  0.31 0.18 0.19 0.17 0.30 0.21 0.32 
 
Sensitivity = True positive rate; Specificity = True negative rate; MCC = Matthews Correlation Coefficient 
 
 
 
 
 
= Specificity below  0.5 
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Table 5.4. PPV (positive predictive value) analysis for 13 structural alerts for non-genotoxic carcinogenicity included in carcinogenicity alert 
profiler by ISS in 7 carcinogenicity databases.         = PPV lower than 0.5 and need to be improved or omitted 
N
on
-g
en
ot
ox
ic
 c
ar
ci
no
ge
n 
st
ru
ct
ur
al
 a
le
rt 
 
Alert  
TRUE POSITIVE FALSE POSITIVE 
TO
TA
L 
FP
 
 
TO
TA
L 
TP
 
TO
TA
L 
PP
V
 
SU
G
 
VEGA LAZAR ISSCAN DDS CPDB CRDAG SAR VEGA LAZAR ISSCAN DDS CPDB CRDAG SAR  
PHCA 13 9 19 11 17 0 2 3 0 11 0 7 0 5 26  51 77.0 0.66 K  
BENZD 5 3 7 4 7 0 4 3 0 5 0 4 1 2 15  23 38.0 0.61 K  
TCE 5 4 16 5 10 0 4 1 0 1 0 1 0 1 4  35 39.0 0.90 K  
THCAR 10 1 15 8 11 0 8 8 0 20 0 27 0 7 62  44 106.0 0.42 I 
HALBN 10 10 2 10 4 5 13 15 0 0 0 0 6 8 29  34 63.0 0.54 K  
HALDB 1 2 6 1 4 0 3 1 0 1 0 0 0 1 3  14 17.0 0.82 K  
SACA 3 4 4 5 4 0 4 4 0 9 0 5 0 3 21  15 36.0 0.42 I 
QUERC 1 0 2 1 1 0 1 0 0 4 0 3 0 1 8  5 13.0 0.38 I 
PHTAL 1 2 2 1 3 0 1 1 0 5 0 3 0 2 11  7 18.0 0.39 I 
STERO 4 1 5 0 7 0 8 0 0 1 0 6 0 1 8  24 32.0 0.75 K  
IMIDA 5 3 5 4 6 0 11 6 0 12 0 8 0 2 28  27 55.0 0.49 K  
BENSU 2 2 4 2 4 0 5 0 0 3 0 5 0 1 9  15 24.0 0.63 K  
ALKHL 7 7 13 7 10 1 1 3 0 7 0 6 0 4 20  32 52.0 0.62 K 
TOTAL 67 48 100 59 88 6 65 45 0 79 0 75 7 38 244  326 570.0 0.57 
 
 
PHCA = (Poly)Halogenated Cycloalkanes, BENZD = 1,3-Benzodioxoles,  TCE =Trichloro (or fluoro) ethylene and Tetrachloro (or fluoro) ethylene , THCAR= Thiocarbonyl  , HALBN= Halogenated benzene ,  
HALDB = Halogenated Dibenzodioxone ,  SACA = Substituted n-alkylcarboxylic acids , QUERC = Quercetin type flavonoids ,  PHTAL= Phthalate (or butyl) diesters and monoesters , STERO =Steroidal estrogens  
IMIDA = Imidazole, benzimidazole, BENSU = Benzenesulfonic ethers, ALKHL= Alkyl halides ,SUG = suggestion, I = need to Improve or omit , K= Keep . 
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Table 5.5. PPV analysis for 13 structural alerts for non-genotoxic carcinogenicity included in 
carcinogenicity alert profiler by ISS in 7 carcinogenicity databases.         = PPV lower than 0.5 
and need to be improved or omitted. 
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ALERT        TOTAL 
TOTAL 
FP 
 
TOTAL 
TP 
 
ppv SUGGESTION 
(Poly)Halogenated Cycloalkanes  77.0 26 51 0.66 Keep  
1,3-Benzodioxoles  38.0 15 23 0.61 Keep 
Trichloro (or fluoro) ethylene and 
Tetrachloro (or fluoro) ethylene  39.0 4 35 0.90 Keep 
Thiocarbonyl  106.0 62 44 0.42 Improve or omit 
Halogenated benzene  63.0 29 34 0.54 Keep 
Halogenated Dibenzodioxone 17.0 3 14 0.82 Keep 
Substituted n-alkylcarboxylic acids  36.0 21 15 0.42 Improve or omit 
Quercetin type flavonoids  13.0 8 5 0.38 Improve or omit 
Phthalate (or butyl) diesters and monoesters  18.0 11 7 0.39 Improve or omit 
Steroidal estrogens  32.0 8 24 0.75 Keep 
Imidazole, benzimidazole  55.0 28 27 0.49 Keep 
Benzenesulfonic ethers 24.0 9 15 0.63 Keep 
Alkyl halides  52.0 20 32 0.62 Keep 
TOTAL  570.0 244 326 0.57  
PPV after ignoring suggested structural alerts 0.64 
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Table 5.6. PPV analysis of each structural alert in oncologic carcinogenicity profiler through 7 carcinogenicity databases.         = PPV lower than 
0.5 and need to be improved or omitted 
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ALERT 
TOTAL TOTAL 
TP 
TOTAL 
FP 
PPV SUGGESTION 
Acrylamide Reactive Functional Groups 25 18 9 0.72 Keep  
Acrylate Reactive Functional Groups 50 35 15 0.70 Keep  
Aldehyde Type Compounds 138 80 58 0.58 Keep  
Alkanesulfonoxy Ester Type Compounds 6 3 3 0.50 Keep  
Alkyl Sulfate and Alkyl Alkanesulfonate Type Compounds 28 16 12 0.57 Keep  
Alpha, beta-Haloether Reactive Functional Groups 131 65 66 0.50 Keep  
Aromatic Amine Type Compounds 976 565 413 0.58 Keep  
Arylazo Type Compound 0 0 0 0.00 Keep  
Carbamate Type Compounds 63 22 43 0.35 Improve or omit 
C-Nitroso and Oxime Type Compounds 17 12 5 0.71 Keep  
Coumarine and Furocoumarin Type Compounds|Lactone Type Reactive Functional Groups 3 3 0 1.00 Keep  
Epoxide Reactive Functional Groups 99 63 37 0.64 Keep  
Ethyleneimine Reactive Functional Groups 6 6 0 1.00 Keep  
Halogenated Linear Aliphatic Type Compounds 289 193 96 0.67 Keep  
Halogenated Aromatic Hydrocarbon Type Compounds 241 111 139 0.46 Keep  
Lactone Type Reactive Functional Groups 26 14 12 0.54 Keep  
Nitroalkane and Nitroalkene Type Compounds 52 26 26 0.50 Keep  
Nitrogen Mustards Reactive Functional Groups 18 13 5 0.72 Keep  
Nitrosamine Type Compounds 337 266 71 0.79 Keep  
Nitrosamide Type Compounds 3 3 0 1.00 Keep  
Organophosphorus Type Compounds 126 47 80 0.37 Improve or omit 
Peroxide Type Compounds 11 3 8 0.27 Improve or omit 
Phenol Type Compounds 276 117 159 0.42 Keep  
Polycyclic Aromatic Hydrocarbons - Homocyclic 10 9 1 0.90 Keep  
Reactive Ketone Reactive Functional Groups 21 2 19 0.10 Improve or omit 
Sulfur Mustard Reactive Functional Groups 2 2 0 1.00 Keep  
Sultone Reactive Functional Groups 4 3 1 0.75 Keep  
Thiocarbonyl Type Compounds 56 36 20 0.64 Keep  
Triazene Type Compounds 3 3 0 1.00 Keep  
Urea Type Compounds 10 3 7 0.30 Keep  
TOTAL 3027 1739 1305 0.57  
PPV after ignoring suggested structural alerts 0.593 
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5.3.1 Mutagenicity profilers 
The accuracy (percentage of positives and negatives correctly predicted) of the mutagenicity 
profilers varies across the datasets from 51% to 76%. Clearly 51% is barely better than chance, 
whereas 76% is more acceptable because it is in line with the level of error generally seen in 
measured data in most databases. The micronucleus alerts appear to be general and, as such, 
significantly over-predicts mutagenicity. The most common alert triggered by this profiler is 
“Hacceptor-path3-Hacceptor”. This alert indicates the non-covalent binding of the target 
chemical to DNA via two bonded atoms connecting two H bond acceptors (Snyder et al. 2006). 
However, it appears that such a functional group is common in both mutagens and non-
mutagens. It is likely that the performance of this profiler would improve if this specific alert 
was omitted. 
As expected, both DNA binding profilers work best with the data obtained from Ames type 
tests, and do not perform well for chromosome abnormality or micronucleus data. 
The genotoxicity and non-genotoxicity alerts (ISS) have acceptable true positive results but fail 
to distinguish the negatives. Overall, these perform best with Ames type data.  
The OASIS DNA alerts for Ames, micronucleus and chromosomal aberration predict the 
results in Ames datasets fairly well but for both micronucleus data and chromosomal aberration 
data, these profilers under-predict positive compounds with sensitivity rates ranging from 36-
44%. The ISS Ames test alerts have accuracies over 70% for Ames datasets and MCC values 
greater than 0.5 indicate that the performance is independent of skewed sample categories. It, 
however, needs to be noted that the micronucleus/ CA alerts may not be suitable predictors of 
Ames. They need to be considered separately and used, along with Ames, to develop the overall 
weight of evidence.  
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Figure 5.1. Receiver operating characteristic (ROC) curve analysis for mutagenicity profilers 
in the OECD QSAR Toolbox 
 
The receiver operating characteristic (ROC) curve, which is defined as a plot of test sensitivity 
as the y coordinate versus its 1-specificity or false positive rate (FPR) as the x coordinate, is an 
effective method of evaluating the quality or performance of diagnostic tests.  Figure 5.1 shows 
the ROC curve analysis for the in silico profilers. The ROC curve shows that Ames ISS profiler 
was the most efficient profiler that achieved the highest balanced accuracy with both high true 
positive rate and low false positive rate values.  
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5.3.2 Carcinogenicity profilers 
Both DNA binding profilers perform equally poorly for carcinogens and non-carcinogens from 
all datasets, with accuracy values rarely above 60% and, MCC values indicating a performance 
barely better than chance. 
The ISS carcinogenicity alerts fare a little better in predicting carcinogens, but a poor 
segregation of the non-carcinogens reduces the overall effectiveness of this profiler with 
accuracy levels between 57% and 68% for the sample datasets and modest to poor performance 
on skewed datasets as indicated by the MCC values of 0.17 to 0.36. The ROC analysis shown 
in Figure 5.2 indicates that the ISS carcinogenicity profiler preformed the as compared to the 
other three profilers in terms of both true positive rate and false positive rate. 
As discussed in Chapter 2, genotoxic carcinogenicity structural alerts are more accuracy than 
non-genotoxic carcinogenic structural alerts. Based on that, 13 non-genotoxic structural alerts 
among ISS carcinogenicity profiler were analysed individually to test their performance in PPV 
(positive predictive value). As shown in Table 5.4, the overall PPV of ISS non-genotoxic 
carcinogen structural alerts was 57% where 326 substances are correctly predicted as non-
genotoxic carcinogens out of total 570 substances that were detected to contain one of the 13 
NGC structural alerts. 
The precision value (PPV) for non-genotoxic carcinogenicity structural alerts ranged from 0.92 
for (Trichloro (or fluoro) ethylene and Tetrachloro (or fluoro) ethylene) as the highest PPV to 
0.39 for Quercetin type flavonoids. Four out of 13 NGC structural alerts seem to show over-
prediction. These are thiocarbonyl, substituted n-alkylcarboxylic acids, quercetin type 
flavonoids, and phthalate (or butyl) diesters and monoesters. All four of these structural alerts 
predict non-carcinogenic substances as carcinogens in more than 50% of the total substances 
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that contain this structural alert, which as a result lowers the total accuracy of the ISS 
carcinogenicity profiler. 
The thiocarbonyl NGC structural alert was flagged in 106 substances as the only structural alert. 
Any substance that contained more than one NGC structural alerts was not counted in this 
analysis to avoid any interference. Sixty-two non-carcinogenic substances were falsely 
predicted as carcinogenic substances by the thiocarbonyl structural alert with a sensitivity rate 
of 0.42. Due to this over-prediction of the thiocarbonyl alert, it can be suggested that ignoring 
this alert could increase sensitivity of the total NGC structural alerts and the ISS 
carcinogenicity profiler. This would, however, not be the ideal solution, as any thiocarbonyl 
NGCs would be completely out of the scope of the profiler. Instead, it is proposed that further 
research be carried out to see whether performance of this alert can be improved using a larger 
database of thiocarbonyl substances and attempting to revise and clarify its definition. 
Likewise, the other three NGC structural alerts, i.e. substituted n-alkylcarboxylic acids, 
quercetin type flavonoids and phthalate (or butyl) diesters and monoesters also showed a 
precision value lower than 0.5 with a PPV of 0.42, 0.39 and 0.38 respectively. Again ignoring 
these four structural alerts increased the total precision value of NGC structural alerts and 
consequently of the performance of the ISS carcinogenicity profiler. The results (Table 5.4) 
showed that the precision value of ISS non-genotoxic structural alerts was improved from 0.57 
to 0.64 by ignoring these four structural alerts. However, for the reasons mentioned above, it 
is proposed that further research should be carried out to improve the performance of these 
alerts within the profiler. 
The Oncologic primary classification profiler over-predicts carcinogens with sensitivity rates 
of 66-73% at the expense of poor prediction of non-carcinogens (30-46%), resulting in an 
overall performance which is barely better than chance for most of the datasets. All 30 
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structural alerts of the Oncologic primary classification profiler were individually analysed for 
their precision as shown in Table 5.5. Four structural alerts showed over-prediction of non-
carcinogenic substances as being carcinogenic in more than 50% of the total substances 
containing this structural alert. These four alerts were carbamate type compounds, 
organophosphorus type compounds, peroxide type compounds and reactive ketone reactive 
functional groups. Carbamate type compounds’ structural alert for carcinogenicity was 
triggered in 63 substances with only 22 true positive carcinogenic substances. The other 43 
substances that were flagged by this alert to be carcinogenic were non-carcinogenic in 
experimental tests. This give a low precision value for carbamate type compounds of 0.35. The 
second structural alert in oncologic primary classification profiler with low precision value 
(lower than 0.36) was the organophosphorus type compounds structural alert where 80 
substances out of 126 flagged by this alert were wrongly predicted as carcinogenic substances. 
The peroxide type compounds structural alert showed only 0.27 precision (positive predictive 
value) rate with only three correctly predicted carcinogenic substances out of 11 substances 
flagged by the alert. The structural alert with the lowest precision (of 0.1) within the Oncologic 
primary classification profiler was for reactive ketone functional groups where there was an 
over-prediction for 19 out of 21 substances. This mean that only two substances that were 
flagged by this alert were correctly predicted as carcinogenic substances out of the total 21 
substances. 
It can therefore be suggested that all four of these structural alerts could be ignored from the 
Oncologic primary classification profiler to increase the total sensitivity and accuracy of the 
profiler. Indeed, as shown in Table 5.5, the overall precision of the profiler was improved by 
0.023 which is nearly 3% improvement in the overall performance of the profiler.  
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Removal of alerts from profilers would, however, not be an ideal solution, as this will miss 
carcinogenic compounds and would be completely out of the scope of the profiler. Instead, it 
is proposed that further research be carried out to see whether performance of these four alerts 
can be improved using a larger database of relevant substances. 
 
 
Figure 5.2. Receiver operating characteristic (ROC) curve analysis for carcinogenicity profilers 
in the OECD QSAR Toolbox. 
 
5.3.3. Skin sensitisation profilers 
The performance of the protein binding profilers is not consistent across the sample datasets. 
For the CAESAR dataset, these profilers tend to have a low predictivity for non-sensitisers, 
whilst for the other datasets it is the sensitisers which are not well predicted. Overall the 
performance of these profilers is moderate to poor for all the datasets. 
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The peptide depletion profilers showed a similar pattern, with performance being uniformly 
not better than chance for the CAESAR dataset but highly under-predicted for sensitisers in the 
other datasets. The protein binding potency profiler is also uniformly poor across all datasets, 
failing to detect the majority of sensitisers, with sensitivity rates between 12% and 29%. A 
similar pattern is seen with the keratinocyte gene expression profiler, where sensitivity rates 
were 19-43%. 
The overall ROC analysis for all seven profilers shown in Figure 5.3 indicates that protein 
binding OASIS has relatively better performance compared to the other skin sensitisation 
profilers in the OECD QSAR Toolbox. 
 
 
Figure 5.3. Receiver operating characteristic (ROC) curve analysis for the skin sensitisation 
profilers in the OECD QSAR Toolbox. 
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5.4 Discussion and Conclusions: 
The profilers in the OECD QSAR Toolbox are provided for the purpose of constructing 
categories of mechanistic and identifying structural analogues of a target compound. As such, 
they provide a useful means for read-across from experimental data on analogous compounds 
to estimate a property or biological activity of an untested compound, although they are not 
necessarily intended to make toxicological predictions in themselves. The accuracy and 
reliability of a profiler in terms of predicting a target compound is, however, also important for 
defining the structural and functional features so that it is placed in the correct category/group 
of analogous substances. A number of the profilers are also used in other applications for 
indicating certain toxicity endpoints, such as Toxtree (http://toxtree.sourceforge.net/), and 
Oncologic (www.epa.gov/oppt/sf/pubs/oncologic.htm).  
In this regard, those profilers that are equally likely to select endpoint-positive and endpoint-
negative compounds into a grouping of analogues to be used in a read-across will, by definition, 
give rise to equivocal predictions for the target compound. It is therefore essential to know how 
accurately different profilers perform in terms of sensitivity, specificity and accuracy and to 
investigate possibilities for improvement. This requires an understanding of the role and merits 
of each individual alert within a profiler so that only the most relevant and reliable ones are 
kept as indicators for the particular endpoint. As this study has found, the alert “Hacceptor-
path3-Hacceptor” in the micronucleus profiler is too ubiquitous to be a useful indicator of 
mutagenicity. Similarly in three NGC structural alerts within the ISS carcinogenicity profiler 
(thiocarbonyl, sub alkyl carboxylic acid, quercitin and phthalate), and the four structural alerts 
in oncologic primary classification profiler (carbamate type compounds, organophosphorus 
type compounds, peroxide type compounds and reactive ketone functional groups) proved to 
have extremely low precision values. As shown in the examples investigated in this chapter, 
the omission or substitution of these alerts, which unduly draw predictions towards equivocal 
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outcomes within a profiler, can improve the overall performance of the profilers. This, however, 
would bring the drawback of making some of the NGC alerts out of the scope of a profiler and 
therefore further research is needed to find out whether performance of these alert can instead 
be improved, e.g. by exploring larger datasets of relevant substances. 
Another factor influencing the segregation of compounds by the alerts could be the way in 
which the categorical data found in the three endpoint datasets studied here are derived. Very 
often the binary categorisation of data is achieved by manipulation of the continuous data in 
some way to provide “cut-off” points for positive or negative assignment. The way in which 
this is done may affect the flagging of an alert in an essentially “negative” compound, or vice 
versa. By definition, most alerts have been derived from datasets of endpoint-positive 
compounds, because deriving “negative alerts”, like proving a negative hypothesis, is generally 
not feasible. In this context, this study has given an insight into those alerts that may be found 
equally in endpoint-positive or negative compounds, and those which may be more effectively 
utilised to form groups of analogues for read-across predictions.  
Further in-depth research in this area is necessary to study the suitability and merits of each of 
the alerts within the profilers in the OECD QSAR Toolbox and other in silico toxicity platforms 
to identify the root causes of the inadequacies and to investigate possibilities for improvement 
in the performance. This will, by implication, also improve the reliability of chemical read-
across and grouping/categorisation for use in classification, labelling and risk assessment.  
 
 
 Chapter 6: Discussion 
This chapter consists of two sections. The first provides a summary and discussion of the main 
research carried out, and the conclusions drawn, as detailed in Chapters 2 to 5. The second 
section provides insights for future work that could improve the assessment and evaluation of 
the currently available structural alerts for carcinogenicity, mutagenicity and skin sensitisation, 
and how such work could be translated into a practical tool to help the end-user. This will 
address the much-needed improvement in the reliability of in silico evaluations of carcinogenic, 
mutagenic and skin sensitising substances amongst the ingredients intended for use in cosmetic 
products during safety assessment.    
6.1 Progress in the development and assessment of  structural alerts for carcinogenic 
substances. 
6.1.1 Summary of work 
From the outset, the main focus of the work presented in this thesis was to evaluate the 
reliability of, and to identify the need for improvement in, the currently available structural 
alerts and in silico profilers of carcinogenicity and mutagenicity. For a broader comparative 
assessment of cosmetic ingredients, skin sensitisation profilers were also included later on in 
the study. The assessment of the profilers and structural alerts was essential to underpin 
confidence in their reliability in different software platforms, and to point out the need for 
refinements where necessary. Such refinements need to be in the form of a continuous process 
that aims to make the alerts and profilers more accurate and thus facilitate the safety assessment 
of the chemical ingredients used in cosmetic products.  
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6.1.2 The reliability of structural alerts in toxicity assessment  
It is worth noting at the outset of this investigation that terms such as “carcinogenic/non-
carcinogenic”, “sensitiser/non-sensitiser” and “safe/unsafe” are used in this thesis for the sake 
of simplicity. It is fully recognised that assigning a chemical to be toxic or non-toxic depends 
on dose, exposure and threshold of toxicity for a particular endpoint that cannot be 
oversimplified with absolute terms. Structural alerts have gained wide regulatory acceptance 
for a number of reasons, foremost amongst them being that they are easily generated and 
interpreted. However, there has been growing concern about the accuracy of structural alerts 
to predict toxicity. The main concern about these alerts is that they represent only a part of the 
whole structure; i.e. functional groups that can be found in both toxic and non-toxic 
compounds; this may lead to over-prediction of toxicity. This over-prediction of toxicity with 
high sensitivity but low specificity was seen very clearly in the assessment of the predictivity 
of structural alerts undertaken in Chapters 3 and 5, as summarised in Tables 3.5, 5.1, 5.2 and 
5.3. In Chapter 3, a total of 28 structural alerts were found to be inaccurate for use as part of 
the six mutagenic profilers studied. All of the structural alerts showed positive predictivity of 
less than 45% and more than ten substances were predicted to be positive for mutagenicity by 
these alerts. This phenomenon can be explained by the fact that the reactivity of these 
substructural alerts can be affected by other groups in the molecule, especially when the 
chemical properties of the substructures are dependent on the other groups in the same 
molecule (Alves et al., 2016). The scientific community has been debating the issue of the 
accuracy of predictions from structural alerts and hence their reliability. The OECD 
characterises read-across as a technique to predict a determined endpoint, but it requires that 
expert judgement is used and a justification of molecular similarity should be provided (OECD, 
2007). The OECD sponsored the development of OECD QSAR Toolbox, a software 
application to predict (eco)toxicity based on chemical grouping and read-across, whilst leaving 
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the assessment of the prediction to the end user. The significance of structural alerts to predict 
toxicity was described in relation to the Toxtree software used in Chapter 2 to evaluate the 
reliability of structural alerts for nongenotoxic carcinogenicity. Toxtree also has a module for 
skin sensitisation that implements structural alerts. Contributing to the confusion over the 
significance of alerts as predictors of toxicity, the developers of Toxtree recently placed a 
statement on their website saying that they changed the name of the module from “Skin 
sensitisation alerts” to “Skin sensitisation reactivity domain” explaining that alerts provide only 
grouping into a reactivity mode of action and do not predict skin sensitisation potential. 
Although not explicitly reported, this conspicuous change in nomenclature is most likely due 
to pitfalls and deficiencies in the method. For instance, the use of simple categories led to the 
misclassification of 25% of compounds evaluated for respiratory sensitisation, including non-
sensitisers containing alerts, and sensitisers that did not contain alerts (Alves et al., 2016; Enoch 
et al., 2010). Given these shortcomings in the ability of structural alerts to predict toxicity, it 
can be argued that alerts may be useful for the initial flagging of potential toxic compounds but 
not necessarily for predicting toxicity. It is also important to point out that the original profiler 
alerts were also developed for grouping and read-across and hence were not intended to be 
predictive.  
 
6.1.3 The feasibility of predicting human nongenotoxic carcinogenicity via structural alerts 
The identification of nongenotoxic carcinogens remains one of the most challenging areas in 
toxicology. Even with a full dataset, setting protective levels for exposure is known to be 
problematic (Braakhuis et al., 2018). As with most toxicological endpoints, the majority of 
data relating to this endpoint are derived from animal experimentation with extrapolation to 
humans to allow for chemical risk assessment. This raises many potential problems, not least 
of which is the inter-species differences and potential for being over-protective with regard to 
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this endpoint, i.e. classification of compounds as carcinogens which are likely not to be harmful 
to humans. A further complication is that in silico models for toxicology can only be based on 
the data available, thus for nongenotoxic carcinogenicity, they will be based on information 
derived from standard rodent bioassays.  
One of the possible shortcomings of structural alerts to predict nongenotoxic carcinogenicity 
is animal-to-human extrapolation. Nongenotoxic carcinogens act in species-specific, dose-
dependent ways and include multiple mechanisms of action that involve many different 
chemical structures, which makes the extrapolation of predictivity from animal to human 
possibly inaccurate. For example, in long-term studies, chemicals that elicit the peroxisome 
proliferation phenomenon in rodents are associated with hepatocarcinogenesis. Upon treatment 
with these chemicals in high doses, the tumorigenic reaction appears to be related to both 
oxidative stress and increased cell proliferation. Non-rodent species have been shown to be 
highly resistant to the induction of peroxisome proliferation as compared to the rat (Corton et 
al., 2018). There are several potential explanations for the species-specific differences in 
response to peroxisome proliferation induction. One theory indicates that the differences in 
susceptibility to peroxisome proliferation between rats and humans is due to the variation in 
the comparative expression of PPARα between species (Lawrence et al., 2001). Expression of 
PPARα in human liver is relatively lower than in rat liver which limits the number of genes 
induced by the ligand upon exposure. The other explanation suggests that non-rodent species 
have a defect in the response element (PPRE) within the promoter that prevents the receptor 
from binding or regulating genes. This hypothesis was confirmed after analysing several human 
genomic samples that showed a defect in PPREs within the fatty acyl -CoA oxidase promoter 
(Lawrence et al., 2001). Advances in the human-relevant assessment of PPARa were reviewed 
recently by Felter et al. (2018) along with other modes of actions e.g. Constitutive Androstane 
Receptor (CAR).  
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The problem of in silico prediction of nongenotoxic carcinogenicity is well established. QSARs 
and structural alerts show the best performance for genotoxic endpoints as compared to non-
genotoxic carcinogenicity (Carnesecchi et al., 2020). The reason for this is almost certainly 
that models for reactivity with DNA can be created relatively simply (e.g. structural alerts for 
covalent reactivity). For nongenotoxic carcinogenicity, there are a number of subtle 
mechanisms and initiating events, e.g. receptor binding, that are more difficult to model 
(Benigni and Bossa, 2019).  
Whilst there are few, if any, reliable QSARs for human toxicity and chronic toxicity, specific 
endpoints such as human carcinogenicity are particularly poorly addressed - this is because of 
the emphasis on QSARs for regulatory endpoints and the lack of data (Gluck et al., 2018). 
However, toxicology and safety assessment are moving on and there is an opportunity in the 
future to improve the situation. Recent examples have demonstrated this with novel data 
sources and means of creating alerts (Golbamaki et al., 2016; Benigni et al., 2013). The 
opportunities for QSAR and structural alerts for nongenotoxic carcinogenicity include:  
i) Ensuring that models are properly annotated and anchored to a mechanism of action. For 
instance, basing models around AOPs, and specifically initiating events, may be appropriate 
for this. 
ii) Better definition of the domain of applicability of models, not only in terms of the chemistry 
but also the potential biology.  
iii) Increasing knowledge of human non-genotoxic carcinogens with (where possible) new data 
sources e.g. using data from human cell lines. 
Regarding the use of new data sources, there are several recent examples:  Yamane et al. (2018) 
derived information for 20 compounds from human embryonic stem cells; Tung and Jheng 
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(2014) and Liu et al. (2011) used transcriptomics data to model non-genotoxic 
hepatocarcinogenicity. These and other researchers have also demonstrated that integrating 
mechanistic (biological) data and chemical structure information improves the prediction of 
nongenotoxic carcinogenicity. For instance in vitro and mechanistic data have been shown to 
improve the quality of QSARs (Guan et al., 2018; Chen et al., 2013; Lui et al., 2011).  
Ultimately, there will always be uncertainty in using SARs / predictive methods and this is 
usually reflected in performance statistics. However, to predict non-genotoxic carcinogens the 
added uncertainty arising from extrapolation from one species to another must also be included. 
In order to achieve this, we need to define uncertainty and understand the consequences. 
Aspects of the models associated with high uncertainty could then be reduced - obvious areas 
of high uncertainty at the current time are relevance to humans and mechanistic underpinning 
of the models. Whilst we are currently not in an ideal position, it is likely that the models will 
be over-predictive. This is, in itself, consistent with the precautionary principle that implies we 
should accept the worst-case scenario and then provide evidence to reduce the risk e.g. PPAR 
only relevant to rodents. What is of greater concern is whether there are human-specific 
mechanisms of action that are not captured by the model. This will require knowledge of such 
mechanisms, again with reference to AOPs where possible (Rooney et al., 2018).   
 
6.1.4 The significance of single alerts in a complex chemical structure. 
 
Structural alerts highlight the importance of specific structural features as determinants of a 
compound’s toxicity. However, biological effects are measured for the entire molecule, raising 
doubts about whether a fragment can always adequately define the property of the whole 
molecule. Several studies have been performed to examine the relationship and interplay 
between the fragment and the whole molecular structure (Alves et al., 2016). A small change 
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in molecular structure, i.e. replacement of one functional group with another in the same 
position, causes changes in many descriptor values which reflect the interconnectivity and 
mutual influence of all fragments in a molecule. Nitroaromatic compounds, which are used in 
hair dyes, are a good example to illustrate the mutual influence of substituents in the molecule 
on the overall toxic effect of these compounds. Kuz’min et al. (2008) developed a QSAR model 
for rat acute toxicity which demonstrated that the nitro group attached to the aromatic ring, 
which was known to increase toxicity, shows variations in its toxic effect depending on the 
number and nature of other substituents in the aromatic ring. Thus, the main finding of their 
study was that although an aromatic nitro group is considered to be a toxicophore, its 
contribution to toxicity could be significantly modified by other substituents. Chloro-
substituted nitrobenzenes are a good example to illustrate this finding. Increasing the number 
of chlorine substituents in a nitrobenzene molecule was expected to increase toxicity but 
interestingly this was not completely true as it was determined that the influence of a chlorine 
substituent is not clear and depends strongly on the structural environment. For instance, a 
chlorine atom in the ortho-position to the nitro group is present in both the most toxic (2,6-
dichloronitrobenzene) and the least toxic (2,3,5-trichloronitrobenzene) compounds. Overall, 
the insertion of a chlorine substituent in nitrobenzene increases its toxicity; the ortho-isomer is 
the most toxic. Introduction of the second chlorine results in large changes in toxicity, that are 
observed for dichloronitrobenzenes. Addition of chlorine substituents decreases the difference 
in toxicity between the isomers. Moreover, the accumulation of chlorine atoms in the benzene 
ring decreases their influence on toxicity, i.e., the increase in toxicity is not proportional to the 
number of chlorine atoms or, even more, the addition of chlorine decreases the toxicity 
(Kuz’min et al., 2008). The effect of sequential insertion of chlorine substituents into the 
benzene ring was also analysed. In Figure 6.1, the toxicity of each molecule is represented as 
six separate contributions of the corresponding carbon of the aromatic ring and its substituent. 
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Insertion of a chlorine atom in the ortho-position to the nitro group leads to an increase in 
toxicity in comparison with nitrobenzene. This effect is not limited to the chlorine atom alone. 
In fact, the contributions to toxicity of all other atoms are augmented (except C–H bond in 
ortho-position to the C–Cl bond, Figure 6.1). Insertion of an additional chlorine adjacent to the 
previous ortho-chlorine has only a small effect on toxicity. Although the new C–Cl bond 
(position 3) increases the toxicity of the molecule, the contributions of the nitro group and other 
C–Cl fragment (position 2) have been diminished. Thus, in spite of the redistribution of 
influence on toxicity between different fragments of 2,3-dichloronitrobenzene, the toxicity of 
the whole compound hardly changes compared to 2-chloronitrobenzene. A dramatic change in 
toxicity was predicted for 2,3,5-trichloronitrobenzene. However, substitution of hydrogen by 
chlorine in position 5 results in substantial lowering of toxicity. This resulted in the diminishing 
toxicity of all fragments analysed, especially the chlorine in the 2-position (Kuz’min et al., 
2008; Alves et al., 2016). These examples emphasise an important conclusion that compound 
toxicity can be substantially affected by the mutual interactions and influences between its 
structural components. Moreover, individual substructures do not act directly and 
independently as is saliently presumed by the concept of structural alerts. Instead, various 
substructures, even including distant neighbours, mutually influence their contributions. 
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Figure 6.1. Relative influence of structural fragments on the rat acute toxicity of 
chlorosubstituted nitrobenzenes, where pLD50 is the negative logarithm of the molar dose that 
causes 50% lethality (Alves et al., 2016).  
 
6.1.5 Assigning cut-off values for the identification and evaluation of structural alerts 
Of  
A cut-off value of 0.5 PPV was applied in the evaluation of the reliability of carcinogenicity, 
mutagenicity and skin sensitisation structural alerts performed in Chapters 3 and 5. Thus, any 
structural alerts showing positive predictivity lower than 50% were classified as inaccurate. 
This was to ensure that none of these profilers have lower predictivity power compared to the 
Ames test. One of the key purposes of the Ames test is to predict rodent carcinogenicity. The 
high predictive power of a positive Ames ranges from 77% to 90% depending on the various 
factors. This makes it superior to any other in vitro genotoxicity assay, all of which have lower 
performance in terms of predicting genotoxicity (Kazius et al., 2006). 
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In Chapter 4, the main goal of adjusting the cut-off value was to select the minimum number 
of carcinogenicity and mutagenicity scaffolds that would cover the largest possible number of 
carcinogenic and mutagenic compounds, ultimately in order to identify a precise structural alert. 
The ratio of activity (carcinogenicity or mutagenicity) (C1/S), where C1 represents total active 
compounds (carcinogenic or mutagenic) and S represents the number of active compounds that 
contain this scaffold, was adjusted to 0.7, which achieved predictive power comparable to the 
Ames test and should cover at least 10 compounds based on the selection criteria discussed 
above. 
On the other hand, an essential factor influencing the segregation of compounds by the alerts 
could be the way in which the categorical data found in the three endpoint datasets studied here 
are derived. Very often the binary categorisation of data is achieved by manipulation of the 
continuous data in some way to provide “cut-off” points for positive or negative assignment. 
The way in which this is performed may affect the flagging of an alert in an essentially 
“negative” compound, or vice versa. By definition, alerts have been derived from datasets of 
endpoint-positive compounds, since deriving “negative alerts”, similar to proving a negative 
hypothesis, is generally not feasible. In this context, this study has provided an insight into 
those alerts that may be found equally in endpoint-positive or negative compounds, and those 
that may be more effectively utilised to form groups of analogues for read-across predictions. 
Further in-depth research in this area is needed to study the suitability and merits of each of the 
alerts in the profilers in the OECD QSAR Toolbox and other in silico toxicity platforms to 
identify possibilities for improvement in performance. This will, by implication, also improve 
the reliability of chemical read-across and grouping/categorisation for classification, labelling 
and risk assessment.  
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6.1.6 Conclusions  
It is widely known that carcinogenicity is one of the main causes of death around the world 
(Frankish, 2003). Testing chemicals for carcinogenicity, especially non-genotoxic 
carcinogenicity, is not straightforward, and in silico methods provide a means for rapid initial 
screening in this regard. The work presented in this thesis has assessed and evaluated the 
available structural alerts and profilers of carcinogenicity and mutagenicity in a number of in 
silico predicting programmes such as  the OECD QSAR Toolbox, Toxtree and Leadscope. 
Many structural alerts were found to have unacceptably low positive predictivity for 
mutagenicity and carcinogenicity, which has a bearing on the performance of various profilers. 
These structural alerts need to be investigated further to improve their predictivity and, as a 
result, the predictivity of the respective profilers. The study also identified a number of 
carcinogenicity scaffolds through the use of the SAR carcinogenicity database. Although these 
are linked to carcinogenicity, the chemistry-based alerts are not likely to be useful for the 
formation of chemical categories or read- across because they lack a mechanistic interpretation 
of how a MIE is induced within the AOP paradigm.  
This thesis is positioned as a programmatic statement that could change the thinking of both 
regulators and researchers. Informing the scientific community about the limitations of 
structural alerts that were discussed in previous sections, especially those that could be very 
useful in understanding the underlying mechanisms of toxicity, was not, however, the main 
goal of the discussion. The main goals were to show how toxicity prediction should not be 
performed by blindly relying on structural alerts, as well as how to boost safety assessment by 
combining the strongest parts of the alerts and QSAR models. It was demonstrated that blind 
reliance on structural alerts could lead researchers astray. Conversely, this discussion is not 
suggesting that QSAR models should be used instead of structural alerts. Although it was 
demonstrated that “black box” QSAR predictions usually provide the user with statistically 
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more accurate predictions, we also showed how alerts could serve as actionable structural 
hypotheses that could be validated by QSAR predictions. The best solution is to propose an 
integrated approach to desing new green chemicals by the structural modification of existing 
functional, but toxic, compounds using a combination of structural alerts and QSAR models. 
Another important point is that the influence of any part of a compound on its biological effect(s) 
is not constant and strongly depends on its structural environment. Thus, any alert, even one 
derived by mechanistic interpretation of statistically significant QSAR models does not have 
automatic predictive power. Alerts should be viewed as structural hypothesds of chemical 
action only and their true predictive power should be confirmed by QSAR predictions and, if 
possible, by experimental validation. The major recommendations discussed in this thesis are 
as follows: 
1. In most cases, it is unreliable to use structural alerts alone to predict toxicity and this 
should be avoided.  
2. Structural alerts act within the whole chemical structure, so their toxic effect depends 
mainly on the structural environment. Large datasets can be used to evaluate the extent 
of the interdependency of structural alerts. 
3. The optimum way to confirm the significance of structural alerts is by using a QSAR 
model or, preferably, by experiment. 
4. The accuracy of toxicity prediction of structural alerts can be improved by combining 
them with a QSAR model or a chemical biological read-across (CBRA) model.  
5. Although structural alerts often fail in predicting chemical toxicity, they can still be 
useful in developing local QSAR models by spiltting large datasets into smaller subsets 
based on their mechanism of action. 
6. Combining structural alerts with QSAR models in an intelligent way can be used to 
design functional non-toxic compounds e.g. for green chemistry applications. 
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6.2 Prospects for future work 
The work presented in this thesis has enabled verification and refinement of the current 
structural alerts and profilers for carcinogenicity (both genotoxic and non-genotoxic), 
mutagenicity and skin sensitisation as well as the identified 18 carcinogenicity scaffolds to be 
included as structural alerts for carcinogenicity (see Tables 4.2, 4.3, 4.5, 4.6 and 4.9). These 
alerts can be used for both toxicity prediction and grouping. The information about structural 
alerts can be captured either in CSRML or SMARTS strings to be incorporated in software like 
Toxprint that can search for these alerts among a large number of chemicals. Publishing these 
findings will not be the only way to distribute these alerts: they will be donated to be used in 
software such as Toxtree and the OECD QSAR Toolbox to allow them to be used by the 
greatest possible number of scientists and researchers. However, further work is needed to 
develop new alerts using other databases such as ToxCast which, contains a huge number of 
peroxisome proliferator activated receptor assays for nearly 2,000 compounds. This could be 
an excellent resource for identifying new non-genotoxic carcinogenic structural alerts, refining 
the poorly predictive structural alerts presented in the previous chapters.  
6.2.1 Combining structural alerts with QSAR models  
A newly suggested technique to increase the predictive power of structural alerts is to 
combine them with QSAR prediction models. Structural alerts can be used to classify the 
investigated compounds based on their putative mechanisms of action. A good example is the 
skin sensitisation dataset. In the skin sensitisation process, the molecular initiating event (MIE) 
is protein binding that is represented by a number of protein binding structural alerts based on 
well-known organic chemistry principles, but they are not highly efficient to predict skin 
sensitisation. Structural alerts can be very helpful with large datasets in assigning a mechanism 
of action to the compounds investigated and in developing local QSAR models. The local 
QSAR models could be united with mechanism-uninformed global models in a consensus 
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ensemble that may have comparable or higher predictive power and coverage than separate 
models.  
The shortcomings of individual structural alerts can also be avoided using a new approach 
called chemical biological read-across (CBRA). In contrast to classical read-across that 
predicts the toxicity of unknown compounds from their chemical analogues, CBRA uses both 
chemical and biological analogues, which achieves more accurate and reliable predictions 
(Low et al., 2014). The similarities between chemicals are assessed in CBRA based on two 
factors: chemical and biological. The chemical descriptors are usually obtained as computed 
structural and molecular properties while the biological descriptors can be obtained by 
experiment or the predicted result of biological measurement of chemical compounds. CBRA 
can achieve more understanding towards the prediction of complex toxicity, which is why it is 
described as “next generation read-across” (Low et al., 2014). As shown in Figure 6.2, CBRA 
represents the data for the user as a radial plot where the compound of interest is represented 
by a large central node. The chemical and biological nearest neighbours to the compound of 
interest are represented by smaller nodes surrounding the central node. The level of similarity 
of the biological and chemical neighbours to the compound of interest is visualised by two 
indicators. First, by the colour of the neighbouring node, indicating its observed activity 
(red=toxic, green=non-toxic) and second, by the relative position of the neighbouring node 
relative to the central node. The more similar two compounds are, the closer the neighbouring 
node is to the central node. In the radial plot, the nearest neighbour to the compound of interest 
in both chemical and biological descriptor space will be at the 12 o’clock position. CBRA 
provides a better understanding of the structure-activity relationship of the compound of 
interest, or for a group of similar compounds, thanks to its visual radial plots. The visual aspect 
makes it very useful for understanding the common chemical and biological neighbours and 
the activity landscape of the compound of interest, and this will help in the design of greener 
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chemicals.  The chemical and biological models may show conflicting predictions when they 
are used as separate models; this aspect is solved by CBRA as it maximises the integration of 
both data streams.  
 
Figure 6.2. Eugenol radial CBRA plot showing its biological neighbours (left side) and 
chemical neighbours (right side) coloured based on their activity (red=toxic , green=non-toxic) 
(as per Alves et al., 2016). 
 
 
6.2.2 Refinement of poorly predictive structural alerts for carcinogenicity and mutagenicity: 
The analysis presented in Chapters 3 and 5 of the performance of the available profilers for 
carcinogenicity and mutagenicity yielded 28 poorly predictive mutagenic structural alerts and 
eight poorly predictive carcinogenic structural alerts (see Tables 3.12, 5.4 and 5.5). The work 
demonstrated the importance of continued analysis and assessment of the accuracy of current 
profilers within various in silico programmes such as Toxtree and the OECD QSAR Toolbox 
to improve their reliability. Therefore, it is envisaged that future work will involve further 
investigations to identify other shortcomings associated with the alerts.. All this information 
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will identify the core issues and pave the way for their improvement. The identified alerts with 
poor predictivity could also be used to determine whether there are certain structural features 
linked to over-predictions in terms of false positive (or false negative) results.  
 6.2.3 Use of in vitro/in chemico data to discern mechanistic information for chemistry-based 
alerts 
The work performed in Chapter 4 enabled the development of 17 carcinogenic scaffolds and 
23 mutagenic scaffolds that are chemistry-based structural alerts and as such do not have a 
mechanistic basis associated with them. As the chemistry-based structural alerts can trigger 
predictions for various types of chemicals, the probability that they will be useful in identifying 
carcinogenicity or mutagenicity via more than one mechanism is higher than that of the 
mechanism-based structural alerts. In view of this, the chemistry-based structural alerts can be 
refined in conjunction with mechanism-based alerts to increase their reliability and accuracy. 
This could also be done by further combining in vitro and in chemico data to separate the 
mechanistic information for each chemical structure, which may have the same chemical alert 
but initiate a different MIE (see Table 6.1 for some in chemico approaches). The association of 
a mechanistic hypothesis with each chemical structure will eventually solve the issues 
associated with structural alerts that may exert their action via multiple mechanisms and thus 
help in refining the usefulness of chemical-based alerts for toxicity assessment of untested 
chemicals.  
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Table 6.1. Examples of in chemico reactivity for mutagenicity and skin sensitisation 
measured during non-pharmaceutical research and development (Cronin et al., 2009). 
 
Toxicity 
endpoint  
In chemico approach 
DNA binding 
 
Reactivity toward 2 ́-deoxyguanosine 
 
 
 
Skin 
sensitisation 
Depletion of glutathione assessed by using UV 
Rate constant for reaction with n-butylamine (as part of the Relative 
Alkylation Index, RAI) 
 
High-throughput kinetic profiling approach for covalent binding to 
peptides, providing second-order rate constants 
 
 
6.2.4 Development of additional carcinogenic and mutagenic alerts: 
Although the work carried out in this thesis has developed a number of chemistry based 
structural alerts for carcinogenicity and mutagenicity, the need to develop additional alerts, both 
mechanistically and chemically based, to cover the relatively small chemical space is still high. 
Databases such as ToxCast, ChEMBL, TGGates can be used to develop additional mechanism- 
and chemistry- based alerts. In the Toxcast databases nearly 2,000 chemicals from a wide range 
of different sources were evaluated, including: industrial and consumer products, food additives 
and potentially "green" chemicals that could be safer alternatives to existing chemicals. 
Chemicals were evaluated in over 700 high-throughput assays covering a range of high-level 
cellular responses and approximately 300 signalling pathways (Epa.gov, 2015). This database 
contains a large number of assays for binding to the peroxisome proliferator activated receptor 
(PPAR) which is one of the main non-genotoxic carcinogenic mechanisms. The data are freely 
available at http://www.epa.gov/ncct/toxcast/. 
 It is envisaged that the scaffold analysis process used in Chapter 4 could be used to develop one 
or more new carcinogenic and mutagenic structural alerts.. Thus, it is expected that adding 
further structural alerts to current carcinogenicity and mutagenicity profilers would expand the 
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chemical domain covered by these profilers and reduce the false negative results in the in silico 
profilers. It is envisaged that carcinogenicity and mutagenicity structural alerts (both those 
derived in this thesis and those that could be developed in future) can be used in in silico 
predictive tools such as the OECD QSAR Toolbox or predictive software such as KNIME. 
Several benefits might be achieved using these newly developed structural alerts. First, they can 
be used to screen chemical inventories in order to detect and identify chemicals having the 
potential to induce carcinogenicity and mutagenicity. Second, these alerts, in combination with 
other alternative techniques and information obtained from the scientific literature, could help 
in the development of AOPs for other mechanisms of carcinogenicity, especially for non-
genotoxic carcinogens.   
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Appendix I. List of the 43 inorganic mutagenic chemicals in CCRIS DB that failed to be 
identified by any of six mutagenic profilers in the OECD QSAR Toolbox (Chapter 3). 
ID Chemical Name SMILES 
1 Sodium nitrite [Na+].[O-]N=O 
2 Ozone [O-][O+]=O 
3 Sodium selenite [Na+].[Na+].[O-][Se]([O-])=O 
4 Cadmium chloride Cl[Cd]Cl 
5 Selenic acid  [Na+].[Na+].[O-][Se]([O-])(=O)=O 
6 Diborane BB 
7 Lead [Pb] 
8 Cadmium; Cadmium compounds [Cd] 
9 Selenium Sulfide S=[Se] 
10 Aluminum chloride  Cl[Al](Cl)Cl 
11  Potassium bromate [K+].[O-]Br(=O)=O 
12 Zirconium, dichloro-di-pi-cyclopentadienyl Cl[Zr](Cl)(C1C=CC=C1)C1C=CC=C1 
13 Titanium, dichlorobis(eta5-2,4-cyclopentadien-1-yl) Cl[Ti](Cl)(C1CC=CC=1)C1CC=CC=1 
14 Magnesium oxide (MgO) O=[Mg] 
15 Hypochlorous acid [Na+].[O-]Cl 
16 Hydrogen peroxide,  OO 
17 Potassium nitrite  [K+].[O-]N=O 
18 Cyanoguanidine NC(=N)NC#N 
19 Manganese [Mn] 
20 Manganese chloride  Cl[Mn]Cl 
21 Manganese(II) sulfate  [Mn+2].[O-]S([O-])(=O)=O 
22 Nickel chloride (NiCl2) Cl[Ni]Cl 
23 Permanganic acid (HMnO4) [K+].[O-][Mn](=O)(=O)=O 
24 Platinate(2-), hexachloro-, dihydrogen, hexahydrate [H+].[H+].O.O.O.O.O.O.Cl[Pt-
2](Cl)(Cl)(Cl)(Cl)Cl 
25  Dipotassium hexachloroplatinate [K+].[K+].Cl[Pt-2](Cl)(Cl)(Cl)(Cl)Cl 
26 Potassium tetrachloroplatinate(II) [K+].[K+].Cl[Pt-2](Cl)(Cl)Cl 
27  cis-Dichlorobis(2-methyl-2-propanamine)platinum Cl[Pt]Cl.CC(C)(C)N.CC(C)(C)N 
28  Platinum, diamminedibromo-, (SP-4-2)- (9CI) N.N.[Br-].[Br-].[Pt+2] 
29  Dichloro-(S,S)-(N,N'-diethyl-2,4-pentanediamine)platinum(II) [Cl-].[Cl-].[Pt+2].CCNC(C)CC(C)NCC 
30 Potassium superoxide;  [K+].O=O 
31 Triammonium hexachlororhodate; Rhodate(3-),  [N+H4].[N+H4].[N+H4].[Cl-].[Cl-].[Cl-
].[Cl-].[Cl-].[Cl-].[Rh+3] 
32 Dipotassium pentachlororhodate [K+].[K+].Cl[Rh-2](Cl)(Cl)(Cl)Cl 
33 Silane [Si] 
34 Silane, dichloromethylvinyl C[Si](Cl)(Cl)C=C 
35 Silver iodide (AgI) [Ag]I 
36 Sodium sulfide, nonahydrate O.O.O.O.O.O.O.O.O.[Na+].[Na+].[S-2] 
37 Titanium chloride (TiCl3) Cl[Ti](Cl)Cl 
38 Ammonium Hexachloroplatinate (iv) [N+H4].Cl[Pt-2](Cl)(Cl)(Cl)(Cl)Cl 
39  Boric acid, sodium salt [Na+].[Na+].[Na+].[O-]B([O-])[O-] 
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40 Bis(chlorotriammineplatinum) tetrachloroplatinate(II) N.N.N.N.N.N.Cl[Pt+3].Cl[Pt+3].Cl[Pt-
2](Cl)(Cl)Cl.Cl[Pt-2](Cl)(Cl)Cl.Cl[Pt-
2](Cl)(Cl)Cl 
41 Bis(p-methoxyphenyl)selenide COc1ccc([Se]c2ccc(OC)cc2)cc1 
42 cis-Dichlorobis(3,5-dimethylpyridine)platinum Cl[Pt]Cl.Cc1cncc(C)c1.Cc1cncc(C)c1 
43 Dichloro-(s)-3-aminohexahydropyridine Platinum (ii) Cl[Pt]Cl.NC1CCCCN1 
 
 
Appendix II. List of the 112 various organic mutagenic chemicals in CCRIS DB that failed to 
be identified by any of six mutagenic profilers in the OECD QSAR Toolbox and do not have 
any chemical unifying characters to be grouped or used to initiate a new rule for a new chemical 
structural alert (Chapter 3). 
ID Chemical Name SMILES 
1 2-Mercaptobenzothiazole S=C1Nc2ccccc2S1 
2 Thiodiphosphoric acid (((HO)2P(S))2O), 
tetraethyl ester (9CI) 
CCOP(=S)(OCC)OP(=S)(OCC)OCC 
3 1,3-Dioxane C1COCOC1 
4  1,2,3,5-Tetramethylbenzene Cc1cc(C)c(C)c(C)c1 
5 1-Naphthalenol, methylcarbamate;  CNC(=O)Oc1cccc2ccccc12 
6 Cyclohexanone, oxime ON=C1CCCCC1 
7 Dicyclohexylamine C1CCC(CC1)NC1CCCCC1 
8 1,3-Diphenylguanidine N=C(Nc1ccccc1)Nc1ccccc1 
9 Ferrocene [Fe+2].c1cc[c-H]c1.c1cc[c-H]c1 
10 1,3-Butadiene C=CC=C 
11 Acrylonitrile C=CC#N 
12 Propargyl alcohol OCC#C 
13  Acetaldehyde oxime CC=NO 
14 o-Chloropyridine Clc1ccccn1 
15 Butyraldehyde oxime CCCC=NO 
16 Propene CC=C 
17 Benzothiazyl disulfide S(Sc1nc2ccccc2s1)c1nc2ccccc2s1 
18  Methyl styryl ketone CC(=O)C=Cc1ccccc1 
19 Decane CCCCCCCCCC 
20 2',3',4'-Trichloroacetophenone CC(=O)c1ccc(Cl)c(Cl)c1Cl 
21 3-((Methoxycarbonyl)amino)phenyl N-(3-
methylphenyl)carbamate (phenmedipham) 
COC(=O)Nc1cccc(OC(=O)Nc2cccc(C)c2)c1 
22 2-Methyl-3-butenenitrile CC(C=C)C#N 
23 Phthalide, 3-propylidene (6CI,8CI) CCC=C1OC(=O)c2ccccc12 
24 Benzenamine, 4-butyl-N-((4-
methoxyphenyl)methylene) 
CCCCc1ccc(cc1)N=Cc1ccc(OC)cc1 
25 Di(N-octyl)tin-S,S'-
bis(isooctylmercaptoacetate) 
CCCCCCCC[Sn](CCCCCCCC)(SCC(=O)OC(C)CC
CCCC)SCC(=O)OC(C)CCCCCC 
26 4-Butyloxybenzal-4'-ethylaniline CCCCOc1ccc(cc1)C=Nc1ccc(CC)cc1 
27 Trans-2,3-dibromo-2-butene-1,4-diol OCC(Br)=C(Br)CO 
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28 Pentanedinitrile, 2-methyl- CC(CCC#N)C#N 
29  Linolenic acid (8CI) CCC=CCC=CCC=CCCCCCCCC(O)=O 
30 3-Pentenenitrile; pent-3-enenitrile CC=CCC#N 
31  Bromopicrin [O-][N+](=O)C(Br)(Br)Br 
32 1,3,5-Tris(hydroxy-ethyl)s-hexahydrotriazine OCCC1NC(CCO)NC(CCO)N1 
33 Trimethylene oxide (8CI) C1COC1 
34 Trimethyloxonium hexachloroantimonate(1-) C[O+](C)C.Cl[Sb-](Cl)(Cl)(Cl)(Cl)Cl 
35 Allyl urea NC(=O)NCC=C 
36 Urea NC(N)=O 
37 2-Chloro-2-nitropropane CC(C)(Cl)[N+]([O-])=O 
38 1,1-Dichloro-1-nitroethane CC(Cl)(Cl)[N+]([O-])=O 
39 Methyl sulfoxide C[S+](C)[O-] 
40 1,4-Benzenediamine, N,N'-diphenyl- N(c1ccccc1)c1ccc(Nc2ccccc2)cc1 
41 2,6-Octadiene, 1,1-diethoxy-3,7-dimethyl- CCOC(OCC)C=C(C)CCC=C(C)C 
42  Chloropicrin [O-][N+](=O)C(Cl)(Cl)Cl 
43 o-Tolyl phosphate Cc1ccccc1OP(=O)(Oc1ccccc1C)Oc1ccccc1C 
44 Methacrylic acid CC(=C)C(O)=O 
45 Benzoic acid, p-(dichlorosulfamoyl) OC(=O)c1ccc(cc1)S(=O)(=O)N(Cl)Cl 
46 1,3-Dimethyl-2-nitrobenzene Cc1cccc(C)c1[N+]([O-])=O 
47  1-Chloronaphthalene Clc1cccc2ccccc12 
48  N,N'-Di-2-naphthyl-p-phenylenediamine N(c1ccc(Nc2ccc3ccccc3c2)cc1)c1ccc2ccccc2c1 
49 2,3,6-Trichlorophenol Oc1c(Cl)ccc(Cl)c1Cl 
50 2,4,5-Trichlorophenol Oc1cc(Cl)c(Cl)cc1Cl 
51 Butanone oxime CCC(C)=NO 
52 2,2'-Methylene-bis (4-chlorophenol) Oc1ccc(Cl)cc1Cc1cc(Cl)ccc1O 
53  2-Vinylpyridine C=Cc1ccccn1 
54 Bis(cyclopentadienyl)vanadium chloride Cl[V](Cl)(C1C=CC=C1)C1C=CC=C1 
55 Bis(1,5-cyclooctadiene)nickel [Ni].C1CC=CCCC=C1.C1CC=CCCC=C1 
56 (1S,4S,4aS,6S,8aS)-4-isopropyl-1,6-
dimethyldecahydronaphthalene 
CC1CCC2C(C)CCC(C(C)C)C2C1 
57 2-Methylpropanenitrile CC(C)C#N 
58 C.I. Natural Orange 4 CC(C=CC=C(C)C=CC(O)=O)=CC=CC=C(C)C=CC
=C(C)C=CC(O)=O 
59 Retinol palmitate CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C
(C)C=CC1=C(C)CCCC1(C)C 
60 MENTHONE CC(C)C1CCC(C)CC1=O 
61 sodium dimethyldithiocarbamate [Na+].CC(C)C([S-])=S 
62 Anisole, p-propenyl-, trans-;  COc1ccc(C=CC)cc1 
63 Biphenyl-4-ol Oc1ccc(cc1)-c1ccccc1 
64 5-beta-Cholan-24-oic acid, 3-alpha,7-alpha-
dihydroxy- 
CC(CCC(O)=O)C1CCC2C3C(O)CC4CC(O)CCC4(
C)C3CCC12C 
65 Deterrol CC(=C)c1ccc(C)c2ccc(CO)c2c1 
66 7H-Benz(de)anthracen-7-one O=C1c2ccccc2-c2cccc3cccc1c32 
67  1,2,3-Trimethylbenzene Cc1cccc(C)c1C 
68 2,3'-bipyridine c1ccc(nc1)-c1cccnc1 
69 4,4'-bipyridine c1cc(ccn1)-c1ccncc1 
70  tributylborane CCCCB(CCCC)CCCC 
71 2-Nitrobutane CCC(C)[N+]([O-])=O 
72 2(1H)-Quinolinone O=C1Nc2ccccc2C=C1 
73 Ursodeoxycholic acid CC(CCC(O)=O)C1CCC2C3C(O)CC4CC(O)CCC4(
C)C3CCC12C 
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74 Deoxycholic acid CC(CCC(O)=O)C1CCC2C3CCC4CC(O)CCC4(C)C
3CC(O)C12C 
75 Cholic acid CC(CCC(O)=O)C1CCC2C3C(O)CC4CC(O)CCC4(
C)C3CC(O)C12C 
76 1,3,5-Cycloheptatriene, 1-methoxy- COC1CC=CC=CC=1 
77 nitrocyclopentane [O-][N+](=O)C1CCCC1 
78 Nitrocyclopentane nitronate [O-][N+]([O-])=C1CCCC1 
79 1,3-dithiane C1CSCSC1 
80 p-Dithiane C1CSCCS1 
81 Isonicotinaldehyde oxime ON=Cc1ccncc1 
82  Naphthoresorcinol Oc1cc(O)c2ccccc2c1 
83 1,6-Naphthalenediol Oc1ccc2c(O)cccc2c1 
84 Sesquiterpene, stearic acid ester CCCCCCCCCCCCCCCCCC(=O)OCC1=CC=C2C(
C)=CCC(C=C12)C(C)=C 
85 1H-Phenalen-2-amine, 2,3-dihydro-N-
methyl-, hydrochloride 
Cl.CNC1Cc2cccc3cccc(C1)c23 
86  Phenalen-1-one O=C1C=Cc2cccc3cccc1c23 
87 Bithionol sulfoxide Oc1c(Cl)cc(Cl)cc1[S+]([O-])c1cc(Cl)cc(Cl)c1O 
88 Phosphoramidothioic acid, O,S-dimethyl 
ester 
COP(N)(=O)SC 
89  2-Nitropropane nitronate CC(C)=[N+]([O-])[O-] 
90  1,6-Pyrenequinone O=C1C=Cc2ccc3C(=O)C=Cc4ccc1c2c43 
91 1,8-Pyrenequinone O=C1C=Cc2ccc3C=CC(=O)c4ccc1c2c34 
92 2,3-dichloropyridin Clc1cccnc1Cl 
93 Pyridine, 2-fluoro- Fc1ccccn1 
94 1-Methyl-4-phenyl-2,3-dihydropyridinium 
perchlorate 
[O-]Cl(=O)(=O)=O.C[N+]1CCC(=CC=1)c1ccccc1 
95 Thiazolidine C1CSCN1 
96  Vanadic acid, ammonium salt N.O[V](=O)=O 
97 2-Mercaptoethanol thionitrite OCCSN=O 
98 Chlorinated trisodium phosphate [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].
[Na+].[Na+].[Na+].[Na+].[Na+].[O-]Cl.[O-]P([O-
])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-
])=O.[O-]P([O-])([O-])=O 
99 3,3'-Dipyridyl c1cncc(c1)-c1cccnc1 
100 2,4'-Dipyridyl c1ccc(nc1)-c1ccncc1 
101 1,4-pentadiene-3-ol; Penta-1,4-dien-3-ol OC(C=C)C=C 
102  4-Biphenylyl methylcarbamate CNC(=O)Oc1ccc(cc1)-c1ccccc1 
103 1,2,3,4,4a,10a-hexahydrophenanthrene C1CCC2C(C1)C=Cc1ccccc21 
104 1,2,3,9,10,10a-hexahydrophenanthrene C1CC=C2C(C1)CCc1ccccc12 
105 1,1'-Dimethyl-3,3'-bipyridinium diiodide [I-].[I-].C[n+]1cccc(c1)-c1ccc[n+](C)c1 
106 4-(2'-Pyridyl)-1-methylpyridinium iodide [I-].C[n+]1ccc(cc1)-c1ccccn1 
107 (4aR,10aS)-6-methoxy-1,2,3,4,4a,10a-
hexahydrophenanthrene 
COc1ccc2C=CC3CCCCC3c2c1 
108  9-Methyl-trans-1,2,3,4,4a,10a-
hexahydrophenanthrene 
CC1=CC2CCCCC2c2ccccc12 
109  4-(1-phenylureido)benzoic acid NC(=O)N(c1ccccc1)c1ccc(cc1)C(O)=O 
110 10-Methoxyacenaphtho(1,2-b)quinoline COc1ccc2nc3c(cc2c1)-c1cccc2cccc-3c21 
111  4-(5-cyano-3-oxopentyl)benzoic acid OC(=O)c1ccc(CCC(=O)CCC#N)cc1 
112  2,5,9,11-Tetramethyl-5H-quinindoline CC1C2C(=Nc3ccc(C)cc23)N(C)c2ccc(C)cc12 
 
